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Abstract	
Stx	bacteriophages	are	responsible	for	the	dissemination	and	production	of	Shiga	toxin	 genes	 (stx)	 across	 the	 Shigatoxigenic	 	E.	 coli	(STEC).	 These	 toxigenic	bacteriophage	 hosts	 can	 cause	 severe,	 life-threatening	 illness,	 and	 Shiga	 toxin	(Stx)	is	responsible	for	the	severe	nature	of	EHEC	infection,	a	subset	of	pathogenic	STEC.	At	 the	point	 of	 Stx	 phage	 infection,	 the	 injected	phage	DNA	 can	direct	 its	integration	 into	the	bacterial	chromosome	becoming	a	prophage;	 the	host	cell	 is	then	 known	 as	 a	 lysogen.	 Unusually,	 our	model	 Stx	 phage,	Φ24B,	 can	 integrate	into	 at	 least	 four	 distinct	 sites	 within	 the	E.	 coli	genome	 that	 shared	 no	 easily	identifiable	recognition	sequence	pattern.	The	 identification	of	what	are	actually	required	 for	 phage	 and	 bacterial	 DNAs	 recombination	 has	 been	 tested	 using	both	in	 vitro	and	in	 situ	recombination	 assays.	 These	 assays	 enabled	 the	 simple	manipulation	of	bacterial	attachment	site	(attB)	and	phage	attachment	site	(attP)	sequences.		The	aim	of	the	study	is	to	fully	characterize	the	requirements	of	this	promiscuous	integrase,	 carried	by	 the	Stx	phage	Φ24B	(IntΦ24B),	 to	drive	 integration.	These	assays	 enabled	 us	 to	 identify	 the	 minimal	 necessary	 flanking	 sequences	for	attB	site	 identified	 (21	 bp	 and	 49	 bp	 from	 the	 right	 and	 left	 the	 cross	 over	region,	 respectively)	 and	 the	attP	site	 (200	 bp	 each	 side).	 Furthermore,	 we	identified	that	the	Φ24B	integrase	does	not	need	Integration	Host	Factor	(IHF)	to	drive	integration.			Finally,	 as	 this	 integrase	 can	 integrate	 the	 phage	 genome	 inside	 at	 least	 four	different	bacterial	attachment	sites	(attBs),	these	sites	were	identified,	sequenced	and	cloned	in	different	compatible	plasmids	to	be	transformed	to	one	cell,	and	the	frequency	and	preference	of	each	recombination	were	tested	by	means	of	qPCR.	The	results	showed,	the	recombination	with	secondary	attachment	sites	was	less	frequent	than	that	with	the	primary	site.	Furthermore,	within	five	minutes,	there	was	also	a	preference	of	site,	as	recombination	occurred	in	both	attB1	and	attB2,	while	 recombination	 with	 the	 attB4	 and	 attB3	 sites,	 took	 1	 hour	 and	 2	 hours,	respectively.	
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CHAPTER	1. INTRODUCTION		
1.1	Viruses	
	Viruses	 are	 the	 most	 abundant	 biological	 agents	 on	 the	 planet	 (Wilhelm	 and	Suttle	 1999).	 They	 cannot	 replicate	 and	 produce	 new	 progeny	 without	 first	infecting	and	replicating	inside	another	organism’s	living	cells.	They	can	infect	all	types	 of	 life	 forms	 from	 plants	 and	 animals	 to	 microorganisms	 like	 protozoa,	bacteria	and	archaea	(Lawrence	et	al.,	2009).	Every	studied	cellular	organism	has	its	own	viruses	or	virus-like	genetic	elements	(Fauquet	and	Fargette,	2005).	Since	they	were	first	described	in	1892	(Iwanowski,	Sept.	1892),	more	than	5000	viral	species	 have	 been	 described	 in	 details	 (Breitbart	 and	 Rohwer,	 2005).	 Viruses	possess	 a	 variety	 of	 genetic	 replication	 and	 expression	mechanisms	 (Fig.1.1)	 in	contrast	 to	 the	 uniformity	 of	 the	 cellular	 genetic	 cycles	 (DNAÞRNAÞProtein)	(Carter	and	Saunders,	2007).	
	
When	 the	 virus	 is	 not	 inside	 an	 infected	 living	 cell,	 they	 exist	 in	 the	 form	 of	particles	 known	 as	 virions,	 which	 are	 composed	 of	 two	 or	 three	 parts;	 double	stranded	or	single	stranded,	DNA	or	RNA	genomic	material	and	the	capsid,	which	is	a	protein	coat	that	surrounds	and	protects	the	genetic	material.	In	some	cases,	viruses	 have	 an	 envelope	 of	 lipids	 that	 surrounds	 the	 inside	 or	 outside	 of	 the	capsid	 when	 the	 virus	 is	 outside	 their	 host	 cells	
2	
	
	
Figure	 1.1.	 Schematic	 diagram	 explaining	
transcription	of	virus	genomes.	According	 to	 the	difference	 in	 their	 genome	 composition,		transcription	 of	 the	 viral	 genome	 can	 be	classified	into	seven	classes.	 	The	class	I	viruses	have	 dsDNA	 genome	 (Red	 color)	 and	transcription	 is	 similar	 to	 that	 of	 the	 higher	organisms	 that	 have	 dsDNA.	 The	 genomes	 of	most	of	these	viruses	have	open	reading	frames	(ORFs)	 in	 both	 directions,	 which	 is	 the	 reason	behind	 why	 (-)	 and	 (+)	 are	 not	 indicated	 for	dsDNA.	 Class	 II	 have	 genomes	 with	 either	 (+)	which	 means	 they	 have	 same	 sequence	 as	 the	mRNA	 (except	 that	 thymine	 replaces	 uracil),	 or	(-)	 (orange	 color)	 which	 means	 these	 viruses	have	 ssDNA	 sequence	 complementary	 to	 the	mRNA.	Class	IV	Vial	genomes	with	(+)	RNA	have	the	same	sequence	as	the	mRNA,	while	classes	V	viruses	 with	 (-)	 RNA	 have	 the	 sequence	complimentary	 to	 the	 mRNA.	While	 both	 of	 (-)	and	 (+)	RNAs	 sequences	are	present	 in	class	 III	dsRNA	 (blue	 color)	 genome	 viruses.	 	 Class	 VI	viruses	 genome	have	 the	same	 sequence	 as	 the	mRNA,	 however,	 unlike	 class	 IV	 (+)RNA,	 its	genome	 transcribes	 to	 give	 (-)DNA	 	 in	 stead	 of			(-)RNA	 in	 class	 IV.	 In	 Class	 VII	 genome	transcription,	the	(+)	RNA	shown	in	blue	color	is	a	 pregenome	 RNA,	 functions	 as	 a	 template	 for	DNA	synthesis.		(Adapted	from	Carter	and	Saunders,	2007)	
3	
	
(Prescott	 et	 al.,	 2002).	 Virus	 particles	 are	 diverse	 in	 their	 shapes,	 which	 range	from	 simple	 helical	 and	 icosahedral	 forms	 for	 some	 viral	 species	 to	 more	complicated	structures	for	other	viruses.	Most	virus	species	have	virions	that	are	too	small	to	be	seen	with	an	optical	microscope,	their	sizes	ranging	from	20-300	nm	in	diameter	(Prescott	et	al.,	2002).	
	
In	summary,	viruses	differ	from	other	eukaryotic	or	prokaryotic	living	cells	in	at	least	 three	 things:	 1)	 their	 simple	 non-cellular	 organization,	 2)	 the	 presence	 of	either	 DNA	 or	 RNA	 as	 genetic	material	 but	 not	 both	 and	 3)	 they	 are	 unable	 to	replicate	independently	of	a	host	cell	as	eukaryotes	and	prokaryotes	do	(Prescott	et	al.,	2002).		
	
1.1.1	Bacteriophages	
The	majority	of	viruses	are	that	infect	and	replicate	inside	bacterial	cells	(Hambly	and	 Suttle,	 2005).	 These	 viruses	 are	 called	 bacteriophages	 or	 phages	 for	 short.	Phage	 infection,	 for	 all	 bacteriophages,	 can	 lead	 to	 the	 production	 of	 progeny	phages	 via	 the	 lytic	 replication	 cycle.	 Lytic	 replication	 describes	 the	 process	 by	which	the	phage	uses	the	bacterial	host	cell	as	a	factory	in	order	to	produce	new	phage	 capsids,	 tails	 and	 other	 structural	 proteins	 to	 form	 new	 phage	 particles	within	 the	 bacterium	 (Fig.	 1.2).	 These	 particles	 are	 often	 released	 by	 phage-directed	lysis	of	the	host	cell,	resulting	in	the	escape	of	~100	progeny	phages	per	infected	 host	 cell	 (Bradley,	 1967).	 However,	 not	 all	 bacteriophage	 immediately	
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replicate	upon	entering	a	host	cell.	Some	phage,	like	P1	phage,	inject	their	genome	into	 their	 host	 cell	 where	 the	 genome	 becomes	 an	 extrachromosomal	 episome	capable	 of	 self	 replication	 and	 thus	 part	 of	 the	 genome	of	 the	 infected	host	 cell	(Ikeda	and	Tomizawa,	1968)	
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Figure	 1.2.	 The	 temperate	 bacteriophage	 lytic	 and	 lysogenic	 cycle.	 There	 are	 two	 pathways	 that	 generally	 govern	 bacteriophage	replication	once	the	viral	genome	has	entered	the	bacterial	host	cell.		1)	The	lytic	cycle	(left	side)	uses	the	bacterial	cell	as	a	factory	in	order	to	produce	new	phage	capsids,	tails,	other	structural	proteins	and	new	viral	genome	copies	in	order	to	form	new	phage	particles	within	the	bacterium.		If	the	host	cell	is	E.	coli	this	process	can	take	around	45	minutes	before	phage	proteins	direct	the	lysis	of	the	host	cell,	releasing	~100	progeny	phages.	2)	The	lysogenic	replication	cycle	(right	side)	can	also	occur.		The	entering	phage	genome	integrates	itself	within	the	bacterial	genome,	becoming	a	prophage	and	changing	its	host	cell	into	a	lysogen.		The	health	of	the	host	cell	and	the	ratio	of	phages	to	host	cell	numbers	at	 the	point	of	 infection	 can	 influence	which	pathway	 is	 taken,	 though	 the	 lytic	 cycle	 is	more	 frequently	 taken	by	Lambda	phage	(Adapted	from	Campbell,	2003).		
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Sometimes	 the	 injected	 phage	 DNA	 directs	 its	 integration	 into	 the	 host	 cell’s	genome	where	it	becomes	known	as	a	prophage,	and	its	host	cell	becomes	known	as	a	 lysogen.	Phages	capable	of	becoming	a	stable	part	of	 the	host	cell’s	genome	are	known	as	temperate	phage	(Hendrix,	1983).	The	prophage	is	passed	along	to	other	daughter	cells	of	the	lysogen	and	thus	the	prophage	replicates	passively,	but	concomitantly	with	the	lysogen	(Fig.	1.2).		
	
1.1.2	Temperate	Bacteriophages	
Temperate	phages	are	 capable	of	 entering	either	 the	 lytic	or	 lysogenic	 life	 cycle	once	 their	 DNA	 is	 injected	 in	 the	 host	 cytoplasm	 (Fig.	 1.2)(Kaiser,	 1957).	Temperate	 phage	 carry	 at	 least	 one	 gene	 capable	 of	 stabilizing	 the	 prophage	sequences	within	 the	 lysogen’s	 genome	 (Hendrix,	 1983).	 And	 then	 they	 rely	 on	the	activity	of	prophage	encoded	repressors	 to	block	 the	viral	genes	 involved	 in	lytic	 replication(Madsen	 et	 al.,	 1999).	 In	 the	 lysogen,	with	 the	 exception	 of	 one	prophage	gene,	all	prophage	gene	expression	is	turned	off.	The	protein	product	of	this	single	expressed	gene	provides	immunity	to	superinfection	against	incoming	homoimmune	phages	by	ensuring	all	genes	in	the	incoming	phage	are	repressed.	The	prophage	genome	is	passively	replicated	as	part	of	the	lysogen’s	genome	and	distributed	to	the	offspring	bacterial	cells	as	the	lysogen	grows	and	divides	(Fig.	1.2).	 Though	 it	 is	 possible	 to	 turn	 on	 the	 lytic	 replication	 mechanism	 of	 the	prophage,	 a	 process	 known	as	 induction.	 The	prophage	 is	 rarely	 induced	 in	 the	lysogenic	 daughter	 cells,	 and	 the	 passive	 replication	 of	 the	 prophage	 might	 be	
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repeated	 indefinitely	 (Hendrix,	 1983).	 The	 lytic	 and	 lysogenic	 pathways	 are	controlled	by	a	number	of	specific	factors	that	must	be	synthesized	in	the	phage-infected	host	to	direct	either	lytic	or	lysogenic	replication	of	the	infecting	phage.	
	
1.2	Lambda	phage,	the	archetypal	lambdoid	phage	
Lambda	 phage, ",	 the	 archetype	 of	 phages	 within	 the	 lambdoid	 family,	 was	 the	first	 temperate	 phage	 discovered	 in	 the	 early	 1960s	 (Hendrix,	 1983).	 Its	regulatory	 and	 replication	 mechanisms	 have	 been	 well	 understood	 following	more	than	60	years	of	extensive	studies	(Court	et	al.,	2007).	 	This	bacteriophage	being	 a	 temperate	 phage,	 follows	 either	 a	 lytic	 or	 lysogenic	 lifecycle	 inside	 its	bacterial	 host	 cell,	Escherichia	coli.	 As	 a	 result	 of	 all	 of	 this	work,	"	has	 become	useful	 and	 important	 to	 understanding	 molecular	 microbiology	 fields;	 like	detection	of	frameshift	mutation		(Hendrix	and	Duda,	1992),	DNA	recombination	(Meselson	 and	 Weigle,	 1961;	 Signer	 and	 Weil,	 1968),	 and	 	 Horizontal	 gene	transfer	(Young	et	al.,	1979).	
	
Lambda	 phage	 possesses	 an	 icosahedral	 head	 (capsid)	 of	 about	 50-60	 nm	 in	diameter.	 	The	components	of	 this	capsid	are	encoded by ten head genes (Nu1, A, W, 
B, C, Nu3, D, E, FI, and FII) (Fig.1.3).  The phage also possesses	 a	 long,	 flexible	 tail	of	 about	 150	 nm	 length,	 which is encoded by 12 genes (Z, U, V, G, T, H, M, L, K, I, J, 
lo and stf) (Fig.1.3). The	Lambda	genome	 is	 comprised	of	double-stranded	DNA	of	~48.5	 kb.	 	 This	 DNA	 is	 linear	 when	 packaged	 into	 the	 phage’s	 capsid and	
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circularises	 once	 it	 is	 injected	 into	 the	 host	 cell’s	 cytoplasm	 by	 the	 action	 of	 a	bacterial	enzyme	(E.	coli	DNA	 ligase	 in	 case	of	 lambda	phage	using	 the	cohesive	ends	found	on	the	lambda	genome)(Gellert,	1967).	
	
When	"	phage	 genomic	 DNA	 enters	 the	 host	 cell,	 both	 the	 N	 and	 cro	 genes	 are	immediately	 transcribed,	 after	 the	 binding	 of	 bacterial	 RNA	 polymerase	 to	 the	promoters	PR	and	PL	 in	the	phage	chromosome	(Fig.	1.3).	The	protein	N	is	called	an	anti-terminator	as	it	effectively	turns	on	genes	in	the	phage	DNA	immediately	downstream	of	N	and	cro	by	promoting	the	extension	of	the	mRNAs	of	N	and	cro	beyond	 the	 transcription	 termination	 signals	 that	 lie	 at	 the	 3’	 ends	 of	 these	 2	genes.	The	N	protein	is	able	to	extend	the	length	of	the	transcripts	begun	at	PR	and	PL	due	to	its	ability	to	bind	specific	sequences	called	Nut	(N	utilisation).		
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Figure	1.3.	Lambda	genome	and	transcription	map.	There	are	two	Nut	sites	(red	color),	one	is	located	between	PL	promoter	and	N	gene,	and	the	second	one	 is	 located	 just	 to	the	right	of	cro	gene.	After	the	N	protein	 is	produced,	 it	binds	to	Nut	sites	 in	order	 for	transcription	to	proceed.	This	transcription	 is	enabled	beyond	the	terminators	tR1	and	tL1.	The	early	transcripts	from	PL	and	PR	are	presented	as	red	arrows.		Due	to	the	actions	of	the	N	protein,	cIII,	xis	and	int	genes	are	turned	on	from	PL,	and	cII,	O,	P,	and	Q	genes	are	turned	on	from	PR.		The	terminators	tL1,	tL,	tR1,	tR2,	tR’	are	labeled	with	red	color.	The	late	transcription	from	PR’	is	shown	as	black	arrow.	The	PRM	transcript	activated	by	CI	is	presented	by	green	arrow.	Transcription	activated	by	CII	from	the	promoters	PI,	PRE	and	PAQ	are	shown	with	blue	arrows	(Adapted	from	Court	et	al.,	2007).		
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When	the	N	protein	is	bound	to	the	Nut	sites	RNA	polymerase	can	pass	over	the	terminator	 sequences	 that	 would	 otherwise	 terminate	 transcription.	 The	 Nut	sequences	are	located	between	PL	and	the	end	of	the	N	gene,	and	the	second	one	is	located	 just	 to	 the	 right	 of	 cro	 (Oppenheim	 et	 al.,	 2005;	 Friedman	 and	 Court,	1995).	 In	 the	 early	 infection	 stages,	 and	 due	 to	 the	 action	 of	 the	N	 protein,	 the	genes	cIII,	xis	and	int	are	turned	on	from	PL,	and	cII,	O,	P,	and	Q	genes	are	turned	on	from	 PR.	 The	 balance	 between	 expression	 and	 activities	 of	 these	 various	 gene	products	then	determines	whether	the	infecting	phage	will	replicate	according	to	the	lytic	or	lysogenic	pathways	(Fig	1.3).	
	
1.2.1	Lambda	lytic	cycle	
The	lytic	replication	cycle	of	lambda	phage	becomes	the	preferred	pathway	when	high	 levels	of	Q	 protein	are	 expressed	 from	 the	PR	promoter,	which	enables	 the	activation	of	the	late	gene	promoter	by	Q.		The	late	gene	promoter,	controlled	by	Q,	is	responsible	for	the	production	of	the	structural	proteins,	which	comprise	the	capsid	and	tail	structures	and	the	expression	of	the	proteins	responsible	for	lysis	of	 the	 host	 cell	 (S,	 R,	 Rz	 and	 Rz)	 (Fig.1.3).	 The	 production	 of	 Q	 has	 to	 reach	 a	threshold	level	to	initiate	the	lytic	cycle.	At	that	point,	the	Q	protein,	at	sufficient	levels,	 works	 as	 an	 anti-terminator	 for	 E.	 coli	 RNA	 polymerase	 at	 qut	 sites	 (Q	utilization,	similar	to	Nut	sites.),	which	lie	immediately	downstream	of	the	Q	gene,	at	an	area	called	PR’.	The	promoter	PR’	enables	transcription	the	phage	late	genes	and	enables	subsequent	host	cell	lysis	(Roberts	et	al.,	1998).	
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At	 the	 same	 time,	 the	 expression	 of	 the	 CI	 repressor	 is	 prevented	 due	 to	 the	binding	of	Cro	dimers	to	the	operator	binding	sites	OR3	and	OR2.	Cro	protein	also	binds	to	OL2	and	OL3	to	turn	off	the	PL	promoter,	shutting	off	all	transcription	in	the	 leftward	direction.	At	high	concentrations,	Cro	protein	can	also	binds	to	OR1	preventing	further	Cro	expression	from	PR.	conditions	that	result	in	this	very	high	concentration	of	Cro	are	 the	same	conditions	 that	enable	 the	amount	of	Q	 to	be	sufficient	to	activate	the	production	of	late	genes.	The	transcription	of	genes,	as	a	result	of	Q	activation	from	PR’,	 is	 faster	than	the	transcription	of	genes	activated	by	 N	 (Yang	 et	 al.,	 1987;	 Kobiler	 et	 al.,	 2005).	 Newly	 replicated	 phage	 genome	copies	are	then	encased	into	the	newly	synthesized	capsids,	tails	are	then	added	and	the	phage	directs	the	lysis	of	the	host	cell	with	S,	Rz	and	Rz1,	releasing	all	of	the	newly	synthesized	phage	progeny	(Hendrix,	1983).			
	
1.2.2	Lambda	lysogenic	pathway		
The	 two-phage	 proteins	 necessary	 for	 the	 formation	 of	 stable	 lysogens	 are	integrase	(Int)	and	repressor	(CI).	The	expression	of	these	proteins	is	dependent	on	the	activity	of	another	protein,	CII,	which	is	expressed	the	early	in	the	infection	process	 from	 PR	 after	 N	 alleviates	 the	 tR1	 terminator	 (Fig.	 1.3).	 CII	 is	 a	transcription	 activator	 that	 encourages	 the	 host	 RNA	 polymerase	 to	 initiate	transcription	 at	 three	promoters,	 PInt	,	 PRE	and	PAQ	(Oppenheim	et	 al.,	 2005).	 PInt,	PRE	 and	 PAQ	 are	 phage	 promoters	 that	 control	 the	 transcription	 of	 integrase,	
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repressor	 and	 anti-sense	 Q	 transcripts,	 respectively.	 In	 order	 to	 activate	 the	expression	 from	 these	 promoters,	 CII	 needs	 to	 accumulate	 to	 a	 threshold	 level	within	the	 infected	cell’s	cytoplasm.	The	accumulation	of	CII	 is	 limited	by	a	host	cell	encoded	protease,	HflB	(also	known	as	FtsH).	HlfB	is	capable	of	destroying	CII	by	 cleaving	 the	 carboxy	 terminus	 of	 CII.	 	 The	 phage	 attempts	 to	 limit	 this	degradation	 by	 the	 expression	 and	 action	 of	 the	 CIII	 protein.	 CIII	 inhibits	 HfIB	activity	(Shotland	et	al.,	1997;	Halder	et	al.,	2008;	Herman	et	al.,	1997).	The	levels	of	HflB	are	controlled	by	the	health	of	the	bacterial	cell.	 	So	only	conditions	that	inhibit	the	expression	of	bacterial	HlfB	(e.g.	low	nutrient	availability,	sub-optimal	growth	conditions,	etc)	result	in	conditions	where	CII	survives	and	acts	upon	the	three	promoters,	PInt,	PRE	and	PAQ	(Kobiler	et	al.,	2007;	Kobiler	et	al.,	2002).		
When	 Int	 protein	 is	 produced	 it	 functions	 as	 an	 enzyme	 that	 is	 capable	 of	catalyzing	 site-specific	 recombination	 between	 the	 phage	 and	 bacterial	 host’s	genomes	(Int	function	will	be	discussed	in	1.4.1	Tyrosine	recombinases).	The	gene	
int	is	actually	transcribed	from	two	different	promoters	PL	and	PInt	(Schindler	and	Echols,	 1981).	 Transcription	 that	 begins	 at	 PInt	 is	 actually	 activated	 by	 the	 CII	protein	and	stops	at	the	tL	termination	site	(Fig.	1.3).	While	transcription	that	is	initiated	from	the	PL	promoter	passes	over	the	tL1	site	(due	to	the	function	of	N)	and	transcribes	the	sib	site	which	is	located	downstream	of	int	(Fig.	1.3).	The	sib	site	forms	a	large	loop	structure	on	the	mRNA	that	serves	as	a	target	for	bacterial	RNase	 III.	RNaseIII	 cleaves	 the	 loop	 leaving	 the	end	3’	of	 the	 int	gene	 transcript	
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susceptible	to	degradation	by	polynucleotide	phosphorylase	(PNPase),	that	stops	
int	transcription	(Hendrix,	1983).			
	
In	order	to	stop	expression	of	the	late	genes,	CII	activates	the	PAQ	promoter.	The	product	of	 the	PAQ	promoter	checks	 the	 function	of	Q	protein	by	creation	of	a	Q	antisense	RNA.	This	antisense	transcript	binds	to	the	complementary	5’	end	of	the	
Q	transcript,	resulting	in	the	destruction	of	the	Q	transcript.	
	
The	 third	 promoter	 activated	 by	 CII	 is	 PRE	 (Fien	 et	 al.,	 1984).	 This	 promoter,	named	the	promoter	for	repressor	establishment,	is	responsible	for	enabling	the	expression	 of	 CI,	 the	 lambda	 repressor.	 The	 CI	 protein	 shuts	 off	 all	 gene	expression	 from	 both	 PR	 and	 PL	 by	 binding	 to	 their	 operator	 sites.	 The	 right	operator	region	(OR),	harbors	2	divergent	promoters	(Fig.	1.3),	PRM	and	PR	whose	activities	 are	 controlled	 by	 regulator	 proteins	 (Cro	 and	 CI)	 that	 bind	 specific	combinations	of	binding	sites	known	as	OR1,	OR2	and	OR3.	There	is	also	a	slightly	more	 simple	 operator	 region,	 OL	 which	 harbours	 one	 promoter,	 PL	 whose	transcriptional	activity	is	controlled	by	three	operator	binding	sites,	OL1,	OL2	and	OL3.	 Two	 CI	 dimers	 bind	 cooperatively	 to	 OR1	 and	 OR2	 to	 repress	 PR,	 and	 to	repress	PL,	another	two	CI	dimers	bind	OL1	and	OL2	(Dodd	et	al.,	2004).	The	two	tetramers	 of	 CI	 are	 then	 capable	 of	 binding	 other	 CI	 dimers,	 creating	 a	 loop	between	 both	 operators	 (Fig.	 1.4).	 At	 this	 point,	 due	 to	 the	 repression	 of	 PR	promoter,	there	is	no	more	CII	production	and	CI	transcription	from	PRE	stops.		
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Figure	1.4.	The	lambda	immunity	region.		
A.	 The	 operator	 OR	 is	 composed	 of	 three	 specific	operator	binding	 sites:	OR1,	OR2	and	OR3,	while	OL	composed	 of	 operator	 binding	 sites:	 OL1,	 OL2	 and	OL3.	 The	 promoters	 PL	 (red	 arrow)	 and	 PR	(green	arrow)	 control	 the	transcription	of	 the	early	genes	N	 and	 cIII	 and	 the	 genes	 cro	and	 cII,	 respectively.	The	promoter	PRM	transcribes	cI.	
B.	Looping	of	 the	operators	OR	and	OL	takes	place	after	 the	 repressor	 CI	 binding.	 The	 affinity	 of	repressor	CI	 for	OR1	and	OL1	is	greater	than	 its	 for	OR2	and	OL2.	While	the	affinity	of	CI	for	OR3	and	OL3	is	 very	 low.	 After	 its	 binding	 to	OR1,	 OR2,	 OL1	 and	OL2,	 the	 levels	of	CI	repressor	drop	 in	the	cell,	OR3	and	OL3	become	free	of	repressor,	the	binding	of	CI	to	OR2	 is	 activates	 the	promoter	PRM	and	 the	 leads	to	reexpression	of	CI	repressor.	The	new	CI	protein	binds	 to	 both	 OR3	 and	 OL3	 blocking	 the	transcription	of	 its	own	 gene	 (Adapted	 from	Dodd	et	al.,	2001)			
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However,	CI,	because	 it	blocks	transcription	from	PR,	prevents	the	production	of	Cro.	Without	the	binding	of	Cro	to	OR3	and	OR2,	expression	of	CI	can	be	driven	from		PRM,	 which	 is	 activated	 because	 Cro	 no	 longer	 represses	 PRM.	 If	 CI	 expression	continues,	it	will	eventually	self-regulate	its	own	expression	by	CI	binding	to	OR3	and	OL3	in	the	loop	repressing	PRM,	itself.	When	levels	of	CI	begin	to	drop	OR3	will	be	 unbound	 enabling	 re-instigation	 of	 CI	 expression,	 thus	 maintaining	 the	lysogenic	 replication	 cycle	 and	 blocking	 possible	 infections	 by	 other	homoimmune	phages	phages	(Lewis	et	al.,	2016)	(Fig.	1.4).	
	
1.2.3	Lambda	phage	induction	
Once	lambda	has	entered	into	the	lysogenic	cycle,	 the	prophage	is	kept	silent	by	the	autoregulation	of	CI,	keeping	 it	 stable	and	allowing	 the	phage	genome	 to	be	passively	 replicated	 with	 the	 host	 genome	 under	 the	 control	 of	 host	 cell	replication	 (Raya	 and	 H'bert,	 2009;	 Burnet,	 1934).	 If	 the	 lysogen	 finds	 itself	 in	conditions	that	might	 limit	 its	own	survival,	 the	prophage	can	direct	 its	excision	from	the	bacterial	chromosome,	through	a	process	called	induction	and	enter	into	the	lytic	replication	to	create	new	phage	particles	that	will	then	be	released	from	the	host	cell	by	lysis.	One	of	the	conditions	that	the	lysogen	senses	is	DNA	damage.	DNA	 damage	 may	 happen	 due	 to	 exposure	 to	 many	 different	 factors,	 e.g.	ultraviolet	 light	 or	 certain	 antibiotics	 (Yue	 et	 al.,	 2012;	 Ennis	 et	 al.,	 1985).	 The	accumulation	of	 the	 ssDNA	due	 to	dsDNA	damage	and	breakage	 turns	on	about	10-20	 of	 the	 bacterial	 survival	 genes	 that	 together	 are	 associated	with	 the	 SOS	response	 (Fonville	 et	 al.,	 2010;	 Mustard	 and	 Little,	 2000).	 The	 SOS	 response	
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involves	 the	 activation	 of	 RecA,	 a	 protein	 that	 is	 ordinarily	 involved	 in	 DNA	recombination	 (Hendrix,	1983)and	DNA	replication.	The	RecA	protein	promotes	the	autolysis	LexA	protein,	a	protein	that	usually	activates	the	survival	genes	in	E	
coli.	 RecA	 also	 induces	 the	 autolysis	 of	 CI	 protein	 (Pedersen	 et	 al.,	 2010).	 This	destruction	of	CI	frees	OR	and	OL	from	the	repressor,	restarting	transcription	from	PL	and	PR	(Mustard	and	Little,	2000).		
The	reactivation	of	PL	and	PR	is	associated	with	the	concomitant	expression	of	Cro	and	N.	CII	 fails	 to	 survive	within	 the	 cell	 and	 two	genes	downstream	of	cIII	 are	then	expressed,	the	xis	gene,	encoding	excisionase	(Xis)	enzyme,	and	the	int	gene	encoding	 Int	 enzyme,	 under	 the	 control	 of	 PL	 promoter	 (Court	 et	 al.,	 2007).	Integrase	now	works	with	its	cognate	recombination	directionality	factor	(Xis)	to	drive	the	excision	of	the	integrated	prophage	DNA.	The	lytic	cycle	starts	and	the	new	phages	are	released	(Hendrix,	1983).		
	
There	are	 four	genes	 responsible	 for	cell	wall	 lysis	 to	enable	progeny	phages	 to	escape	 the	 confines	 of	 their	 host	 cell.	 These	 genes	 are:	 S,	 encoding	 a	 holin;	 R,	encoding	 a	 transglycosidase,	 also	 known	 as	 an	 endolysin;	 and	 the	Rz	 genes	 (Rz	and	 Rz1),	 encoding	 an	 outer	 membrane	 lipoprotein	 which	 is	 a	 type	 II	 signal	anchor	protein	(Fig.	1.5).	Holins	(S)	are	produced	as	a	first	step	in	cell	lysis.	The	S	protein	is	responsible	for	producing	non-specific	 lesions	in	the	inner	membrane,	IM.	These	 lesions	allow	the	endolysin	(R)	to	reach	and	attack	the	peptidoglycan,	which	enzymatically	degrade	the	peptidoglycan	(PG)	layer	of	the	host		
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Figure	 1.5.	 Structure	and	 localization	 of	 the		"	phage	Lysis	cassette.	The	endolysin	(R)	and	holin	(S105)	are	localized	to	the	cytoplasm	and	the	 inner	 membrane	 (IM),	 respectively.	 	 Holin	protein	forms	large	lesions	in	the	IM	to	enable	R	protein	 to	 diffuse	 into	 the	 periplasm	 space,	where	 its	 substrate	 is	 located,	 the	peptidoglycan	 (PG).	 The	 Rz	 genes	 creates	 a	spanin	complex,	the	spanin	structure	composed	of	 two	 component	 spanin	 (Rz	 =	 i-spanin	 and	Rz1=o-spanin).	The	Rz	embedded	into	the	IM	by	an	 N-terminal	 (yellow)	 and	 it	 has	 coiled	 alpha	helical	 periplasmic	 domain	 (4	 brown	 lines)	separated	by	linker	region.	The	Rz1	is	attached	to	 the	outer	membrane	via	 the	 three	 fatty	 acyl	group	(Black	color),	which	is	the	N-terminal	Cys	residue.	 Both	 of	 Rz	 and	 Rz1	 linked	 by	intermolecular	 disulfide	 bonds	 in	 the	periplamic	 domains.	 The	 Rz/Rz1	 spanin	 is	connecting	 the	 Im	 and	 OM	 through	 the	meshwork	of	PG	 (Rajaure	et	 al.,	 2015,	Berry	et	al.,	2012).			
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Figure	1.6.		The	steps	in	the	membrane	fusion	model	for	the	Rz-Rz1	lytic	function.	The	spanin	complexes,	connecting	the	outer	membrane	(OM)	and	the	inner	membrane	(IM),	accumulate	within	the	lacunae	formed	by	the	peptidoglycan	cross-linking.	Endolysin	mediates	destruction	of	 the	PG	 liberates	the	spanins	to	undergo	 conformational	changes	to	bring	the	both	IM	and	OM	 into	 contact	and	stimulate	the	IM-OM	 fusion	(Adapted	from	Rajaure	et	al.,	2015).					
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bacterium		 	 (Summer	 et	 al.,	 2007,	 Young	 et	 al.,	 1979).	 Rz	 and	 Rz1,	 then	 form	 a	spanin	 complex	 that	 spans	 the	 IM,	 the	 outer	 membrane	 (OM)	 and	 the	 entire	periplasm,	enabling	fusion	of	both	membranes	(Fig.1.6)	(Berry	et	al.,	2008).	
	
1.3	Temperate	Phage	and	HGT	
Temperate	 bacteriophages	 are	 among	 the	 major	 contributors	 to	 the	 horizontal	gene	transfer	(HGT).	HGT	involves	the	movement	of	DNA	between	individual	cells	belonging	 to:	 the	 same	 bacterial	 strain	 or	 species,	 cells	 belonging	 to	 the	 same	bacterial	family,	or	even	between	bacterial	cells	that	are	not	closely	related	(de	la	Cruz	 and	Davies,	 2000).	 In	 other	words,	 it	 is	 the	movement	 of	 genetic	material	between	 bacterial	 cells	 other	 than	 by	 the	 transmission	 of	 DNA	 from	 parent	 to	offspring,	also	known	as	horizontal	transmission	(Young	et	al.,	1979)	Phages	can	perform	 this	 DNA	 transfer	 via	 transduction,	 or	 through	 lysogenic	 conversion.	Using	 these	 mechanisms,	 phages,	 prophages	 and	 phage-like	 elements	 play	 an	important	role	in	driving	bacterial	diversity	and	bacterial	evolution	in	many	ways	(Canchaya	 et	 al.,	 2003).	 They	 give	 the	 infected	 host	 immunity	 against	superinfection	by	 the	 same	or	 related	phages.	They	 can	work	as	vectors	 for	 the	transfer	 of	 virulence	 genes	 amongst	 bacterial	 hosts.	 In	 fact	 a	 wide	 variety	 of	bacterial	virulence	factors	are	encoded	by	genes	within	prophages	These	factors	in	some	cases	may	alter	the	phenotypes	of	their	bacterial	host,	such	as	production	of	an	exotoxin	or	exoenzyme	(Holt	et	al.,	2016;	Veses-Garcia	et	al.,	2015),	or	 the	
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expression	 of	 modified	 cell	 surface	 protein	 (Raya	 and	 H'bert,	 2009;	 Holt	 et	 al.,	2016;	Riley	et	al.,	2012;	Veses-Garcia	et	al.,	2015).	
	
1.3.1	Phage	Transduction	
Transduction	is	the	movement	of	genes	from	a	bacterial	donor	cell	to	a	bacterial	recipient	 cell	 using	 phages	 as	 the	 transfer	 vector.	 Ikeda	 and	 Tomizawa	 (1965)	stated,	 after	 their	 experiments	with	 bacteriophage	 P1	 on	E	coli,	 that	 before	 the	donor	host	cell	lysed	following	P1	phage	induction,	the	bacterial	chromosome	had	been	degraded	into	small	DNA	fragments.	P1	was	able	to	package	any	piece	of	this	bacterial	 DNA,	 seemingly	mistaking	 it	 for	 P1	 progeny	 DNA.	 This	 bacterial	 DNA	was	then	packaged	into	the	phage	head	in	place	of	phage	DNA.	When	the	released	progeny	phage	 attack	 a	 new	E.	coli	 cell,	 the	DNA	 injected	by	 some	of	 the	phage	particles	 are	 actually	 fragments	 of	 DNA	 from	 the	 former	 bacterial	 host’s	chromosome.	 The	 newly	 infected	 host	 now	 becomes	 the	 recipient	 host.	 The	transduced	 bacterial	 genes	 can	 be	 incorporated	 inside	 the	 recipient	 host	chromosome	through	DNA	recombination	events.	Certain	phages,	like	P1	and	P22,	are	 able	 to	 transduce	 any	 gene	 in	 the	 bacterial	 chromosome,	 and	 transduction	mediated	by	these	phages	is	known	as	Generalized	Transduction	(Stodolsky	et	al.,	1972).	
	
On	 the	 other	 hand,	 some	 phages	 are	 only	 able	 to	 package	 a	 limited	 number	 of	genes	 from	 a	 donor	 cell.	 This	 type	 of	 transduction	 is	 called	 Specialized	
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Transduction.	 Lambda	phage	 is	 an	 example	of	 a	phage	 that	 is	 an	 instrument	 for	specialized	 transduction.	 When	 lambda	 DNA	 integrates	 into	 the	 bacterial	 host	chromosome,	 it	 does	 so	 in	 a	 site-specific	 manner.	 Lambda	 Int,	 a	 site-specific	recombinase,	ensures	that	the	lambda	genome	always	integrates	at	the	same	site	within	the	E.	coli	genome.	When	the	lambda	prophage	is	induced,	Int,	with	help	of	Xis	 and	 some	 other	 DNA	 binding	 proteins,	 ensures	 that	 the	 lambda	 genome	excises	 precisely	 from	 the	 point	 of	 integration	 to	 produce	 the	 original	 circular	lambda	 chromosome	 and	 to	 start	 the	 lytic	 cycle	 (Cho	 et	 al.,	 2002).	 Very	 rarely,	however,	the	excision	is	imprecise	and	the	resultant	phage	now	carries	a	bacterial	gene	 that	 lay	 close	 to	 the	attL	or	attR	sites.	 For	λ, the E. coli genes close to attR and 
attL are the gal locus, which encode necessary enzymes for galactose metabolism 
(Weickert and Adhya, 1993), and bio, which encodes biotin protein (Shaw et al., 1999), 
respectively. The resultant, excised phage genome is defective due to λ genes that are 
left behind and the host gene that has been acquired. The transducing phages are 
known as λdgal (λ-defective gal) or λdbio (λ-defective bio). The defective 
chromosomes can be packaged into phage heads, which go on to infect other bacterial 
hosts. When the specialised transducing phage, λdgal, infects a new bacterial host, 
even if it carries a genetically different, resident prophage (Griffiths, 2000), it can 
insert its genome either by general, homology-dependent recombination or by specific-
lambda att site, when the λdgal can thus initiate a new lysogenic pathway, because the 
defective phage, λdgal, still encodes the Int enzyme (Griffiths, 1996). The requirements 
for integrase reaction using the hybrid site attL on the λdgal are different from those for 
a phage attP site (Calendar, 2006). However, λdgal, in acquiring the gal gene will have 
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left behind some of the tail structural genes (Fig.1.7). Therefore λdgal will be unable to 
replicate lyti cally. On the other hand, when the defective λdbio, infects another 
bacterial host, its only able to drive the lytic cycle as it left the int gene, or part from it, 
in previous the host cell genome, but it will still has all lysis, head, and tail genes (Dul 
and Drexler, 1988; Griffiths, 2000; Shpakovski and Berlin, 1984). This transduction is 
limited to genes very close to the original integration event and that why it called Specialized	Transduction	(Fig.	1.7).   
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	 	 Figure	 1.7.	 Specialized	 transduction	 by	lambda	phage:	A.	The	normal	precise	excision.	Here	Int	and	 Xis	 insure	 that	 the	 prophage	 excises	exactly	 from	λ	phage	att	sites	so	that	attR	and	attL	are	 precisely	 resolved	 to	 restore	
attP	and	attB.		
B.	In	very	rare	cases,	the	excision	takes	
place	 in	 imprecisely	 sites.	The	 resulting	phage	carries	the	nearby	gene	(gal)	and	 it	leaves	behind	some	phage	genes.	This	new	phage	 is	 called, λ-defective and in this case 
it is λ-defective gal (λdgal). Here the	 phage	still	 encodes	 Int	 enzyme	 so	 it	 still	 able	 to	drive	 site-specific	 recombination	or	 it	 can	insert	 its	 genome	 inside	 new	 host	chromosome	 by general, homology-
dependent recombination. 
C.	 When	 the	 defective	 phage	 infects	 a	
new	 bacterial	 host	 with	 or	 without	 a	
genetically	 different,	 resident	
prophage.	 The	 defective	 phage	 can	 still	integrate	its	genome	at	same	specific	λ-att	
site,	 this	 generate	 a	 helping	 effect	 by	 the	helper	 prophage	 (Adapted	 from	 Griffiths,	2000).	
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1.3.2	Phage	Conversion		
Phage	conversion,	or	lysogenic	conversion,	is	occurs	due	to	one	or	more	changes	in	the	bacterial	host	phenotype	resulting	from	infection	with	a	temperate	phage.	Typically	the	converting	phage	becomes	a	prophage	within	the	chromosome	of	its	bacterial	host	(Rankin	and	Platt,	1995),	or	it	becomes	an	extra	chromosomal	self	replicating	unit	inside	the	bacterial	cell	(Ikeda	and	Tomizawa,	1968).	
	
	Some	phages	carry	genes	that	are	not	related	to	the	lytic	or	lysogenic	processes.	These	 genes	 have	 the	 potential	 to	 produce	 new	phenotypes	 for	 their	 host	 cells.	They	 may	 make	 the	 bacterial	 cell	 resistant	 to	 related	 phages	 (McGrath	 et	 al.,	2002),	 or	 increase	 the	 pathogenic	 capacity	 of	 the	 bacterial	 host	 cell	 (now	 a	lysogen)	 to	 its	 host	 through	 prophage	 carriage	 of	 new	 virulence	 factors	(Allison,2003).	 In	 this	way,	 temperate	bacteriophages	play	 role	 in	 the	 spread	of	virulence	factors	amongst	bacteria.		
	
It	is	also	possible	for	these	new	bacterial	phenotypes	to	become	permanent	due	to	the	decay	(deletion,	 insertion	and	recombination	events)	of	prophage	sequences	that	result	in	the	prophage’s	loss	of	their	ability	to	be	induced	into	lytic	replication	(Hale	et	al.,	2005;	Weinbauer,	2004).	Many	of	 the	bacterial	diseases	 that	 impact	our	 world	 are	 due	 to	 bacterial	 pathogens	 that	 were	 made	 more	 pathogenic	through	the	carriage	of	a	converting	phage.		
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1.3.2.1.	 Down	 stream	 effects	 of	 phage	 conversion	 in	 Vibrio	
cholerae	
The	 phage	 that	 encodes	 cholera	 toxin	 produced	 by	 Vibrio	 cholerae	 is	 the	filamentous	 temperate	 phage	 CTXϕ.	 Vibrio	 cholerae	 acquired	 the	 ability	 to	produce	cholera	toxin	only	after	they	became	lysogens	of	this	phage	(Waldor	and	Mekalanos,	1996).	There	are	over	200	serotypes	of	this	bacteria	species,	however	only	two	serotypes,	O1	and	O139,	are	causative	agents	of	Asiatic	cholera.	Asiatic	cholera	 is	 characterized	 by	 watery	 diarrhea	 and	 severe	 dehydration	 that	 can	progress	rapidly	to	death	(Faruque,	2014).	Cholera	toxin	is	solely	responsible	for	the	 symptoms	 of	 Asiatic	 cholera	 (Faruque	 et	 al.,	 1999;	Waldor	 and	Mekalanos,	1996).	Cholera	toxin	is	an	oligomeric	complex	protein	(known	as	AB5),	made	of	six	subunits;	five	copies	of	the	B	subunits,	each	weighing	~11.6	kDa,	producing	a	ring,	surrounding	 the	 single	 copy	 of	 the	 A	 subunit,	 which	 is	 28	 kDa	 (Sanchez	 and	Holmgren,	 2011).	 The	 A	 subunit	 is	 the	 enzymatic	 part	 of	 the	 toxin	 while	 B	subunits	 bind	 to	 specific	 receptors	 (GM1	 gangliosides)	 on	 the	 cell	 surface,	facilitating	the	entry	of	toxic	A	subunit	 into	the	host	cell.	After	the	A1	domain	of	subunit	 A	 enters	 the	 cytosol,	 it	 activates	 adenylate	 cyclase	 drives	 the	 cAMP	production	by	G	protein	 stimulation.	The	cAMP	 	promotes	 the	activation	of	 	 the	cystic	 fibrosis	 transmembrane	 conductance	 regulator	 (CFTR),	 leading	 to	watery	diarrhea	(Bharati	and	Ganguly,	2011).		
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1.3.2.2.	 Down	 stream	 effects	 of	 phage	 conversion	 in	
Corynebacterium	diphtheriae	
Diphtheria	 toxin	 that	 produced	 by	 Corynebacterium	diphtheriae	 is	 actually	encoded	 by	 a	 temperate	 corynephage	 genome	 that	 carries	 the	 tox	 gene.	
Corynebacterium	diphtheriae	acquired	the	ability	to	produce	diphtheria	toxin	only	after	they	become	lysogens	of	this	phage	(Groman,	1984).		
	
Diphtheria	toxin	is	a	60	kDa	molecular	weight	protein	composed	of	two	subunits	A	and	B.	(Groman,	1984).	Subunit	B	facilitates	the	entry	of	toxin	subunit	A	into	the	human	 host	 cell	 by	 binding	 to	 the	 heparin-binding,	 EGF-like	 growth	 factor	receptor	on	the	cell	surface.	The	A	subunit	enters	the	cell	within	an	endosome	via	receptor-mediated	 endocytosis.	 The	 B	 subunit	 creates	 pores	 in	 the	 endosome	membrane,	 allowing	 the	 escape	 of	 the	 A	 subunit	 into	 the	 cell	 cytoplasm.	 The	 A	subunit	inhibits	the	synthesis	of	new	protein	in	the	affected	cell	(Collier,	1975).	
	
The	 disease	 diphtheria	 is an	 acute	 infection,	 characterised	most	 often	 by	 a	 sore	throat,	fever	(38	°C	or	above),	and	the	development	of	an	adherent	membrane	on	the	 tonsils	 and/or	 nasopharynx	 called	 a	 pseudomembrane.	 This	pseudomembrane	 is	 usually	 produced	 at	 the	 primary	 site	 of	 the	 infection,	normally	 the	 mucous	 membranes	 of	 the	 respiratory	 tract.	 From	 these	pseudomembranes	 diphtheria	 toxin	 can	 spread	 throughout	 the	 body	 to	 cause	systemic	toxic	infections	(Waldor	and	Mekalanos,	1996).		
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1.3.2.3.	 Shiga	 toxin-producing	 and	 enterohaemorrhagic	
Escherichia	coli	
The	 bacteriophage,	Φ24B,	 is	 a	 lambdoid	 phage	 (Stx	 phage)	 that	 gives	 the	enterohaemorrhagic	E.	coli	(EHEC)	their	ability	to	produce	Shiga	toxin	(Stx),	only	after	 they	 become	 lysogens	 of	 these	 phages.	 (Paton	 and	 Paton,	 1998).	 The	Enterohaemorrhagic	E.	coli	(EHEC)	is	a	subset	of	pathogenic	E.	coli	that	can	cause	diarrhea	 or	 hamorrhagic	 colitis	 in	 humans.	 Hemorrhagic	 colitis,	 caused	 be	Enterohaemorrhagic	E.	coli	 (EHEC),	occasionally	progresses	 to	hemolytic	uremic	syndrome	 (HUS),	 an	 important	 cause	 of	 acute	 renal	 failure	 in	 children	 and	morbidity	and	mortality	in	adults	(Geue	et	al.,	2009;	Xu	et	al.,	2012).		
	
The	 main	 reservoirs	 of	 EHEC	 serotypes	 associated	 with	 human	 infections	 are	ruminants,	 in	 particular	 cattle	 (Geue	 et	 al.,	 2009;	 Xu	 et	 al.,	 2012).	 They	 can	 be	transmitted	 to	 humans	 through	 the	 consumption	 of	 contaminated	 food	 and/or	drink,	 and	 even	 person-to-person	 spread	 has	 been	 reported(Nataro	 and	 Kaper,	1998).	 One	 of	 the	 most	 important	 factors	 contributing	 to	 the	 pathogenesis	 of	EHEC	infection,	and	the	single	most	 important	 factor	 in	 the	severe	symptoms,	 is	the	production	of	Shiga	toxin	(Stx)	(Paton	and	Paton,	1998).	Stx	is	encoded	by	two	small	genes	(stxA	and	stxB),	which	are	arranged	in	an	operon	structure.		
	
Stx	 belongs	 to	 a	 family	 of	 AB5	 toxins	 comprising	 of	 a	 single	 A	 subunit	 that	 is	associated	with	pentameric	B	subunits	that	are	responsible	for	toxin	binding	to	its	
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receptors	 in	bacterial	 cells	 (Lingwood,	1999).	The	A	subunit	 is	an	N-glycosidase	which	 cleaves	 the	 N-glycosidic	 bond	 of	 specific	 adenine	 residues	 within	 rRNA,	inactivating	 the	 60S	 ribosomal	 subunits	 leading	 to	 protein	 synthesis	 inhibition.	Moreover,	it	has	been	stated	that	Shiga	toxin	induce	apoptosis	in	many	cell	types	(Sandvig,	2001;	Law,	2000).		
	
Stx	production	is	directly	responsible	for	two	dangerous	EHEC	infection	sequelae,	Hemolytic	Uremic	Syndrome	(HUS)	and	Thrombotic	Thrombocytopenic	Purpura	(TTP)	 (Paton	 and	 Paton,	 1998;	 Paton	 and	 Paton,	 1999).	 Although	 the	 global	incidence	 of	 EHEC	 infection	 is	 low,	 there	 is	 an	 unacceptably	 high	 proportion	 of	infected	individuals	that	go	on	to	develop	severe	disease	(10%)	and	death	(3-5%)	(Watanabe	et	al.,	1999).	The	stx	genes	are	acquired	by	the	bacterial	cell	following	infection	 by	 a	 bacteriophage	 carrying	 the	 stx	 genes,	 like	 Stx	 phage	 Φ24B.	 The	expression	 of	 the	 toxin	 genes	 is	 then	 controlled	 by	 the	 bacteriophage’s	 lytic	replication	 cycle,	 which	 subverts	 the	 host	 cell’s	 resources	 in	 order	 to	 produce	more	phages	in	the	lytic	cycle	(Bradley,	1967).	
		1.3.2.4	Converting	phage	summary	
In	summary,	phages	can	move	genes	from	one	bacterial	host	cell	to	another	new	cell	 through	 the	 process	 of	 phage	 convertion.	 	 Phage	 conversion	 can	 result	 in	bacterial	cells	gaining	abilities	that	they	did	not	possess	prior	to	phage	infection.	Additionally,	once	the	phage	DNA	is	in	the	cell	it	is	free	to	recombine	with	cellular	
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DNA	 sequences	 to	 produce	 genetic	 sequences	 new	 to	 both	 phage	 and	 bacterial	host.		
	
These	 biological	 events	 play	 an	 efficient	 role	 in	 driving	 the	 diversification	 and	evolution	of	 the	bacterial	 cells	 (Allison	2003).	The	 reasons	behind	 the	 ability	of	phages	 to	 mediate	 these	 biological	 events	 are:	 their	 capacity	 to	 inject	 their	genome	inside	the	host	cell’s	cytoplasm	to	become:	1)	an	extra	chromosomal	self-replication	unit	(Ikeda	and	Tomizawa,	1968),	or	2)	integrate	their	genome	inside	the	 host	 cell’s	 chromosome	 and	 become	 a	 prophage	 (Groman,	 1984).	 For	 the	incoming	 phage	 to	 become	 a	 prophage,	 a	 phage	 encoded	 recombinase	 enzyme	must	be	produced	to	direct	prophage	integration	into	the	bacterial	chromosome.	These	 enzymes	 in	 general	 are	 called	 site-specific	 recombinases.	 Phage	 site-specific	recombinases,	in	the	absence	of	any	other	phage-encoded	factors	catalyze	the	 site-specific,	 uni-directional	 recombination	 reaction	 (Serra-Moreno	 et	 al.,	2008).			
1.4	Site-specific	recombination	
Site-specific	DNA	recombination	is	a	genetic	recombination	process	in	which	DNA	strand	exchange	take	place	between	two	DNA	molecules	that	share	DNA	sequence	homology	(Kilby	et	al.,	1993).	Site-specific	recombinases	promote	DNA	fragment	rearrangements	by	identifying	and	binding	to	a	short	DNA	sequence	called	att		
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Figure	 1.8.	 Lambda	 phage	 site–specific	
integration	and	excision.	After	 injection	of	 the	lambda	 genome	 into	 the	 host	 cytoplasm,	 the	phage	 genome	 is	 circularised	 (Blue	 circle).	 The	phage	DNA	 then,	 integrates	 itself	 via	 the	 phage	attachment	 site	 (attP;	Red	arrow),	 into	 the	host	or	bacterial	attachment	site	(attB;	Green	arrow).	This	 reaction	 creates	 the	 prophage	 flanked	 by	the	 new	 hybrid	 attachment	 sites	 attR	 and	 attL.	These	 sites	 are	 the	 start	 points	 of	 the	 excision	reaction	to	regenerate	attP	on	the	excised	phage	DNA	 and	 attB	 on	 bacterial	 chromosome.	 The	phage	 encoded	 integrase	 enzyme	 (Int)	 and	 the	host-encoded	integration	host	factor	(IHF,	a	DNA	binding	 protein	 that	 stabilizes	 the	 DNA	 to	support	 the	action	of	 Int)	 are	 both	 required	 for	integration	 and	 excision	 event.	 However,	excision	 requires	 two	 additional	 proteins:	 Xis	and	 Fis.	 Xis	 is	 a	 phage	 encoded	 recombination	directionality	 factor,	 while	 Fis	 is	 Factor	 for	Inversion	Stimulation,	encoded	by	E	coli	 fis	gene	(Adapted	from	Groth	and	Calos,	2004).		
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sites,	at	which	these	enzymes	cleave	the	DNA	molecules,	and	direct	the	exchange	between	the	two	DNA	molecules	(Fig.	1.8)(Craig,	1988).		
	
Site-specific	recombination	approaches	are	highly	specific,	fast	and	efficient,	even	in	 some	complex	eukaryotic	 genomes	 (Sauer,	1998).	 Site-specific	 recombination	systems	 are	 involved	 in	 different	 types	 of	 cellular	 processes,	 including	 but	 not	exclusive	 to	 bacterial	 pathogenesis,	 bacterial	 genome	 replication	 and	 the	movement	 of	 mobile	 genetic	 elements	 around	 a	 single	 bacterial	 cell’s	 genome.	These	 abilities	 make	 these	 systems	 useful	 for	 the	 development	 of	 genetic	engineering	tools	(Kilby	et	al.,	1993).	
	
Some	site-specific	recombination	systems,	like	that	derived	by	fC31,	need	nothing	more	than	the	recombinase	enzyme	and	recombination	sites	to	function	(Thorpe	and	Smith,	1998).	Other	systems,	like	that	derived	by	λ	phage,	require	a	number	of	accessory	 proteins	 to	 function.	 These	 accessory	 proteins	 are	 either	 encoded	 by	the	bacterial	host	or	are	phage	encoded.	Site-specific	recombination	does	not	need	any	 external	 energy	 source.	 The	 reaction	 takes	 place	 and	 ends	 without	 the	reaction	takes	place	and	ends	without	loss	or	gain	of	any	part	of	DNA	substrates	(Fogg	et	al.,	2014).		
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The	substrates	that	a	temperate	phage’s	site-specific	recombinase	needs	to	drive	integration	 into	 the	 bacterial	 host	 chromosome	 are	 DNA	 sequences,	 typically	between	30-250bp,	within	the	phage	genome	called	attP	(phage	attachment	site)	and	 a	 DNA	 sequence	 within	 the	 host	 chromosome	 named	 attB	 (bacterial	attachment	site).	The	recombination	reaction	between	these	two	sites	creates	an	integrated	 prophage	 flanked	 by	 the	 new	 attachment	 sites	 attR	and	 attL.	 These	sites,	attL	 and	attR,	 are	hybrid	 sites	of	attP	 and	attB	 that	 can	 later	 serve	 as	 the	start	points	for	the	excision	reaction	to	regenerate	attP	on	the	excised	phage	DNA	and	attB	within	the	bacterial	chromosome.	Int	is	the	main	enzyme	in	both	of	these	recombination	reactions,	and	it	is	the	only	phage-encoded	protein	that	is required 
to facilitate the integration reaction.	 Excision	 also	 requires	 a	 phage	 encoded	 Xis	 or	recombination	directionality	factor	(RDF)	(Yin	et	al.,	1985).	
	
Lambda	 site-specific	 recombinase	 or	 integrase	 (Int)	 functions	 as	 a	 homo-tetramer,	 recognizing	 specific	 recombination	 sites	 (attB	 and	 attP)	 in	 both	 the	bacterial	 and	 phage	 DNA,	 respectively.	 The	 Lambda	 bacterial	 attachment	 site,	
attB,	 is	21	bp	while	 its	phage	attachment	site,	attP,	 is	~	240	bp.	These	two	sites	share	an	overlap	region	of	only	7	bp,	which	serves	as	the	core	for	recombination.	The	 tetrameric	 integrase	binds	 the	 two	DNA	substrates	 to	 form	an	 intermediate	Holliday	junction,	which	is	resolved	to	form	new	hybrid	recombination	sites	attL	and	 attR	 (Fig.	 1.8).	 Lambda	 integrase	 cannot	 drive	 the	 DNA	 recombination	without	 the	 presence	 of	 the	 host	 encoded	 accessory	 protein	 Integration	 Host	Factor	(IHF)	(Craig	and	Nash,	1984).	
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The	new	hybrid	sites	attL	and	attR	are	the	start	points	of	the	excision	reaction	to	regenerate	 attP	 on	 the	 excised	 phage	 DNA	 and	 attB	 on	 bacterial	 chromosome	(Cassell	et	al.,	1999).	
	Site-specific	 recombinases	 can	 be	 divided	 according	 to	 amino	 acid	 sequence	homology	 and	mechanism	 of	 action	 into	 two	main	 families,	 tyrosine	 and	 serine	recombinases	(Table	1.1).	Both	of	 these	 families	are	populated	by	recombinases	that	 drive	 a	 variety	 of	 recombination	 functions.	 These	 functions	 include:	 phage	integration	 and	 excision,	 resolution	 of	 DNA	 concatemers	 (Ritchie	 and	 Joicey,	1978)	 and	 DNA	 inversion	 events	 associated	with	 phase	 and	 antigenic	 variation	mechanisms	at	contingency	loci	(Robles-Oteiza	et	al.,	2015).	
	
1.4.1.	Serine	integrases		
The	 serine	 family	 of	 site-specific	 recombinases	 use	 a	 serine	 residue	 as	 the	catalytic	 residue	 to	 drive	 DNA	 recombination.	 This	 family	 is	 populated	 by	enzymes	 like	 the	 invertase	 Gin(Kahmann	 et	 al.,	 1984),	 the	 resolvases	 from	Tn3	(Krasnow	 and	 Cozzarelli,	 1983)	 and	!"	(Reed	 et	 al.,	 1982)	 and	 the	 phage	recombinases	 from	 fC31(Kuhstoss	 and	 Rao,	 1991),	 R4	 (Groth	 et	 al.,	 2000),	TP901-1	(Christiansen	et	al.,	1996)	and	fFC1	(Yang	et	al.,	2002).	The	function	of	the	latter	four	phage	encoded	recombinases	have	been	studied	in	depth,	and	can	be	used	as	representatives	of	most	of	the	family	members	(Table	1.1).	
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The	 att	 sites	 that	 are	 targeted	 by	 serine	 recombinases	 are	 typically	 ~50	 bp,	composed	 of	 a	 variety	 of	 inverted	 repeat	 sequences	 that	 are	 flanked	by	 a	 short	central	region	of	2-12	bp	at	the	crossover	core	(Groth	et	al.,	2000).		
	
Serine	site-specific	recombinases	bind	to	their	specific	attachment	sites,	however	only	 two	 subunits	 (dimers)	 are	 active	 to	 drive	 the	 DNA	 exchanges	 (Fig.1.7),	 as	opposed	 to	 the	 active	 tetramers	 of	 integrase	 (described	 in	 1.4.3	 Tyrosine	recombinases).	The	synaptic	complex	is	where	the	catalytic	serine	residues	act	to	break	 all	 four	 DNA	 strands	 at	 the	 same	 time	 (Groth	 et	 al.,	 2000).	 The	 double	stranded	DNA	is	cleaved	at	 the	3’	end	of	 two	nucleotides	overhangs	 followed	by	the	formation	of	phosphoseryl	covalent	bonds	between	the	four	free	5’	ends	and	each	integrase	monomer.	An	integrase	subunit	rotation	process	takes	place	when	two	 of	 the	 enzyme	 subunits,	 that	 remain	 covalently	 bound	 to	 the	 DNA	 5’	 ends,	rotate	 180°	(Fig.1.9).	 This	 process	 swaps	 the	 two	 half	 sites	 one	 instead	 of	 the	other	and	creates	new	recombination	products	(Fig.	1.9).	The	core	bases	have	to	be	same	in	both	parent	attachments	sites	for	the	integrase	to	drive	recombination	(Ghosh	et	al.,	2003).	
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Table	1.1:	Selected,	well	characterised	site-specific	recombinases	and	their	requirements	for	recombination.		None	of	the	Stx	phage	integrases	or	their	requirements	have	been	well	characterized,	yet.	
(Adapted	from	Fogg	et	al.,	2014	&	Groth	and	Calos,	2004)	Site-specific	recombinase	family		
Phage	name	 Host	Genera	 attB	(bp)	 attP		(bp)	 Required		Host	factor		
RDF	 References		
Serine	
φC31	φBT1	TG1	Bxb1	φRv1		TP901-1	
Streptomyces	
Streptomyces	
Streptomyces		
Mycobacterium		
Mycobacterium	
Lactococcus		
34		36	39		38		40	31	
39	48	43	48	52	50	
		 gp3		gp3	gp25		gp47		Rv1584c/Xis		ORF7	
(Groth	et	al.,	2000,	Kuhstoss	and	Rao,	1991)	(Zhang	et	al.,	2008b)	(Morita	et	al.,	2009)	(Ghosh	et	al.,	2006)	(Bibb	et	al.,	2005)	(Breüner	et	al.,	1999,	Christiansen	et	al.,	1996)	
Tyrosine		
! L5	P2	P22	HP1		
Escherichia	
Mycobacterium		
Salmonella		
Salmonella		
Hemophilus		
21		29	17		27		18			
240	240	220		260		420			
IHF		mIHF	IHF	IHF	IHF	
Xis	Gp36/Xis	Cox	Xis	Cox	
(Abremski	and	Gottesman,	1982,	Enquist	et	al.,	1979)	(Lee	and	Hatfull,	1993,	Lewis	and	Hatfull,	2000)	(Yu	and	Haggård-Ljungquist,	1993)	(Mattis	et	al.,	2008,	Leong	et	al.,	1985)	(Waldman	et	al.,	1986,	Hauser	and	Scocca,	1992)	
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In	 the	phage	fC31	 the	 crossover	 core	 region	 is	TTG,	 flanked	by	 inverted	 repeat	sequences.	The	repeats	in	the	attP	site	are	a	bit	farther	from	the	core	then	in	attB	(Thorpe	 et	 al.,	 2000).	fC31	 	 serine	 site	 specific	 recombinase	 performs	 DNA	recombination	between	bp	39	in	the	attP	site	and	bp	34	in	the	attB	site	(Groth	et	al.,	2000).	Similar	simple	att	sites	can	be	also	found	in	Phages	R4	and	TP901-1	and	their	target	hosts,	all	utilising	minimal	sites	of	56	bp	or	less	for	both	attB	and	attP	(Olivares	 et	 al.,	 2001).	 It	 has	 been	 reported	 that	 for	 efficient	 recombination	 in	both	fC31	and	TP901-1,	2bp	in	the	core	region	have	to	be	conserved;	TT	for	fC31	in	the	TTG	core	region	(Combes	et	al.,	2002)	and	TC	in	the	TP901-1	TCAAT	core	region	(Breüner	et	al.,	2001).	
	
Unlike	most	tyrosine	integrases,	serine	integrases	can	mediate	the	integration	of	their	 phage	 genome	 inside	 the	 bacterial	 host	 chromosome	 without	 the	requirement	of	other	accessory	 factors	 (Fogg	et	al.,	2014).	Serine	 integrases	are	inactive	 on	attR	 and	attL;	 however,	 the	 excision	 reaction	 has	 been	 observed	 in	some	 cases	 (Breüner	 et	 al.,	 1999).	 For	 efficient	 excision	 to	 occur,	 the	 serine	integrases	 require	 the	 action	 of	 a	 phage-encoded	 recombination	 directionality	factor,	RDF.	The	recombination	directionality	factor	is	a	protein	that	drives	phage	excision	and	functions	in	one	of	two	ways:	by	creating	a	synapsis	between	the	attL	and	attR	 sites,	 activating	 excision	or	by	 reducing	 integration	by	 inactivating	 the	synapse	between	the	attB	and	attP	sites	(Bibb	et	al.,	2005).	
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Figure	 1.9.	 Overview	 of	 the	 cleavage	
and	 rejoining	 of	attachment	sites	 by	a	
serine	recombinase.	The	thick	blue	and	orange	 lines	 represent	 the	 DNA	 strands	with	 central	 dinucleotide	 shown,	 in	 this	case,	 two	 T:A	 base	 pairs	 .	 the	 red	 lines	represent	the	position	of	the	breaks	made	when	 the	 recombinase	 cuts	 the	 DNA	strands.	 The	 subunit	 rotation	 process	exchanges	 the	 DNA	 half	 sites	 when	 two	subunits	of	 the	recombinase	(highlighted	by	green	and	yellow	colors),	bound	to	the	half	 sites	 from	 opposing	 DNA	 strands,	rotate	180° compared the other pair of 
subunits which stay waiting, to rejoin the 
DNA strands again in a new recombination 
products (Adapted from Fogg et al., 2014).		
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1.4.2	Applications	of	serine	site-specific	recombinases	
The	minimal	requirements	of	serine	site-specific	recombinases	for	both	the	DNA	substrates	and	the	host	encoded	accessory	factors,	make	many	in	vitro	and	in	situ	DNA	assembly	strategies	far	easier	to	design	and	optimize	compared	to	standard	cloning	 strategies.	 This	 is	 particularly	 apparent	 when	 serine	 recombination	systems	are	used	in	heterologous	cells	that	may	share	very	little	of	the	molecular	machinery	found	in	the	serine	site-specific	recombinase’s	natural	host	(Fogg	et	al.,	2014).		
	
Among	 serine	 recombinases,	 the	 activity	 of	ϕC31	 recombinase	was	 exploited	 in	the	development	of	integration	vectors	for	use	in	its	natural	host,	Streptomyces	as	it	contains	the	ϕC31	attB	site	in	its	genome	(Kuhstoss	and	Rao,	1991).	Due	to	its	high	efficiency	and	extreme	stability	these	plasmids	becomes	efficient	vectors	for	introducing	DNA	sequences	into	the	chromosome	of	Streptomyces	spp.	and	related	bacteria,	and	the	fC31	enzyme	can	be	used	for	accurate	knock-out	of	target	DNA	sequences	 (Zhang	 et	 al.,	 2013).	 In	 fact,	whole	 biosynthesis	 clusters	 of	 antibiotic	resistance	 genes	 have	 been	 integrated	 into	 heterologous	 host	 genomes	 using	ϕC31	recombinase	(Zhang	et	al.,	2013).		
	
The	fC31	 recombinase	 activity	 has	 also	 been	 exploited	 to	 improve	 applications	that	 utilize	 Cre	 and	 FLP	 systems	 in	 sequences	 exchange	 and	 the	 engineering	 of	heterologous	 cells.	 It	 has	 been	 reported	 that	 an	 attB-flanked	 cassette	 can	 be	
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integrated,	 using	 the	 activity	 of	 the	fC31	 recombinase	 inside	mouse	 embryonic	stem	 cells	 (ES	 cells)	 in	 attP-flanked	 cassette	 in	 their	 genome.	 This	 has	 been	performed	by	placing	the	DNA	sequence	flanked	by	either	attP	or	attB	sites	 into	genome	of	ES	cells	(Docking	site).	Then,	a	plasmid	containing	a	sequence	flanked	either	 by	attP	 or	attB	 sites	 (Incoming	 sequence)	 has	 been	 introduced	 in	 the	 ES	cells	(Belteki	et	al.,	2003).	
		
Similar	study	has	demonstrated	the	ability	of	the	same	recombinase	to	introduce	a	 DNA	 sequence	 flanked	 by	 two	 attB	 sites	 inside	 cells	 of	 the	 yeast	
Schizosaccharomyces	pombe	into	an	already	chromosomally	inserted	attP	site.	The	controlled	 directionality	 of	ϕC31	 recombinase	 makes	 it	 much	 better	 suited	 for	cassette	exchange	applications	than	Cre	or	FLP	tyrosine	integrases	(Thomason	et	al.,	2001).	
	
An	expanded	potential	for	the	ϕC31	recombinase	is	coming	from	its	competence	to	 recognize	 mouse	 and	 human	 derived	 pseudo	 attP	 sites	 (genetically	 inserted	
attP	 site),	 and	use	 them	 to	 drive	 integration.	 An	attB	 harboring	 plasmid	 can	 be	integrated	 into	human	cells	within	a	genomic	pseudo	attP	 site	with	a	very	good	integration	frequency	and	holds	much	promise	in	the	applications	of	gene	therapy	(Thyagarajan	et	 al.,	 2001).	The	 integrases	R4	and	TP901-1	are	also	members	of	the	 serine	 recombinase	 family	 and	 are	 being	 successfully	 utilized	 in	 other	mammalian	cells	applications	(Olivares	et	al.,	2001;	Stoll	et	al.,	2002).	
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1.4.3	Tyrosine	recombinases		
Members	of	the	tyrosine	site-specific	recombinase	family,	also	generally	referred	to	as	integrases,	use	the	amino	acid	tyrosine	within	their	active	site	to	attack	the	DNA	backbone	during	cleavage.	This	 family	 is	 currently	composed	of	more	 than	300	 model	 enzymes	 (Groth	 and	 Calos,	 2004).	 The	 recombination	 mechanisms	used	 by	 Int from λ and Cre from phage P1 are representatives of almost all tyrosine 
integrases (Table 1.1) )	(Austin	et	al.,	1981;	Campbell,	1962)	
	
In	most	cases,	 the	attB	site	recognised	by	tyrosine	recombinases	 is	composed	of	two	 inverted	 repeats	 flanking	 the	 core	 region.	 The	 inverted	 repeats	 are	 called	core-type	binding	sites	and	range	from	9	bp	to	13	bp.	The	core	or	the	overlap,	or	some	 times	 called	 the	 crossover	 region,	 is	 usually	 6	 bp	 –	 8	 bp.	 The	 site	attP	 is	more	 complicated,	 containing	 several	 adjacent DNA binding sites called arm-type 
sites (this	 going	 to	 be	 discussed	 in	 Chapter	 3), which are direct repeats that flank the 
core-type sites (Ross et al., 1979).Tyrosine	 integrases	 bind	 to	 the	 core-type	 binding	sites	 of	 attP	and	attB	and	 bring	 the	 two	 sites	 together	 in	 a	 tetrameric	 synapse	(Fig.1.10).	 The	 creation	 of	 the	 correct	 complex	 or	 synapse	 is	 essential	 for	activation	of	the	recombination	activity	of	the	integrases	(Biswas	et	al.,	2005).	The	catalytic	 residues	 (tyrosine)	 for	 this	 enzyme	 in	 two	of	 its	monomers	within	 the	tetramer,	grab	both	attP	and	attB	together	to	create	a	recombination	joint	called	a	Holliday	 junction.	 This	 junction	 is	 then	 resolved	 by	 the	 integrase	 to	 form	 new,	hybrid	 recombination	 sites	 attR	 and	 attL	 (this	 also	 going	 to	 be	 discussed	 in	
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Chapter	3).	The	only	phage	encoded	protein	needed	for	DNA	recombination	is	Int.	However,	 in	 order	 to	 drive	 its	 action,	 Int	 requires	 the	 host	 encoded	 integration	host	factor,	IHF,	which	binds	to	the	attP	arms	and	introduces	sharp	bends	that	are	necessary	 for	 the	 creation	 of	 an	 integration	 competent	 synaptic	 complex	 (Craig	and	Nash,	1984)	(Fig.1.10).		
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Figure	 1.10.	 DNA	 recombination	 by	
lambda	 integrase	 and	 most	 tyrosine	recombinases	taken	from	(Laxmikanthan	et	 al.,	 2016).	 Four	 protein	 monomers	bind	 to	 the	 DNA	 strands.	 The	 reaction	starts	 with	 two	 active	 integrase	monomers	 performing	 the	 first	 set	 of	DNA	cleavages	in	both	attB	and	attP	sites	and	 two	 inactive	 monomers.	 The	 result	of	 the	 first	 cleavage	 set	 is	 the	 formation	of	 a	3’-phosphotyrosyl	 intermediate	and	free	 5’	 hydroxyl	 groups	 and	 strands	exchanges	 to	 create	 a	 Holliday	 junction	(HJ)	 intermediate.	 Once	 the	 HJ	intermediate	 is	 formed,	 the	 second	 pair	of	 integrase	 monomers	 becomes	 active	to	 perform	 the	 second	 set	 of	 strands	exchanges	 resulting	 in	 the	 final	 ligation	of	 the	 recombination	 mechanism.	 The	host-encoded	 integration	 host	 factor	(IHF,	 a	 DNA	 binding	 protein	 that	stabilizes	 the	 DNA	 confromationally	 to	support	the	action	of	Int)	is	necessary	for	recombination	 derived	 by	 tyrosine	recombinase	(Adapted	from	Rajeev	et	al.,	2009).		
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The	newly	formed	attR	and	attL	sites,	created	from	the	fusion	of	the	attP	and	attB	sites,	are	 not	 substrates	 for	 Int	 or	 IHF	 binding.	 Resolution	 of	 the	 attL	and	attR	sites	to	excise	the	now	integrated	prophage	requires	an	additional	phage-encoded	recombination	 directionality	 factor	 (RDF,	 also	 known	 as	 excisionase	 [Xis])	 in	addition	 to	 integrase	 and	 IHF,	 and	 the	 host	 encoded	 protein	 Fis	 (Factor	 for	Inversion	 Stimulation,	 encoded	 by	 E.	 coli	 fis	 gene,	 Gene	 ID:	 947697).	 The	 four	proteins	work	together	in	binding	to	the	P-arm	in	attR	inducing	a	loop	shape	that	rearranges	 the	 tetrameric	 integrase	 complex	 bound	 to	 the	 core	 sequence.	Sequential	DNA	cleavage	and	strand	exchange	reaction	to	reproduce	attP	and	attB	sites	(Fig.	1.10)(Lewis	and	Hatfull,	2001).	 
	
In	addition	to	the	catalytic	tyrosine	(T342	in	λ),	five	other	amino	acids	are	highly	conserved	in	the	tyrosine	family	of	recombinases,	three	of	them	corresponding	to	λ	R212,	H308,	and	R311,	which	all	together	comprise	what	is	known	as	the	RHR	triad.	 The	 two	 other	 amino	 acids	 are	 lysine	 and	 histidine	 residues,	 which	 are	present	 in	 >90%	 of	 the	 family	 members,	 corresponding	 to	 λ,	 K235	 and	 H333,	respectively,	 and	 making	 the	 classic	 pentad	 RKHRH	 (Nunes-Düby	 et	 al.,	 1998).	Lambda	integrase	is	composed	of	356	amino	acids	and	possesses	two	functional	domains.	The	N-terminal	domain,	 comprised	of	 residues	1-64,	 is	 responsible	 for	binding	 to	 the	 arm	 type	 binding	 sites	 of	 attP.	 The	 C-terminal	 domain,	 which	contains	the	catalytic	residues,	binds	at	 lower	affinity	to	the	core-type	sites.	The	
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action	of	the	C-terminus	can	be	separated	into	two	activities;	amino	acids	that	are	responsible	for	the	core	type	binding,	residues	65-169,	and	those	associated	with	the	 catalytic	 domain,	 residues	 170-356.	 The	 catalytic	 tyrosine	 and	 the	 RKHRH	pentad	 are	 located	 in	 the	 latter	 region	 (Tirumalai	 et	 al.,	 1998)	 (Fig.	 1.11).	 The	crystal	structure,	solved	by	Kwon	et	al,	of	the	catalytic	C-terminal	domain	showed	that	 the	 RKHRH	 pentad	 residues	 are	 located	 close	 to	 each	 other	 in	 a	 groove	expected	to	be	the	active	site.	Both	N-terminal	and	C-terminal	are	participating	in	the	 protein–protein	 interactions	 between	 the	 integrase	monomers	 (Kwon	 et	 al.,	1997).		
	
The	 interaction	 between	 tyrosine	 recombinases	 and	 their	 att	 sites	 are	 highly	specific.	λ	present	Int	 is	so	closely	related	to	HKO22	Int.	They	share	about	70	%	homology	 and	 both	 integrases	 can	 recognise	 same	 attP	 arm-type	 binding	 sites.	Nevertheless,	neither	integrase	can	recombine	the	att	sites	of	the	other	phage.	The	particular	DNA	base	pairs	 that	are	 responsible	 for	 this	 specificity	are	present	 in	the	core	type-sites.	
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Figure	1.11.	Protein	domain	structure	of	λ	Int.	The	orange	and	yellow	coloured	regions	are	the	DNA	binding	domains,	which	are	separated	by	the	arm	type	and	the	core	type	binding	domains.	The	white	region	 is	catalytic	domain.	The	conserved	catalytic	residues	are	 labelled.	The	catalytic	domain	 is	 the	residues	 170-356.	 In	 addition	 to	 the	 catalytic	 tyrosine	 residue	 (T342	 in	 λ),	 five	 other	 amino	 acids	 are	 highly	 conserved	 in	 the	 tyrosine	 family	 of	recombinases;	 three	of	 them	λ	R212,	H308,	and	R311,	 together	 comprise	what	 is	known	as	the	RHR	triad.	The	other	 common	amino	acids	(λ	K235	and	H333)	are	present	in	>90%	of	the	family	members	(Adapted	from	Groth	and	Calos,	2004).		
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These	sites	are	B’	sites	in	λ	and	HK022,	the	site	C	in	HK022	and	some	close	bases	in	the	flanking	sequences	of	these	cores	sites	(Nagaraja	and	Weisberg,	1990).	
1.4.4	Applications	of	tyrosine	recombinases		
Due	 to	 their	 ability	 to	 specifically	 and	 efficiently	 recombine	 DNA	 sequences	 in	living	 cells,	 tyrosine	 recombinases,	 or	 integrases,	 underpin	many	 biotechnology	techniques.		
1.4.4.1	GatewayÒ	cloning	system	
The	 GatewayÒ	 cloning	 method	 is	 the	 most	 widely	 used	 technique	 reliant	 on	tyrosine	 recombinases.	GatewayÒ	 is	 an	 in	vitro	 application	 that	uses λ	 integrase	to	 facilitate	 fast	 cloning	 of	 linear	DNA	 into	 especially	 designed	 plasmid	 vectors.	Once	the	desired	sequence	has	been	cloned	it	can	be	moved	with	ease	into	various	other	 specific	 plasmids	 for	 downstream	 use	 (e.g.	 induction	 vectors	 for	 protein	expression	or	protein	purification).	This	system	uses	the	ability	of	the	λ	integrase	to	promote	 integration	and	excision	reactions	with	high	accuracy	and	specificity	to	rearrange	att	sites	that	flank	the	multiple	cloning	sites	of	the	GatewayÒ	vectors	(Freuler	et	al.,	2008).		
	
The	 GatewayÒ	 systems	works	when	 the	 DNA	 insert	 of	 interest	 is	 cloned	 using	cassette	exchange	into	a	GatewayÒ	entry	plasmid.	The	entry	plasmid	is	designed	so	that	the	cloned	gene	of	interest	is	flanked	by	attL1	and	attL2	after	attB/attP	 
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	 Figure	 1.12.	 The	 GatewayÒ	cloning	system:	A.	 the	 cloning	of	the	interested	gene	inside	the	donor	or	entry	vector	using	the	
attB/attP	 recombination	reaction	 and	 that	 makes	 the	interested	 gene	 flanked	 now	with	 attL1	 and	 attL2	 hybrid	sites.	B.	The	 transferring	of	 the	interested	gene	 from	the	donor	vector	to	the	destination	vector	using	 the	 attR/attL	recombination	 reaction	(Adapted	 from	 Liang	 et	 al.,	2013).	
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recombination	 reaction	 (Fig.	 1.12).	 GatewayÒ	 system	 comes	 into	 its	 own	 by	enabling	 precise	 and	 efficient	 downstream	 cloning	 of	 the	 gene	 of	 interest	 into	destination	plasmids,	which	are	engineered	to	contain	negative	selectable	marker	that	are	flanked	by	attR1	and	attR2.	The	negative	selectable	marker	is	usually	the	
ccdB	 gene,	 coding	 for	 the	 toxic	 protein	 (CcdB)	 that	 acts	 as	 a	 DNA	 poison,	ultimately	causing	cell	death.  
	
The	 recombination	 reactions	 between	 the	 donor	 or	 entry	 plasmids	 and	 the	destination	 plasmids	 are	 performed	 in	 a	 test	 tube	 in	 the	 presence	 of	 a	 suitable	reaction	buffer	along	with	purified	Int	and	IHF.	The	recombinant	DNA	product	is	the	 destination	 plasmid	 that	 now	 harbors	 the	 gene	 of	 interest	 flanked	 by	recombination	 sites	 attB1	 and	 attB2.	 The	 direction	 of	 this	 approach	 can	 be	reversed	with	the	presence	of	the	λ	Xis	protein	to	restore	the	original	substrates	(Esposito	et	al.,	2009).		
	
The	 utilization	 of	 lambda	 recombinase	 in	 the	 GatewayÒ	 system	 drastically	reduces	problems	associated	with	traditional	cloning	e.g. time-consuming reactions, 
reliance on the presence and compatibility of restriction sites, and multiple purification 
steps. The recombination-based Gateway cloning technique enable efficient parallel 
transfer of the desired gene from the entry vector into a variety of different living cells 
protein expression systems, like E. coli cells expression system, yeast cellsexpression 
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system, and mammalian cells expression system (Walhout et al., 2000; Park et al., 
2015) 
	
1.4.4.2	Chromosomal	integration		
Integrase-mediated	 systems	 have	 been	 utilized	 to	 construct	 chromosomal	integration	 vectors	 since	 its	 first	 description	 in	 the	 early	 1990s	 for	 several	bacterial	species	(Atlung	et	al.,	1991).	These	systems	depend	on	the	use	of	either	a	single	suicide	plasmid	encoding	a	selectable	marker	gene,	attP	and	int	gene,	or	a	two-plasmid	 system	 in	 which	 an	 attP	 is	 carried	 on	 a	 suicide	 plasmid	 and	transformed	 to	 target	 cells	 that	 already	 harbor	 a	 separate	 integrase	 expression	plasmid.	Site-specific	recombination	can	take	place	with	the	endogenous	attB	site	and	can	be	selected	for	after	transformation	(Atlung	et	al.,	1991;	Lee	et	al.,	1991a;	Lee	et	al.,	1991b).	Chromosomal	integration	is	so	stable	and	the	reaction	can	not	reverse	itself,	as	the	excision	requires	an	RDF	and	xis	is	not	present	in	the	suicide	vector	used	in	this	approach	(Landy	and	Ross,	1977).		
	
This	 technique	 has	 also	 been	 used	 for	 the	 creation	 of	 recombinant,	 attenuated	vaccines	 against	 Mycobacteria	 tuberculosis,	 using	 the	 strain	 Bacillus	 Calmette-Guerin	 (BCG).	 BCG	 is	 an	 attenuated	 bovine	 strain	 has	 been	 successfully	 used	 to	stimulate	 immunity	 against	 Mycobacteria	 tuberculosis,	 the	 primary	 causative	agent	of	tuberculosis.	In	order	to	allow	the	expressing	of	foreign	antigens	in	BCG	
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and	 increase	 its	 immunogenicity,	 an	 integrating	 plasmid	 harboring	 the	mycobacteriophage	 L5	 attP	 site	 along	 with	 its	 cognate	 integrase	 gene,	 and	expressing	a	 cassette	 consisting	of	 a	promoter	 region	and	 including	 the	 first	 six	codons	of	the	heat	shock	protein	Hsp60	followed	by	a	multiple	cloning	site.	Genes	encoding	 the	 interesting	 antigens	 could	 then	 introduced	 as	 fusion	protein	 to	 be	expressed	in	vivo	post-vaccination	(Stover	et	al.,	1991).		
	
Another	 example	of	 the	use	of	 integrases	 to	drive	 chromosomal	 integration	 is	 a	plasmid	vector	that	depends	on	the	activity	of	the	recombinase	from	the	phage	f	CTX.	 In	addition	 to	 the	recombinase	gene,	 the	vector	harbors	 the	cognate	f	CTX	
attP	 site,	 a	 resistance	 marker	 gene	 and	 a	 multiple	 cloning	 site.	 This	 plasmid	efficiently	 directs	 integration	 of	 its	 recombinant	 cargo	 into	 the	 chromosome	 of	
Pseudomonas	aeruginosa	 ,	when	 this	 plasmid	 is	 introduced	 through	 conjugation	(Wang	et	al.,	1995).	
	
Flp	 recombinases,	 encoded	 by	 Saccharomyces	 cerevisiae	 (Dymecki,	 1996),	 can	facilitate	the	removal	of	the	entire	plasmid	backbone,	from	a	plasmid	that	has	its	target	 FRT	 sites	 flanking	 the	 multiple	 cloning	 sites,	 to	 create	 a	 markerless	recombinant	strain,	which	can	be	an	essential	feature	some	biological	or	medical	applications.	A	mediate	simultaneous	or	sequential	multiple	integrations	can	also	beperformed	using	different	 integrases	 to	 integrate	different	plasmids	 into	 their	respective	 attB	 sites.	 Integrases	 that	 are	 used	 in	 this	 approach	 are	 usually	
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provided	 from	 phages	 that	 infect	 bacterial	 strains	 intended	 for	 genetic	manipulation.	As	most	of	these	assays	relay	on	the	presence	of	targeted	attB	sites	for	each	 integrase	and	the	required	host-encoded	accessory	 factors	(St-Pierre	et	al.,	2013;	Rodriguez	et	al.,	2003)	
	
1.4.4.3	Tyrosine	integrases	in	mammalian	cells	
Lambda	integrase	has	even	been	successfully	used	in	many	applications	of	genetic	engineering	 in	 mammalian	 cells.	 However,	 mutations	 being	 introduced	 to	integrase	 gene,	 makes	 this	 integrase	 so	 suitable	 in	 such	 applications.	 Lambda	integrase	 recognizes	 a	 big	 size	attP	 site,	 and	 it	 requires	 a	 supercoiled	DNA	 and	integration	 host	 factor	 protein	 IHF,	 to	 drive	 DNA	 recombination.	 The 
development of mutants so that the integrase does not need IHF or supercoiling 
requirements to perform DNA recombination may increase its utility. Two types 
of mutations were introduced in int gene to produce Int-h and Int-h/218. Both of 
the resulting mutant integrases have been shown to drive its function but without 
the requirement of accessory factors or supercoiled DNA (Lorbach et al., 2000). 
The mutant integrase Int-h can recombination in the absence of IHF but at a 
lower level of function. In vitro studies revealed that Int-h prefer supercoiled 
DNA if IHF present in the reaction buffer, but no preference were showed in the 
absence of IHF. It was stated that the reason behind the ability of mutant 
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integrase to work even without the presence of IHF was due to an increased 
affinity of the enzyme for core-type sites (Patsey and Bruist, 1995). 
	
The	 Int-h/218	 mutant	 integrase	 has	 been	 used	 to	 perform	 intermolecular	recombination	 in	 embryonic	 stem	 cells	 chromosomes	 of	 mouse.	 The	 mutant	integrase	 can,	 at	 a	 low	 frequency,	 integrate	 a	 cassette	 that	 carries	 a	 resistant	marker	in	to	the	genome.	The	cassette	has	to	have	suitable	lambda	att	sites	for	the	integration	 to	 take	 place.	 Excision	 of	 the	 resistance	 marker,	 which	 activated	transcription	 of	 a	 green	 fluorescent	 protein	 gene,	 could	 be	 detected	 by	 FACS	analysis	occurred	at	a	frequency	of	0.01	–	0.1%	(Christ	and	Dröge,	2002).	
	
The	 recombinase	 Flp,	 from	 the	 yeast	 Saccharomyces	 cerevisiae,	 and	 Cre	recombinase,	 from	phage	P1,	are	 two	more	examples	of	 the	use	of	 integrases	 in	mammalian	cells.	Both	recombinases	promote	site-specific	recombination	events	between	 two	 identical	DNA	sequences.	The	 target	 sequence	 for	Flp	 is	 the	48-bp	FRT	 site	 and	 that	 for	Cre	 is	 the	34-bp	 loxP	 site.	Both	Flp	 and	Cre	belong	 to	 the	simple/	bidirectional	 tyrosine-type	recombinase	 family	and	do	not	require	host-encoded	accessory	proteins	or	specific	flanking	sequences.	This	simplicity	makes	both	 the	 Cre/loxP	 and	 Flp/FRT	 systems	 useful	 tools	 for	 in	 vivo	 DNA	rearrangements	 and	 gene	 knock-out	 or	 knock-in	 in	 variety	 of	 heterologous	environments,	 including	 human	 cells	 (Hirano	 et	 al.,	 2011;	 Austin	 et	 al.,	 1981;	Broach	et	al.,	1982).	
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The	 combination	 of	 gene	 targeting	 techniques,	 performed	 by	 Flp/FRT	 and	 site-specific	 recombination	 systems,	 by	 Cre/loxP,	 have	 been	 widely	 exploited	 to	produce	gene	insertions,	deletions,	exchanges	and	inversions	in	higher	eukaryotes	cells	 such as mammalian	 or	 mice	 cells,	 since	 both	 of	 these	 integrases	 can	recombine	 specific	 DNA	 sequences	 with	 high	 fidelity	 and	 without	 accessory	proteins	requirements	(Branda	and	Dymecki,	2004). 	
1.5.	!24B	Integrase	Protein	
The	bacteriophage	ϕ24B	 is	a	Shiga	 toxin-encoding,	 temperate	phage.	To	date,	all	characterized	 Stx	 phages	 belong	 to	 the	 lambdoid	 family.	 This	 phage	 can	 follow	either	 lytic	 or	 lysogenic	 replication/infection	 strategies	 in	 the	 E.	 coli	 bacterial	host.	When	the	phage	genome	is	integrated	into	the	host	chromosome,	it	becomes	a	prophage	and	gives	 its	host	 the	ability	of	producing	Shiga	 toxin.	This	 infection	converts	 the	 E.	 coli	 into	 a	 Shiga-toxin	 producing	 E.	 coli	 (STEC)	 (Allison,	 2007;	O'Brien	et	al.,	1984).		
	
The	integrase	that	drives	the	integration	the	f24B	phage	genomic	DNA	into	the	E.	
coli	host	chromosome	is	a	phage-encoded	protein	belonging	to	the	tyrosine	family	of	 site-specific	 integrases.	 Normally,	when	 lambdoid	 phages	 integrate	 into	 their	host’s	 genome,	 the	 prophage	 confers	 immunity	 against	 other	 related	 lambdoid	phages	being	able	to	infect	the	lysogen	E.	coli	host.	However,	this	immunity	model	
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does	not	hold	for	the	Stx	phage	f24B	(Allison	et	al.,	2003)	or	for	other	phages	that	carry	 an	 integrase	 like	 the	 one	 encoded	 by	 f24B	(Koudelka	 et	 al.,	 2004).	 Phage	
f24B	can	integrate	into	more	than	five	sites	within	a	single	bacterial	chromosome.	This,	 consequently,	 increases	 the	 pathogenic	 potential	 of	 the	 infected	 bacterial	host,	 enabling	multiple	 copies	 of	 Shiga	 toxin	 genes,	 which	 can	 lead	 to	 increasd	toxin	 production	 from	 the	 stx	 gene	 (Fogg	 et	 al.,	 2007;	 Fogg	 et	 al,	 2011).	 This	multiple	integration	takes	place	inside	one	bacterial	chromosome	as	ϕ24B	Int	has	been	shown	to	be	able	to	integrate	within	four	distinct	sites	within	the	E.	coli	host.	However,	 these	bacterial	 attachment	 sites	 share	only	 about	50%	DNA	sequence	homology.	 The	 first	 recognized	 site,	 the	 primary	 site,	 shares	 24	 bp	 complete	identity	 with	 the	 phage	 attachment	 site,	 attP	 sequence	 (discussed	 further	 in	Chapter	5).	
	
The	 efficiency	 of	 new	 prophage	 integration	 increases	 with	 each	 successive	superinfection	 event	 due	 to	 the	 increased	 level	 of	 Int	 production.	 It	 has	 been	stated	that	 the	expression	of	ϕ24B	Int	 is	enhanced	2.6	 fold	 in	 the	double	 lysogen	and	 7.5	 fold	 in	 the	 triple	 lysogen,	 compared	 to	 its	 expression	 level	 in	 single	lysogen	 (Fogg	 et	 al.,	 2011).	 Unlike	 lambda	 integrase,	 ϕ24B	Int	 is	 not	 under	 the	control	 of	 repressor	 protein,	 CI.	 The	 orientation	 ϕ24B	 Int	 gene	 is	 inverted	compared	 to	 integrase	 genes	 in	 other	 lambdoid	 phages,	 which	 means	 it	 is	 not	repressed	 in	 the	 lysogen.	 In	 fact,	 Int	 has	 been	 shown	 to	 be	 constitutively	
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Figure	 1.13.	 The	 integrase	 region	 in	 the	 ϕ24B	 phage	 genome.	 This	 genetic	 map	 display	 the	 integrase	 transcription	 in	 an	 inverted	 orientation	compared	to	 its	orientation	 in	lambda	phage.	Because	of	its	orientation,	the	transcription	of	ϕ24BInt	is	not	under	the	control	of	repressor	CI	(Adapted	from	Fogg	et	al.,	2011).		
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expressed	by	f24B	lysogens	so	that	active	enzyme	is	always	being	made	(Fogg	et	al.,	2007).	Several	experiments	were	performed	to	confirm	this	 interpretation	of	the	control	of	f24B	Int	expression.	Artificial	expression	of	the	CI	repressor	gene	by	an	arabinose	inducible	promoter	and	the	use	of	qPCR	confirmed	that	the	f24B	Int	gene	 was	 not	 repressed	 though	 the	 f24B	 Q	 gene	 was	 repressed	 as	 expected	(Fig.1.13).	The	Q	antiterminator	gene	expression	was	use	as	positive	control	 for	this	assay	(Fogg	et	al.,	2011).	However,	f24B	forms	an	inducible	prophage,	so	that	the	excision	of	the	prophage	genome	from	the	E.	coli	chromosome	must	somehow	still	be	regulated	by	CI	repression.	This	was	indeed	found	to	be	the	case.	Int, itself, 
though necessary for excision, requires an additional recombination 
directionality factor. Conforming	to	the	model	of	tyrosine	recombinase	activities,	the	ϕ24B	integrase	 is	 responsible	 for	 the	phage	DNA	 integration	 inside	bacterial	chromosome,	however,	bacteriophage	ϕ24B	excision	 is	also	catalyzed	by	Int	and	an	 RDF,	 and	 this	 RDF	 is	 under	 control	 of	 PL,	 which	 cannot	 be	 repressed	 by	 CI	(Fogg	et	al.,	2011).	 
1.6.The	study	aims	
The	 aim	 of	 this	 study	 is	 to	 fully	 characterize	 the	 requirements	 of	 the	 integrase	carried	 by	 the	 Stx	 phage	 Φ24B	 (IntΦ24B)	 to	 drive	 integration,	 as	 the	 four	confirmed	 integration	 sites	 in	 a	 characterized	 E.	 coli	host	 share	 little	 sequence	identity.	The	strategy	for	characterizing	the	requirements	for	the	integrase	is	to:		
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1.	Establish	a	working	protocol	for	both	an	in	vitro	and	an	in	situ	integration	assay	based	upon	 the	 in	vitro	assay	used	 for	 the	bacteriophage	Lambda	 integrase	 and	the	working	in	situ	IntΦ24B	assay.		
2.	 Clone	 the	 minimal	 sequence	 lengths	 surrounding	 the	 characterised	 primary	integration	site	required	for	both	attB	and	attP.		
3-	Determine	which	 nucleotides	within	 the	minimal	attB	site	 are	 necessary	 and	essential	to	support	integrase	recognition	through	site	directed	mutagenesis.		
4-Determine	the	recombination	frequency	and	preference	of	each	recombination	site	 with	 the	 E.	 coli	 chromosome,	 as	 ϕ24B	 integrase	 can	 integrate	 the	 phage	genome	inside	more	than	five	different	bacterial	attachment	sites	attBs.	
5-Determine	the	 importance	of	bacterial-encoded	 integration	host	 factor,	 IHF,	 in	the	phage	integration.	
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CHAPTER	2. GENERAL	MATERIALS	AND	METHODS	
2.1.	Bacterial	Strains		
All	bacterial	strains	used	are	listed	and	described	in	Table	2.1.1.	E.	coli	K-12	strain,	MC1061,	was	used	as	the	source	for	the	attB1-4	sequences.	E.	coli	K-12	strain	BL21	was	used	to	produce	recombinant	IHF,	while,	E.	coli	K-12	strain	TOP10	was	used	to	host	all	of	the	in	situ	recombination	assays.	
Table	2.1.1.	Bacterial	strains	used	in	this	study		
Strain	 Description	 References	MC1061		 E.	coli	K-12	derivative	 {James,	 2001,	 Lytic	 and	 lysogenic	infection	 of	 diverse	 Escherichia	coli	 and	 Shigella	 strains	 with	 a	verocytotoxigenic	 bacteriophage;	Casadaban,	1980,	Analysis	of	gene	control	signals	by	DNA	fusion	and	cloning	in	Escherichia	coli}	TOP10	 Competent	cells,	recA-*	 Invitrogen	
BL21(AI)	 araB¶::T7RNAPÀ-tetAÃ,	recA-	 Invitrogen	JW1702-1	 ΔihfA786::kanÁ	 Coli	Genetic	Stock	Centre	(Baba	et	al.,	2006)	
*	recA-_:	mutation	in	DNA	repair	recombinase	gene. 
¶ araB:	arabinose	inducible	promoter.	
À T7RNAP:	bacteriophage	T7	RNA	polymerase.	
ÃtetA:	tetracycline	resistance	gene.	
ÁΔihfA786::kan	 :	 Integration	 host	 factor	 production	 deficient	 mutant	 created	 by	 the	 allelic	replacement	 of	 the	 ihfA	 gene	 with	 the	 aphA	 gene	 conferring	 resistance	 to	 the	 antibiotic	kanamycin.	
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Table	2.2.1.	Plasmids	used	in	this	study		 	 	Plasmid	 Description		 Source	pEE2003	 Derivative	of	pET16b,	AmR * (Frumerie	et	al.,	2005)	
pBAD/Myc-His	C			 araBAD,	 C-myc/His6	 epitope,	 pBR322	ori,	AmR	 Invitrogen	pBR322	 pMB1	ori,	tetR	 (Bolivar	et	al.,	1977)	pME	4510	 pBR322	ori,	GenR (Rist	and	Kertesz,	1998)	
pCR2.1	 TA	Cloning,	KanR/	AmR	 Invitrogen	pΦ24B-int	 pBAD	carrying	24B	int (Fogg	et	al.,	2011)	pACYCDuetTM-1	 P15A	ori,	CmR	 Novagen	pCDF	DuetTM-1	 CDF	ori,	Sp/SmR	 Novagen	pET	DuetTM-1	 pBR322	ori,	AmR Novagen	pRSFDuetTM-1	 RSF	ori,	KanR	 Novagen	pCOLADuetTM-1	 ColA	ori,	KanR	 Novagen	pET	DuetGen	 pBR322	ori,	GenR This	study	pCOLADuettet	 ColA	ori,	tetR	 This	study	
pCR-Φ24B-attB600 pCR2.1 carrying Φ24B	attB1	(600	bp) This	study	
pCR-Φ24B-attB400 pCR2.1 carrying Φ24B	attB1	(400	bp) This	study	
pCR-Φ24B-attB300 pCR2.1 carrying Φ24B	attB1	(300	bp) This	study	
pCR-Φ24B-attB200 pCR2.1 carrying Φ24B	attB1	(200	bp) This	study	
pCR-Φ24B-attB100 pCR2.1 carrying Φ24B	attB1	(100	bp) This	study	
pCR-Φ24B-attP600 pCR2.1	carrying	Φ24B attP (600 bp)	 This	study	
pCR-Φ24B-attP400 pCR2.1	carrying	Φ24B attP (400 bp)	 This	study	
pCR-Φ24B-attP300 pCR2.1	carrying	Φ24B attP (300 bp)	 This	study	
pCR-Φ24B-attP200 pCR2.1	carrying	Φ24B attP (200 bp)	 This	study	
pCR-Φ24B-attP100 pCR2.1	carrying	Φ24B attP (100 bp)	 This	study	
pΦ24B-attB1		 pACYCDuet		carrying	Φ24B attB1 (600 bp)	 This	study		
pΦ24B-attB1-324 pACYCDuet		carrying	Φ24B attB1 (324 bp)	 This	study		
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pΦ24B-attB1-125 pACYCDuet		carrying	Φ24B attB1 (125 bp)	 This	study		
pΦ24B-attB1-110 pACYCDuet		carrying	Φ24B attB1 (110 bp)	 This	study		
pΦ24B-attB1-93 pACYCDuet		carrying	Φ24B attB1 (93 bp) This	study		
pΦ24B-attB1-60 pACYCDuet		carrying	Φ24B attB1 (60 bp) This	study		
pΦ24B-attB1-25 pACYCDuet		carrying	Φ24B attB1 (25 bp)	 This	study		
pΦ24B-attB2 pRSFDuet	carrying	Φ24B attB2 (600 bp)	 This	study		
pΦ24B-attB3 pETDuetGen	carrying	Φ24B attB3 (600 bp)	 This	study		
pΦ24B-attB4 pCOLADuettet	 carrying	Φ24B attB4 (600 
bp)	 This	study		
pΦ24B-attP600 pCDFDuet	carrying	Φ24B attP (600 bp) 	 This	study		
pΦ24B-attP427 pCDFDuet	carrying	Φ24B attP (427 bp) 	 This	study		
pΦ24B-attP350 pCDFDuet	carrying	Φ24B attP (350 bp) 	 This	study		
pΦ24B-attP237 pCDFDuet	carrying	Φ24B attP (237 bp) 	 This	study		
pΦ24B-attP140 pCDFDuet	carrying	Φ24B attP (140 bp) 	 This	study		*AmR	:	Ampicillin	resistance	gene	.		araBAD:	arabinose	inducible	promoter.	His6:	C-terminal	hexa-histidine	tag.	C-myc:	C-terminal	myc	human	oncogene	peptide	epitope.		KanR:	kanamycin	resistance	gene	.		P15A ori: P15A	replicon.	
 CmR : chloramphenicol	acetyl	transferase	gene	.	
CDF ori: CloDF13-derived	CDF	replicon	. 	SpR/SmR: 	spectinomycin	resistance	gene	.  pBR332	ori:	the	pBR322-derived	ColE1	replicon.		GenR:		Gentamicin	resistant	gene	.		
RSF ori:	the	RSF1030-derived	RSF	replicon;	
 ColA ori:	the	COLA	replicon	from	ColA(1)	.			
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Table	2.2.2.	Composition	of	growth	media,	buffers	and	antibiotic	preparations		Media/buffers/antibiotics	 Composition	LB	Agar	Plates	 3.7%	 (w/v)	 Luria	 Bertani	 Agar	 (Merck	 KGaA,	 Darmstadt,	Germany)	LB	Growth	Media		 2.5% (w/v) Luria Bertani Broth(Merck	 KGaA,	 Darmstadt,	Germany) SOC	Growth	Media		 10%	 (w/v)	 Bactotryptone,	 0.5%(w/v)	 Yeast	 extract,	 10mM	NaCl,	 2.5	 mM	 KCl,	 10	 mM	 MgCl2,	 10	 mM	 MgSO4,	 20	 mM	Glucose	IPTG	(100X	stock)	 100	mM	IPTG	(Bioline,	ES532-BO25850	)	Arabinose	(100X)	 205(W/v)	L-Arabinose	(Sigma,	#	MKBN4207V)	X-Gel	 5-broma-4-chliro-3-ndolyl-"-D-galactoside.	TfB	I	Buffer		 30	mM	KOAc,	50	mm	MnCl2,	100	mM	KCl,	10	mM	CaCl2,	15%	(v/v)		Glycerol	TfB	II	Buffer		 10	 mM	 Na	 MOPS	 (PH7),	 75	 mM	 CaCl2,	 100	 mM	 KCl,	 15%	(v/v)		Glycerol	TAE	(50X	stock)	 2	M	Tris	Base,	1	M	Glacial	Acetic	Acid,	0.05	M	EDTA		Ampicillin	(1000X)	 100	mg	ml-1	Ampicillin	sodium	salt		(Sigma,	#	BCBG2945V)	Kanamycin	(1000X)	 50	mg/ml	Kanamycin	Monosulphate	(Melford,	K0126)																												Spectinomycin	(1000X)	 100	mg/ml	Spectinomycin	dihydrochloride		(	Sigma,	102KO544)		Chloramphenicol	(1000X)	 12.5mg/ml	Chloramphenicol	(Sigma,	C-0378)		Tetracycline	(1000X)	 5	mg/ml	Tetracycline	(	Sigma,T8032	Gentamicin	(1000X)	 10		mg/ml	Gentamicin	(Melford,GO124)																																				Lysis	Buffer		 50	mM	NaH2PO4,	300	mM	NaCl,	10mM	imidazole,	pH	adjusted	to	be	8	using	NaOH.	Washing	Buffer		 50	Mm	NaH2PO4,	300	mM	NaCl,	20mM	imidazole,	pH	adjusted	to	be	8	using	NaOH.	Elution	buffer		 50	 Mm	 NaH2PO4,	 300	 mM	 NaCl,	 250mM	 imidazole,	 pH	adjusted	to	be	8	using	NaOH.	Tricine	Sample	Buffer	2X For	50	ml:	 5	ml	Tris-Cl(1M,PH6.8),	 12	ml	Glycerol,	 4	 g	 SDS,	1.55g	DTT,	10	mg	Coomassie	Blue	R250,	water	up	to	50	ml,	stored	at	room	temperature.			
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2.2.	Plasmids,	culture	conditions,	and	buffers	used	in	this	study		
The	plasmids	used	throughout	this	study	are	listed	in	Table	2.2.1,	while	routinely	used	 growth	media,	 buffers	 and	 antibiotics	 are	 listed	 in	Table	 2.2.2. Both the 
primary bacterial attachment site and the bacteriophage attachment site were cloned 
each inside its pCR2.1 plasmid, as we were testing them in an in vitro recombination 
assay. However, in order to drive an in situ recombination assay we had to clone phage 
attachment site and bacterial attachment sites each in its compatible plasmid.   
2.3.	Bacterial	genomic	DNA	Extraction	
An overnight culture of the desired E. coli strain or lysogen was processed using the ISOLATE	 II	 Genomic	 DNA	 Kit	(Bioline,London,U.K.)	 according	 to	manufacturer’s	instructions.	Samples	were	quantified	using	NanoDrop	(Thermo-Fisher	Scientific	Inc.,	MA,	USA)	spectrophotometry.	DNA	samples	were	stored	at	-20oC.	
	
3M	Tris-HCl/SDS	pH8.4 182g	Tris	 base	 in	300ml	dH2O	 (pH	8.45	by	 add	HCl),	water	until	500ml,	1.5g	SDS	,	30ml	5M	NaCl.	Anode	Buffer,	10X	 242g	 Tris	 base	 in	 700	ml	 dH2O	 (pH	 8.45	 by	 add	 HCl),	 Q.S.	Water	1L.	Cathode	Buffer,	10X	 179.2	Tricine	in	800	ml	dH2O	(pH	8.3),	50	ml	20%	SDS,	water	until	1L.	Coomassi	stain	solution	 2g	 Coomassu	 blue,	 450ml	 Methanol,	 450	 ml	 dH2O,	 100	 ml	Glacial	acetic	acid.		Coomassi	destain	solution	 450ml	Methanol,	100	ml	Glacial	acetic	acid,	Q.S.	1L	dH2O.	Ampicillin	 resistance	 gene	 (AmR);	 araBAD:	 arabinose	 inducible	 promoter;	 His6:C-terminal	 hexa-histidine	 tag;	 C-myc:	 C-terminal	 myc	 human	 oncogene	 peptide	 epitope;	 kanamycin	 resistance	 gene	(KanR); P15A	ori:	P15A replicon; chloramphenicol	acetyl	transferase	gene	(CmR);	CDF	ori:	CloDF13-
derived CDF replicon;	 spectinomycin	 resistance	 gene	 (SpR/SmR); pBR332 ori: the pBR322-
derived ColE1 replicon; Gentamicin resistant gene (GenR); RSF	 ori: the RSF1030-derived RSF 
replicon; ColA ori: the ColA replicon from ColA.  
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2.4.	Plasmid	recovery	
2.4.1	Plasmid	mini	prep	
In order to purify plasmid DNA from bacterial cells, the ISOLATE	II	Plasmid	Mini	Kit	(Bioline,	 London,	 U.K.)	 was	 used.	 Five	 millilitres	 of	 an	 overnight	 culture	 of	bacterial	cells	harbouring	the	plasmid	of	interest	were	centrifuged	at	11,	000	x	g	for	 1	 min.,	 and	 the	 resulting	 cell	 pellets	 were	 processed	 according	 to	 the	manufacturer’s	 instructions.	 	Cells	were	 resuspended	 in	250	µL	of	 resuspansion	buffer	 P1.	 The	 cells	 were	 lysed	 by	 the	 addition	 of	 250	µL	 P2.	 The	 sample	 was	inverted	 6-8	 times	 for	 mixing	 and	 incubated	 at	 room	 temperature	 for	 5	 min.	Neutralisation	buffer	(300	µL)	were	added	and	the	sample	was	mixed	by	inverting	6-8	 times.	 	 Cell	 debris	was	 removed	 from	 the	 DNA	 sample	 by	 centrifugation	 at	11,000	x	g	for	5-10	min.	Miniprep	columns	(Bioline)	were	loaded	with	the	sample	supernatant	and	centrifuged	at	11,000	x	g	for	1	min.	Columns	were	washed	with	washing	buffer	1	(PW1)	and	washing	buffer	2	(PW2),	before	a	final	centrifugation	step,	at	11000g	for	2	min,	to	remove	any	remaining	ethanol.	The	DNA	was	eluted	using	an	appropriate	amount	(30-50ul)	of	pre	heated	(50	°C)	dH2O.	
	
2.4.2.	Plasmid	midi	prep	
QIAGEN midi kit (W. Sussex, U.K.) was used for plasmid midi preparation. Twenty Five	 millilitres	 of	 an	 over	 night	 culture	 of	 bacterial	 cells	 harbouring	 the	 the	plasmid	of	 intrest	were	centrifuged	at	6,000	x	g	 for	15	min	at	4o°C,	and	samples	pellets	were	 processed	 according	 to	 the	manufacturer’s	 instructions.	 Cells	were	
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resuspanded	in	4	ml	of	buffer	P1.	The	cells	were	lysed	by	the	addition	of	4	ml	of	buffer	p2,	and	the	samples	were	vigorously	inverted	4-6	times,	before	they	were	incubated	for	5	min	at	room	temperature.	A	four	millilitres	of	pre	chilled	Buffer	P3	were	added,	mixed	thoroughly	by	inverting	4-6	times,	and	incubated	in	ice	for	15	min.	The	samples	were	centrifuged	at	20,000	x	g	for	30	min	at	4	°C.		
	
To	make	them	ready	to	be	used,	 the	QIAGEN-tip	100	columns	were	equilibrated	by	applying	4	ml	of	buffer	QBT,	and	columns	allowed	to	empty	by	gravity	flow.	
Then,	the	samples	supernatant	were	applied	to	the	QIAGEN-tip	100,	and	left	to	be	moved	though	it	by	the	effect	of	gravity	flow.	After	that,	and	by	the	same	way,	the	QIAGEN-tip	100	were	washed	with	10	ml	of	buffer	QC	 for	 two	 times	before	 the	DNA	 was	 eluted	 using	 5ml	 of	 buffer	 QF	 in	 to	 15	 ml	 vessel.	 The	 DNA	 was	precipitated	by	adding	3.5	ml	room-temperature	 isopropanol	and	centrifuged	at	15000g	 for	 30	min	 at	 4°C.	 The	 supernatant	was	 carefully	 discarded;	 the	 pellets	were	washed	with	70	%	ethanol	and	centrifuged	at	15000g	for	10	min.	After	the	careful	 decant	 of	 the	 supernatant,	 the	DNA	pellets	were	 air-dried	 for	 5-10	min.	The	DNA	redissolved	in	the	suitable	volume	of	appropriate	buffer.	
	
2.5.	Polymerase	chain	reaction	(PCR)	
MyTaq	(Bioline,	London,	U.K.)	was	routinely	used	in	DNA	amplification.	When	an	error	 free	PCR	product	was	needed,	 the	DNA	amplification	was	conducted	using	the	hot	start	Highly	Fidelity	Q5	DNA	Polymerase	(New	England	Biolabs,	Ipswich,	
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USA).	 The	 PCR	 conditions	 using	 MyTaq	 polymerase	 stared	 with	 2	 min	 initial	denaturation	step	at	95	°C,	 followed	by	30	cycles	of	denaturation	at	95	°C	for	10	sec.,	 primer	 annealing	 (temperature	 determined	 depending	 on	 the	 specific	primers	Table	2.5.2.)	for	10	sec.	and	ended	an	extension	at	72	°C	for	30	sec.	per	kb	of	the	desired	amplified	product,	and	a	final	extension	step	at	72	°C	for	2	min.	On	the	other	hand,	the	typical	thermo	cycling	PCR	program	using	the	Highly	Fidelity	Q5	 DNA	 Polymerase	 started	 with	 initial	 denaturation	 step	 at	 98	°C	for	 30	 sec.,	fallowed	by	30	cycles	of	denaturation	at	the	same	temperature	for	10	sec.,	primer	annealing	 time	 was	 15	 sec	 at	 the	 specific	 primer’s	 temperatures.	 The	 PCR	extension	 took	 place	 at	 72	°C.	 It’s	 time	was	 30	 sec.	 per	 kb	 product.	 All	 the	 PCR	amplifications	were	run	using	Eppendrof	(New	York,	USA)	thermo	cycler.	dNTPs	(Bioline,	 London,	 U.K.)	 is	 one	 of	 necessary	 gradient	 in	 the	 PCR	 reaction	 that	performed	using	 the	Highly	 Fidelity	Q5	DNA	Polymerase.	 Specific	 primers	were	purchased	from	Eurofins	Genomics	(Wolverhampton,	U.K.).		DNA	templates	for	50	%l	 PCR	 reaction	 were	 1-2	%l	 of	 10-50	 ng	 DNA	 preparations,	 or	 0.5	%l	 -1	%l	 of	 a	resusupanded	 bacterial	 colony	 in	 water	 (100 	% l)	 (colony	 PCR).	 	 All	 PCR	experiments	were	 performed	 along	with	Negative	 controls,	 in	which	water	was	added	 instead	of	DNA	templates.	 	PCR	products	were	separated	on	TAE-agarose	gel.	
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Table	2.5.1.	PCR	mastermix	using	Q5	high	fidelity	DNA	polymerase	
Reagent	 5Q	polymerase	(50	ul	reaction)	
Reaction	buffer	 1x	
dNTPs	 200	%M	
Oligonucleotides	primers	 0.5	%M	
DNA	polymerase	 0.02	U	%l-1	
	
Table	2.5.2.	Oligonucleotide	primers	used	for	PCR	amplifications	of	DNA	
Primers	 Sequence	(5’-3’)	 Annealing	
temp.	(°C)	
	
Reference	
T7	promoter	 TAATACGACTCACTATAGGG	 60	 Novagen	
T7	terminator	 GCTAGTTATTGCTCAGCGG	 60	 Novagen	
M13	F	 GTAAAACGACGGCCAGT	
	
60	 Invitrogen	
M13	R	 CAGGAAACAGCTATGAC	 60	 Invitrogen	
pBAD	F	 ATGCCATAGCATTTTTATCC	 60	 Invitrogen	
pBAD	R	 GATTTAATCTGTATCAGG	 60	 Invitrogen	
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Int	F	 TTATATCCATTTAACTAAG	 50	 This	study	
Int	R	 TTAACCGAGCTGTTTA	 50	 This	study	
Ihf	A	F	 GCAGAGCGGCCTTTTTA	 65	 (Frumerie	 et	al.,	2005)	
Ihf	A	R	 TCCAGGCATCATTGAGGGA	 65	 (Frumerie	 et	al.,	2005)	
ACYCDuetUP1	F	 GGATCTCGACGCTCTCCCT	 65	 Novagen	
pET	Upstream	 ATGCGTCCGGCGTAGA	 65	 Novagen	
attP600	F	 CTGAAGGATTTGCGTAAACAGC	 60	 This	study	
attP600	R	 GATAGTTCCTGCTGGAGTAATCC	 60	 This	study	
attP	427	F	 ACAGTCGGCGATGGTGA	 55	 This	study	
attP	427	R	 ATCCTGTACACAAGTTTATAA	 55	 This	study	
attP	427		F		(PCR	cloning)	 *CATCACCACAGCCAGGATCC	ACAGTCGGCGATGGTGA	 1-					55	2-					60	
This	study	
attP	427	R	(PCR	cloning)	 *GTTTCTTTACCAGACTCGAG	ATCCTGTACACAAGTT	 1-					55	2-					60	
This	study	
attP	350	F	 CGTGGATCGGTTTAA	 50	 This	study	
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attP	350	R	 GCGTACATATTGAG	 50	 This	study	
attP	350	F	(PCR	cloning)	 *CATCACCACAGCCAGGATCC		
CGTGGATCGGTTTAA	
1-					50	
2-					60	
This	study	
attP	350	R	(PCR	cloning)	 *GTTTCTTTACCAGACTCGAG	
	GCGTACATATTGAG	
1-					50	
2-					60	
This	study	
attP	237	F	 AGTGGAGTAAAGAACATGC	 60	 This	study	
attP	237	R	 CGAACTTACACCTTGATTTTA	 60	 This	study	
attP	237	F	(PCR	cloning)	 *CATCACCACAGCCAGGATCC	
AGTGGAGTAAAGAACATGC	
1-					60	
2-					60	
This	study	
attP	237	R	(PCR	cloning)	 *GTTTCTTTACCAGACTCGAG	
CGAACTTACACCTTGATTTTA	
1-					60	
2-					60	
This	study	
attP	140	F	 GGTACTAATATGACGATTAT	 55	 This	study	
attP	140	R	 GACGGTATTATCAGTCATA	 55	 This	study	
attP	140	F	(PCR	cloning)	 *CATCACCACAGCCAGGATCC	
GGTACTAATATGACGATTAT	
1-					55	
2-					60 
This	study 
attP	140	R	(PCR	cloning)	 *GTTTCTTTACCAGACTCGAG	
GACGGTATTATCAGTCATA	
1-					55	
2-					60 
This	study 
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attB	600	F	 ATCTGCTTAACGGTGAGCAT	 65 This	study 
attB	600	R	 TTAACGGTACGCTGCACTGG	 65 This	study 
attB	342	F	 GCGTAAAGCAGAAG 50	 This	study	
attB	324	R	 CCATGACGAACTGT 50	 This	study	
attB	324	F	(PCR	cloning)	 *CATCACCACAGCCAGGATCC	
GCGTAAAGCAGAAG	
1-					50	
2-					60	
This	study	
attB	324	R	(PCR	cloning)	 *GTTTCTTTACCAGACTCGAG		
CCATGACGAACTGT	
1-					50	
2-					60	
This	study	
attB	125		F	 CCCCGCACTCCATT	 55	 This	study	
attB	125	R	 GCGAACTGATAAATGG	 55	 This	study	
attB	125		F	(PCR	cloning)	 *CATCACCACAGCCAGGATCC	
CCCCGCACTCCATT	
1-				55	
2-				60	
This	study	
attB	125	R	(PCR	cloning)	 *GTTTCTTTACCAGACTCGAG	GCGAACTGATAAATGG	 1-				55	2-					60	
This	study	
attB	110	R	 GTGTCCCCTGCAGGA	 60	 This	study	
attB	110	R	(PCR	cloning)	 *GTTTCTTTACCAGACTCGAG		
GTGTCCCCTGCAGGA	
1-					60	
2-					60	
This	study	
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attB	60		F	 GGGTATACTCATGCC	 55	 This	study	
attB	60	R	 TTAGCCCTTAGGAGG	 55	 This	study	
attB	60		F	(PCR	cloning)	 *CATCACCACAGCCAGGATCC		
GGGTATACTCATGCC	
1-					55	
2-					60	
This	study	
attB	60	R	(PCR	cloning)	 *GTTTCTTTACCAGACTCGAG	
	TTAGCCCTTAGGAGG	
1-					55	
2-					60	
This	study	
attB	25		F	(PCR	cloning)	 GTCCTCTTAGTTAAATGGATATA	
ACTCGAGTCTGGTAAAGAAAC	
60	 This	study	
attB	25	R	(PCR	cloning)	 TTATATCCATTTAACTAAGAG	
GAC	GGATCCTGGCTGTGGTGATG	
60	 This	study	
GenR	gene	F	 GTCCAACCAGCGGCACCAG	 55	 This	study	
GenR	gene	R	 TTAGGTGGCGGTACTTGGG	 55	 This	study	
GenR	gene	F	
(PCR	cloning)	
*CTAAATACATTCAAATATGTA	
TCCGGTCCAACCAGCGGCACCAG	
1-					55	
2-					60	
This	study	
GenR	gene	R	
(PCR	cloning)	
*GTAAACTTGGTCTGACAGT	
TACCAATTAGGTGGCGGTACTT	
GGG	
1-					55	
2-					60	
This	study	
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TetR	gene	F	 TTCTCATGTTTGACAGC	 55	 This	study	
TetR	gene	R	 TCAGGTCGAGGTGGCC	 55	 This	study	
TetR	gene	F	(PCR	cloning)	 *GGGAAATGTGCGCGGAA		
TTCTCATGTTTGACAGC	
1-					55	
2-					60	
This	study	
TetR	gene	R	(PCR	cloning)	 *CGCTCATGAGACAATAACCC	
TGTCA	GGTCGAGGTGGCC	
1-					55	
2-					60	
This	study	
attPMut.	 (2.17.	Site-directed	mutagenesis)		
GTATTTAAATCAATGAGTTAATACTTGTATTCATTATATCCATTTAACTAAGAGGACGTTGTTGC,	
60	 This	study	
attPMut.	 R	 (2.17.	 Site-directed	mutagenesis)	 GGATATAATGAATACAAGTATTAACTCATTGATTTAAATA	CATAAAGCACCGAAATAATCGTC	
60	 This	study	
	
qPCR	primers	
Primers	 Sequence	(5’-3’)	 Annealing	
tamp.	(°C)	
Reference	
Spect	F	 TCGCCTTTCACGTAGTGGAC	 53	 This	study	
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Spect	R	 CGCAGTAACCGGCAAAATCG	 53	 This	study	
RL1	F	 CGCACTCCATTAGCGGGTAT	 53	 This	study	
RLR	 CGTGGATCGGTTTAA	 53	 This	study	
RL2	F	 TGCATCCGGTTACTTGTTGGT	 53	 This	study	
RL3	F	 GTGATGACTCGTGCTTAGATCAA	 53	 This	study	
RL3	R	 ACAGTCGGCGATGGTGA	 53	 This	study	
RL4	F	 CGGGTGGCGATTTCCACGG	 53	 This	study	
RL4	R	 GACGGTATTATCAGTCATA	 53	 This	study	
*	These	primers	were	used	first	to	amplify	the	insert	sequence	using	annealing	Temp.	1.	The		
annealing	Temp.2		was	used	in	the	amplification	of	the	plasmid	backbone	in	the	PCR	cloning	.	
2.6.	Agarose	gel	electrophoreses	
TAE-agarose	 gel	 electrophoresis	 was	 used	 to	 separate	 DNA.	 The	 gel	concentrations	were	0.7%,	1%	or	1.5	%	depended	on	the	DNA	size,	and	they	were	run	 at	 100	 V	 and	 400	mA,	 unless	 otherwise	 stated.	 The	 DNA	 sample	were	 run	along	 with	 the	 Hyperladder	 I	 (Bioline,	 London,	 U.K.)	 molecular	 weight	 marker.		The	gels	were	viewed	under	UV	trans-illumination	at	a	wavelength	of	302	nm.		
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2.7.	Recovery	of	the	DNA	from	the	agarose	gel	
The	desired	DNA	band	was	cut	out	from	the	gel	after	they	were	viewed	using	the	blue	light	box.		The	gel	slice	was	processed	using	PCR	and	gel	extraction	kit	from	(Bioline,	London,	U.K.).	DNA	was	eluted	in	25	%l	of	water.			 	
	
2.8.	Restriction	endonuclease	digestion	
All	restriction	digestions	were	done	 in	 final	volume	of	20	%l	composed	of	1	%l	of	the	 appropriate	 enzyme,	 2x	 of	 its	 recommended	proprietary	 buffer,	 and	1	%g	 of	the	DNA.	The	restriction	enzymes	that	were	used	in	this	study	were	STAR	activity	enzymes	(Fermantus,	MA,	USA),	incubated	at	their	recommended	temperature	for	1h.		The	resultant	restriction	reaction	was	separated	on	a	TAE	agarose	gel	and	the	desired	DNA	band	was	recovered.		
	
2.9.	Ligation	of	DNA	fragments	
The	final	volume	of	ligation	reaction	was	20	%l	composed	of	1:1	or	1:3	of	plasmid	and	insert	molar	ratios.	Plasmids	and	inserts	were	incubated	with	T4	DNA	ligase	(T4	DNA	Ligase,	Fermantus,	#EL0011)	and	its	ligase	buffer	for	10	min	at	22	oC.					
	
2.10.	Production	of	electrocompetent	cells	
LB	 broth	 (400	mL)	was	 inoculated	with	 1	ml	 of	 an	 overnight	 culture.	 This	was	incubated	at	37	 °C	with	 shaking	at	200	 r.p.m	 to	OD600=	0.5-0.8.	The	culture	was	
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placed	 in	 ice	 and	 cells	 harvested	by	 centrifugation	 at	 5,000	 x	 g	 for	 10	min.	 The	pellet	was	resuspended	carefully	in	1/10	vol	of	ice-cold	ddH2O.	After	3	repeats	of	the	 wash	 step,	 the	 cells	 were	 finally	 resuspended	 in	 10%	 ice-cold	 glycerol.	Aliquots	 of	 100	%l	 were	 flash-frozen	 in	 liquid	 nitrogen	 and	 stored	 at	 -80°C	(Sambrook	et	al.,	1989)	
	
2.11.	Transformation	of	electrocompetent	cells	
Plasmid	 DNA	 (200-400	 ng)	 was	 added	 to	 100	%l	 chilled	 competent	 cells.	 The	mixture	 of	 cells	 and	 plasmid	 DNA	was	 transformed	 to	 a	 disposable	 cold	 1	mm	aperture	 electro	 cuvette.	 Electroporation	was	 performed	 at	 2.50	mV,	 200	Ω	and	25	µF.	Cells	were	diluted	 in	300	%l	of	SOC	broth	media	and	 incubated	at	37°C	for	one	hour.	Aliquots	of	100	%l	were	 flash-frozen	 in	 liquid	nitrogen	and	stored	at	 -80°C	(Dower	et	al.,	1988;	Sambrook	et	al.,	1989).	
	
2.12.	Preparation	of	chemically	competent	cells	
LB	 broth	 400	 ml	 was	 inoculated	 with	 1	 ml	 of	 an	 overnight	 culture.	 This	 was	incubated	at	37	°C	with	shaking	at	200	r.p.m	to	the	OD600	0.5-0.8.	The	culture	was	placed	in	ice	and	cells	harvested	by	centrifugation	at	5000	g	for	15	minutes.	The	pellet	was	resuspend	carefully	in	100	ml	of	ice	cold	TfBI	Buffer	(Table	2.2.2)	and	incubated	on	ice	for	30	minutes.	Cells	were	collected	by	centrifugation	at	5000	g	for	10	minutes	and	resuspended	in	20	ml	of	TfBII	(Table	2.2.2)	and	incubated	for	
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a	further	30	minutes	on	ice.	Aliquots	of	100	%l	were	flash-frozen	in	liquid	nitrogen	and	stored	at	-80°C	(Inoue	et	al.,	1990;	Sambrook	et	al.,	1989).	
	
2.13.	Transformation	of	chemically	competent	cells	
A	 plasmid	DNA	 200-400	 ng	was	 added	 to	 100	%*	of	 ice	 thawed	 competent	 cells	incubated	 on	 ice	 for	 30	 minutes.	 The	 cells	 were	 subsequently	 heat-shocked	 at	42°C	for	45	seconds,	immediately	diluted	1:10	in	SOC	broth	media	and	recovered	at	37°C	for	one	hour.	 	After	 incubation,	150	%*	and	50	%*	were	spread	plated	onto	LB	agar	plates	with	plasmid	specific	antibiotic.	The	plates	were	incubated	at	37°C	for	overnight	(Inoue	et	al.,	1990;	Sambrook	et	al.,	1989).	
	
2.14.	Colony	PCR		
Colony	PCR	is	a	convenient	high-throughput	method	for	determining	the	presence	or	absence	of	 insert	DNA	in	plasmid	constructs.	 Individual	transformants	can	be	lysed	during	the	initial	heating	step.	This	initial	heating	step	causes	the	release	of	the	plasmid	DNA	 from	 the	 cell,	 so	 it	 can	 serve	as	 template	 for	 the	 amplification	reaction.	 Primers	 designed	 to	 specifically	 target	 the	 insert	 DNA	 can	 be	 used	 to	determine	if	the	construct	contains	the	DNA	fragment	of	interest.	
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2.15.	Protein	quantification:	Bicinchoninic	Acid	assay	(BCA)		
The	assay	(Smith et al., 1985, Wiechelman et al., 1988) was	performed	using	BAC	kit	from	 thermo-	 fisher	 scientific	 (MA,	 USA).	 Standards	 curve	 of	 bovine	 serum	albumin	(5	%g	ml-1	–	2000	%g	ml-1)	were	prepared	in	triplicate.		The	BCA	working	reagent	was	made	by	mixing	50	volumes	of	reagent	A	[BCA-Na2 (1%), Na2C4H4O6 
(0.16%), Na2CO3.H2O (2%), NaOH (0.4%), NaHCO3 (0.95%)] with 1 volume of 
reagent B [CuSO4.5H2O (4%)]. Three types of dilutions were performed for the 
samples (1 in 10, 1 in 50 and 1in 100) in PBS using 96 well plates. Twenty five 
microliters of each standard or sample (both neat and the three dilutions) were added to 
individual wells of the microtiter plate. The assay was prepared by adding 200 %l of the 
working reagent to each tube of diluted or undiluted protein solutions and mixed by 
shacking. The standards and samples plates were incubated at 37 oC for 30 min, before 
the absorbance was measured at 562 nm. Depends on the calibration carve that plotted 
using the average measurements of standards; the samples quantity of protein was 
determined. 		 
2.16.	The	Sequencing	analysis	
GenBank	 database	 searches	 were	 employed	 using	 blastn,	 blastp	 and	 tblastn	(http://www.ncbi.nlm.nih.gov).	 Sequence	 manipulation,	 primer	 binding	 sites	 and	restriction	 site	 analyses	were	 performed	 using	 the	 program	 Serial	 Cloner	 2.6-1	(http://serialbasics.free.fr/Serial_Cloner.html).	 Each	 plasmid	 construct	 and	 all	DNA	 recombination	 products	 were	 sequenced	 by	 GATC-Biotech	 (Konstanz,	Germany).		
77	
2.17.	Site-directed	mutagenesis	 
Site-directed	mutagenesis	 technique	(Ke	and	Madison,	1997)	was	used	to	repair	any	 undesired	 mutation	 might	 occur	 during	 PCR	 and	 plasmid	 cloning.	 A	 DNA	mutation	of	two	base	pairs	in	the	left	flanking	DNA	sequence	of	Φ24B	attP	site	was	repaired	 using	 this	 technique.	 The	 long	 oligonucleotide	 primers;	 Forward,	GTATTTAAATCAATGAGTTAATACTTGTATTCATTATATCCATTTAACTAAGAGGACGTTGTTGC,	 and	 Revers,	 GGATATAATGAATACAAGTATTAACTCATTGATTTAAATA	CATAAAGCACCGAAATAATCGTC	(Wolverhampton,	U.K.)	(Table	2.5.2),	possessing	a	40	bp	region	of	complementary	overlap	were	used	to	repair	that	mutation	in	a	one-step	 PCR	 reaction	 using	 the	 hot	 start	 Highly	 Fidelity	 Q5	 DNA	 Polymerase	(New	England	 biolabs,	 Ipswich,	 USA).	 The	mutant	 base	 pairs	 that	 needed	 to	 be	repaired	were	located	in	the	centre	of	the	primer	overlap	area	(Fig.	2.1).	The	PCR	reaction	template	was	the	plasmid	clone	that	had	the	2	bp	mutation.	The	typical	thermo	cycling	PCR	program	started	with	initial	denaturation	step	at	98	°C	for	30	sec.,	followed	by	30	cycles	of	denaturation	at	the	same	temperature	for	10	sec.,	the	primer	annealing	time	was	15	sec.	at	60	°C.	The	PCR	amplifications	were	run	using	an	Eppendorf	(New	York,	USA)	thermo	cycler	Model.		
	
After	 the	 PCR	 reaction	was	 completed,	 the	 PCR	 product	was	 purified	 using	 the	PCR	and	Gel	extraction	kit	from	(Bioline,	London,	U.K.).	The	DNA	was	eluted	with	10	µl	 of	 pre-heated	 water	 (50°C)	 before	 the	 spin	 column	 was	 centrifuged	 at	11,000	g	for	1	min,	as	the	final	step	of	that	purification	(See	2.6.1	Recovery	of	the	DNA	from	the	agarose	gel,	Chapter	2).		
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Figure	 2.1.	 Site-directed	 mutagenesis	 technique	
(Adapted	 from	 Ke,	 1997).	 In	 order	 to	 repair	 any	mutation	 within	 a	 plasmid	 clone,	 long	 PCR	 primers,	sharing	an	overlap	region	of	40	bp,	were	used	 in	a	one-step	 PCR	 reaction.	 The	 mutated	 nucleotides	 had	 to	 be	located	in	the	centre	of	the	primer	overlap	area.	The	PCR	product	was	then	treated	with	DpnI	digestion	enzyme	to	destroy	the	methylated	template	DNA	that	possesses	the	mutation	only,	and	then	the	newly	repaired	plasmid	was	transformed	into	E.	coli	cells.		
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In	order	 to	digest	 the	methylated	 template	plasmid,	8.5	µl	of	 the	restriction	 free	cloning	reaction	were	treated	with	0.5	µl	of	Dpn	 I	(Bioline),	and	1	µl	of	CutSmart	Buffer	 (Bioline, # B7204S)	 for	 2	 h	 at	 37	°C.	 Then,	 5	µl	 from	 the	 reaction	 were	transformed	 into	new	Top	10	Competent	 cells	 and	 transformants	were	 selected	for	on	LB	agar	with	the	plasmid	resistance	antibiotic	at	its	specific	concentration	(Invitrogen).	 Positive	 cloning	 was	 confirmed	 by	 plasmid	 prep	 and	 DNA	sequencing	(Fig.	2.1).		
	
2.18.	Statistical	analysis		
The	 t-test	 analysis	 was	 used	 to	 find	 out	 the	 significance	 of	 the	 qPCR	 results,	Chapter	5.	
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CHAPTER	3. IN	VITRO	RECOMBINATION		
3.1.	Background	
3.1.1.	Site-Specific	Recombinases		
At	the	point	of	lambdoid	bacteriophage	infection,	when	the	phage	DNA	enters	the	bacterial	cell,	a	number	of	specific	factors	must	be	expressed	in	order	to	direct	the	incoming	phage	into	either	the	lytic	or	lysogenic	replication	cycle	(Hendrix,	1983).	For	the	phages	destined	to	become	integrated,	non-self-replicating	prophages,	the	incoming	 phage	 must	 produce	 an	 enzyme	 that	 directs	 recombination	 with	 the	bacterial	 chromosome.	 For	 lambdoid	 phages	 this	 recombinase	 in	 known	 as	integrase.		
	
3.1.2.	Lambda	phage	Integrase	
Lambdoid	 phages	 typically	 encode	 an	 integrase	 (a	 tyrosine,	 site-specific	recombinase	 (see	 also	 1.4	 Site-specific	 recombination,	 Chapter	 1))	 enzyme	 to	drive	 recombination	with	 the	 bacterial	 chromosome	 and	 a	 repressor	 protein	 to	prevent	 the	expression	of	 the	 lytic	 cycle-associated	genes	 (Dodd,	2001).	For	 the	integrase	 to	 direct	 prophage	 integration,	 two	 DNA	 molecules	 (the	 circularised	phage	genome	and	the	bacterial	chromosome)	are	fused	together	by	the	integrase	enzyme	(Fig.	3.1).	The	phage	DNA	attachment	site	 is	within	a	region	called	attP,	while	the	complementary	site	in	the	bacterial	genome	is	called	attB	(Mizuuchi	and	Mizuuchi,	1980).		
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Figure	 3.1.	 Circular	 lambda	 phage	 DNA	 is	 converted	 to	 an	 integrated	 prophage	 by	 a	 reciprocal	
recombination	 between	 attP	 and	 attB.	 The	 attachment	 site	 of	 the	 phage	 chromosome	 (attP)	 is	composed	of	two	integrase	binding	sites	(P,P’)	and	the	core	binding	site(COC’);	while	the	attachment	site	of	 the	bacterial	chromosome	(attB)	 is	composed	of	 two	core	binding	sites	(B,B’)	and	the	overlap	region	(O);	 Int,	 phage	 encoded	 integrase;	 Xis,	 phage	 encoded	 excisionase	 also	 referred	 to	 as	 a	 recombination	directionality	factor;	IHF,	host	cell-encoded	integration	host	factor.	
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DNA	 recombination	 starts	 with	 formation	 of	 a	 DNA	 Holliday	 junction,	 which	 is	then	resolved	at	that	junction	to	create	new	two	sites,	attL	and	attR	(Stark	et	al.,	1992).	This	 process	 needs	 a	 short	 attB	overlap	 region,	 or	 O,	 flanked	 by	 short	imperfect	inverted	repeats	B	and	B’,	and	an	extended	attP	sequence	with	multiple	integrase	binding	sites	as	well	as	binding	sites	 for	accessory	cofactors	(Fig.	3.1).	For	 the	 archetypal	 lambdoid	phage,	 Lambda,	 it	 has	been	discovered	 that	attP	 is	composed	of	 two	of	 integrase	arm	binding	sites	 (P	and	P’)	and	 the	core-binding	site	 (COC’).	 Furthermore,	 for	 lambda	 phage	 integration,	 IHF	 binding	 sites	 exist	between	 COC’	 and	 the	 P.	 On	 the	 other	 hand,	 for	 lambda	 phage,	 the	 bacterial	chromosome	attB	site	is	composed	of	core	binding	sites	B	and	B’	flanking	O	region	(Frumerie	et	al.,	2008)	(Fig.	3.1).	
	
When	the	attB	and	attP	sites	are	cut	by	the	integrase,	between	the	B	and	O	regions	in	 the	 bacterial	 genome	 and	 the	 P	 and	 O	 region	 in	 the	 phage	 chromosome,	respectively,	 the	 bacterial	 and	 phage	 genomes	 are	 recombined	 to	 produce	 new	
attL	 and	 attR	 sites.	 These	 sites	 can	 later	 be	 utilized	 by	 the	 integrase	 and	 its	cognate	 recombination	 directionality	 factor	 for	 excision	 of	 the	 phage	 genome	from	the	bacterial	chromosome	(Sarkar	et	al.,	2009).	Early	studies	of	site-specific	recombination	systems	showed	that	DNA	homology	in	the	DNA	crossover	region	is	 necessary	 to	 promote	 recombination,	 and	 it	 identified	 that	 the	 crossover	regions	 interact	 with	 each	 other	 through	 complementarity	 via	 DNA-DNA	interactions	 in	 addition	 to	 DNA-protein	 interactions	 enabling	 site-specific	recombination	(Weisberg	et	al.,	1983).		
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Recombination	 catalyzed	 by	 lambda	 integrase	 and	most	 tyrosine	 recombinases	takes	place	by	sequential	exchanges	of	the	crossover	regions	of	the	attB	and	attP	sites.	 Four	 recombinase	monomers	bind	 to	 the	DNA	 substrate	 at	 the	 same	 time	(Echols	 and	 Green,	 1979),	 when	 one	 strand	 in	 each	 site	 is	 cut	 by	 the	 first	 two	active	 monomers	 to	 produce	 a	 3’-phosphotyrosyl	 intermediate	 and	 a	 free	 5’-hydroxyl	 group.	 	 The	 next	 step	 involves	 a	 DNA	 strand	 exchange	 and	 rejoining	reaction	when	 the	 cleaved	 strand	 in	 each	 site	migrate	 to	 allow	 the	 5’-hydroxyl	groups	 to	 attach	 the	 phosphotyrosyl	 bond	 of	 the	 opposite	 site	 to	 form	 a	phosphodiester	bond	reforming	the	integrity	of	the	DNA	strand.	This	generates	a	Holliday	junction	(HJ)	intermediate	(Biswas	et	al.,	2005).	The	HJ	is	resolved	when	the	second	pair	of	the	integrase	monomers	activated	to	carry	out	the	second	cut	of	DNA	followed	by	the	second	exchange	of	the	DNA	strand	and	ligations	results	in	the	 recombinant	 (Hsu	 and	 Landy,	 1984).	 This	 recombination	 model	 is	 called	the“branch	 migration“	 model	 (Weisberg	 et	 al.,	 1983)(Fig.	 1.10,	 Chapter	 1).	Homology	 between	 two	 sites	 is	 important	 for	 branch	 migrations	 (Echols	 and	Green,	1979).	
	
Upon	 conditions	 that	 induce	 the	 host	 cell’s	 SOS	 repair	 system,	 for	 example	irradiation	 with	 ultraviolet	 light,	 or	 DNA	 damage,	 the	 prophage	 is	 induced	resulting	 in	excision	of	 the	 integrated	prophage	 from	the	 lysogen’s	chromosome	and	entry	of	the	excised	phage	genome	into	the	lytic	replication	cycle.	This	results	
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in	 the	 production	 of	 new	 bacteriophages	 that	 are	 released	 after	 the	 burst	 of	bacterial	host	cell	(Hendrix,	1983)	
	
Int	 plays	 a	 central	 role	 in	 prophage	 excision,	 though;	 a	 phage-	 encoded	recombination	 directional	 factor	 RDF	 is	 additionally	 required	 to	 control	 the	reaction	 directionality.	 In	 th	 lambda	 excision	 system,	 both	 the	 phage-encode	excisionase	(Xis)	and	Integration	host	Factor	(IHF)	are	the	RDF	proteins	that	Int	needs	to	drive	excision.		In	addition,	lambda	phage	excision	is	usually	enhanced	by	the	factor	for	inversion	stimulation	(Fis)(Numrych	et	al.,	1992).	
	
As	we	have	mentioned	above,	there	are	two	types	of	lambda	Int	binding	sequence,	core	type	and	arm	type-sites.		There	are	five	arm-binding	sites	located	outside	the	crossover	 region	 on	attP,	attR	 and	attL.	 Three	 neighboring	 sites	 are	 located	 on	
attP	and	attL,	called	P’1,	P’2	and	P’3.	The	two	other	sites	are	called	P1	and	P2	and	located	on	attP	and	attR	(Fig.3.2)(Cho	et	al.,	2002).			
	
Footprint	experiments	showed	that	each	of	these	RDF	proteins,	Int	and	IHF	binds	to	 a	 specific	 sequence	within	att	 sites	 (Fig	 3.2).	 Int	 binds	 to	 all	 of	 the	 five	 arm	binding	sites	and	to	two	more	binding	regains	in	each	core	(B	and	B’	in	attB	and,	C	and	C’	 in	attP).	 IHF	 binds	 to	 one	 site	 in	 P’	 and	 in	 to	 sites	 in	 P	within	attP.	 And	within	 attP	 also,	 Fis	 binds	 to	 F	 site,	 which	 overlaps	 X2	 (one	 of	 two	 Xis	 sites)	(Numrych	et	al.,	1992).	
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Figure	3.2.		Details	of	the		Lambda	attP	and	attB	sites(Numrych	et	al.,	1992).	The	overlap	region	between	them	is	7	bp,	flanked	by	inverted	repeats	of	7	bp	(C,C’,B,	and	B’).	The	Int	arm	type	binding	sites	are	P1,	P2,	P’1,	P’2	and	P’3.	There	are	three	IHF	binding	sites	(H1,	H2,	and	H’),	one	Fis	binding	site	(F)	and	two	Xis	binding	site.		
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Lambda	Xis,	a	recombination	directionality	factor,	identifies	two	direct,	imperfect,	13-bp	 repeats,	 called	 X1	 and	 X2,	 which	 exist	 between	 the	 P2	 site	 and	 the	crossover	region	on	attR.	Xis	binding	 to	X1	and	X2	 facilitates	a	bend	 in	 the	DNA	strands	and	promotes	Int-DNA	binding.	The	binding	between	Int	and	P2	site	is	so	weak	that	it	requires	Xis	to	create	the	attR	nucleoprotein	complex	(Thompson	et	al.,	 1987;	 Yin	 et	 al.,	 1985).	 It	 has	 been	 reported	 that	 Xis	 the	 carboxyl-terminal	region	has	 a	direct	 contact	with	 Int	protein,	while	 the	C-terminal	 region	has	53	amino	acids	that	specifically	bind	to	the	Xis	sites	in	the	DNA,	and	have	no	ability	to	interact	with	Int	(Numrych	et	al.,	1992).	
	
3.1.3.	Integrase	of	Φ24B	
Bacteriophage	Φ24B	is	a	member	of	the	lambdoid	family	(Fattah	et	al.,	2000).	The	integrase	encoded	by	Φ24B	phage	is	a	~45	kDa	protein,	encoded	by	the	 int	gene	(EF397940.1).	 Φ24B	 integrase	 protein	 belongs	 to	 the	 tyrosine	 recombinases	family	 (Balding	 et	 al,	 2005).	 As	 we	 already	 have	 seen	 in	 the	 introduction,	 all	members	 of	 this	 family	 use	 a	 tyrosine	 amino	 acid	 to	 derive	 DNA	 cleavage	 and	integration.		
	
Int	possesses	high	affinity	binding	for	the	attP	site-arm	regions	and	low	affinity	to	the	attP	core-binding	region	(Richet	et	al.,	1988).	 Its	recombination	mechanisms	take	the	form	of	a	tetrad	complex	composed	of	four	Int	monomers;	each	monomer	
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has	 an	 N-terminal	 domain	 that	 resides	 over	 each	 adjacent	 core-binding	 region	(Biswas	 et	 al.,	 2005).	 The	 C-terminal	 domains	 (core	 binding	 and	 catalytic	domains)	recognize	and	bind	to	the	identical	crossover	sequences	in	the	attP/attB	regions	in	a	square	planar	formation,	promoting	DNA	recombination	(Van	Duyne,	2005).	Lambda	integrase	is	the	only	phage-encoded	protein	needed	for	lambdoid	phage	genome	integration	within	the	host	genome	(Hendrix,	1983).	
	
However,	most	tyrosine	integrases	do	not	act	autonomously,	they	also	require	the	help	 of	 bacterial	 encoded	 accessory	 factors	 (Richet	 et	 al.,	 1988).	 The	 accessory	factor	for	Lambda	integrase	is	known	as	integration	host	factor	IHF.	IHF	interacts	with	the	DNA	sequences	surrounding	the	attachment	site	 in	order	to	expose	the	DNA	 to	 the	 action	 of	 integrase	 that	 cuts	 the	 DNA	 using	 its	 topoisomerase-like	activity	(Sugimura	and	Crothers,	2006).	
	
IHF	is	a	~	21.8	kDa	DNA-binding	protein	composed	of	two	monomers	(Sanyal	et	al.,	2014;	Azam	and	Ishihama,	1999).	It	is	a	small	heterodimeric	protein	composed	of	two	subunites,	∝	and	",	which	are	encoded	by	bacterial	genes	(Yang	and	Nash,	1995).	The	subunit	∝	is	encoded	by	the	himA	gene	and	composed	of	300	bp.	The	molecular	weight	of	the	∝	subunit	is	~11,000	kDa.	The	gene	that	is	responsible	for	the	"	subunit	is	himD;	this	gene	is	280	bp	in	length,	and	encodes	a	protein	product	of	~9,500	kDa.	The	active	component	of	 IHF	 is	 the	heterodimer	of	both	∝	and	"	subunits	(Kikuchi	and	Nash,	1978).		
	
88	
IHF	 protein	 works	 as	 an	 accessory	 protein	 that	 enhances	 the	 capacity	 of	 Int’s	enzymatic	activity.	IHF	is	a	site-specific	DNA	binding	protein,	and	there	are	three	loci	surrounding	the	lambda	attP	that	support	a	high	affinity	interaction	with	IHF.	There	 are,	 however,	 specific	 IHF	 binding	 sites	 located	 within	 non-att	 DNA	sequences	in	the	E.	coli	genome.	Most	of	these	sites	are	adjacent	to	genes	whose	expression	 is	 altered	 in	 IHF	 mutants	 (Craig	 and	 Nash,	 1984).	 The	 IHF-DNA	complex	is	unique	among	binding	proteins.	This	protein	typical	binds	to	a	30	-	35	bp	 DNA	 sequence	 that	 is	 composed	 of	 at	 least	 two	 main	 binding	 domains.		Alignment	 among	 IHF	 binding	 sequences	 within	 an	 already	 created	 attL	population	 library	 showed	 that	 the	 3’	 region	 is	 where	 IHF	 binds	 strongly	 and	specifically.	 This	 region	 can	 be	 identified	 as	 a	 13	 bp	 sequence	 of	WATCAANNNNTTR.	Unlike	 the	3’	 region,	 the	5’	 region	 is	 random	 in	most	 cases.	However	 the	 5’	 sequences	 are	 all	 typically	 AT	 rich,	 but	 without	 any	 obvious	sequence	patterns	(Goodman	et	al.,	1999).		
	
In	 addition	 to	 its	 role	 in	 site-specific,	 phage-genome	 integration	 into	 the	E.	coli	genome,	IHF	is	a	necessary	protein	for	a	wide	range	of	cellular	activities	including:	site-specific	 DNA	 recombination,	 DNA	 replication,	 phage	 packaging,	 plasmid	partitioning,	 and	 the	 expression	 of	 some	 genes	 like:	 type	 1	 fimbriae	 of	 E.	 coli,	encoded	by	fimA	(Friedman,	1988;	Arfin	et	al.,	2000;	Le	et	al.,	2013).	
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Lambda	integrase	can	recognize	complex	binding	sites	in	both	the	phage	and	host	bacterial	 genomes	 (Richet	 et	 al.,	 1988).	 The	 l	 phage	 attachment	 site,	 attP,	 is	 a	quite	 complex	 site	 composed	 of	 several	 adjacent	 binding	 sites	 called	 arm-type	sites	 that	 flank	 the	 core-type	 sites	 (Ross	 et	 al.,	 1979).	 Furthermore,	 it	 contains	other	binding	sites	for	factors	involved	in	DNA	integration	and	excision	(Yin	et	al.,	1985).	 On	 the	 other	 hand,	 bacterial	 attachment	 site	 for	 l	 phage,	 attB,	 is	 less	complicated,	 composed	 of	 two	 core-type	 binding	 sites,	 which	 have	 an	 inverted	repeat	 sequences	 flanking	 the	 overlap	 region.	 Crossing	 over	 usually	 occurs	between	 the	 completely	 identical	 overlap	 regions	 in	 both	attB	and	attP	{Sarkar,	2001,	The	 small	DNA	binding	domain	of	 lambda	 integrase	 is	 a	 context-sensitive	modulator	of	recombinase	functions}.	
	
3.1.4	Aims	
• To	over	express	and	purify	both	INT	and	IHF	proteins.		
o Integrase	 enzyme,	 INT,	 is	 necessary	 protein	 to	 run	 DNA	recombination.	However,	it	does	not	normally	function	alone.	
o 	IHF	 is	 a	 required	 cofactor	 for	 the	 function	 of	 most	characterized	tyrosine	recombinases.	
• To	clone	of	both	attB	and	attP	sequences	in	separate	plasmids.	
• To	establish	a	working	protocol	for	an	in	vitro	integration	assay	based	upon	the	in	vitro	assay	used	to	characterize	the	bacteriophage	Lambda.	
	 	
90	
3.2.	Specific	Methods	
3.2.1.	Cloning	of	bacterial	and	phage	attachment	sites	
The	 attB	 core	 and	 either	 100	 bp,	 300	 bp	 or	 600	 bp	 of	 flanking	 sequence	were	amplified	using	attB100	F/R,	attB300	F/R	or	 attB	600F/R	primers,	 respectively	(See	2.5	PCR,	Chapter	2)	(Table	2.2.1).	Each	of	these	attB	sequences	was	cloned,	separately,	 into	 the	 pCR2.1	 cloning	 vector	 (Invitrogen),	 according	 to	 the	manufacturer’s	guidelines.	At	the	same	time,	the	attP	core	and	either	100	bp,	300	bp	 or	 600	 bp	 of	 flanking	 sequence	were	 amplified	 using	attP100	 F/R	 ,	attP300	F/R	or	attP	600F/R	primers,	respectively	(See	2.5	PCR,	Chapter	2)	(Table	2.2.1).	Each	 of	 these	 attP	 sequences	 was	 cloned,	 separately,	 into	 the	 pCR2.1	 cloning	vector	 (Invitrogen),	 according	 to	 manufacturer’s	 guidelines.	 The	 three	 attB	plasmids,	 a	 long	 with	 three	 attP-cloned	 pCR2.1	 plasmids,	 were	 all	 individually	transformed	 into	 Top	 10	 chemically	 competent	 cells.	 The	 transfomants	 were	cultured	 overnight	 on	 LB	 agar	 plates	 containing	 ampicillin	 (100	$g	 ml-1)	 and	kanamycin	(50	$g	ml-1).	The	identity	of	the	desired	transformants	were	confirmed	by	colony	PCR	(See	2.13	colony	PCR,	Chapter	2).	Freezer	stocks	were	made	from	each	 positive	 transformant	 and	 stored	 at	 -80	 °C	 (See	 2.12.	 Transformation	 of	chemically	competent	cells,	Chapter	2).	
	
3.2.2.	Protein	Overexpression		
Overnight	LB	broth	cultures	(1	mL)	of	cells	harboring	the	interested	plasmid	were	used	to	inoculate	10	mL	of	LB	broth.	This	subculture	was	incubated	at	37	℃	with	
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shaking	 at	 300	 r.p.m	 to	 the	 OD600=	 0.5-0.7.	 A	 sample	 (1	 mL)	 was	 immediately	taken	from	the	culture;	the	cells	were	recovered	by	centrifugation	for	20-30	min,	at	10,000	g	at	4	℃,	and	resuspended	in	50	$l	of	Tricine	Sample	Buffer	(Table	2.3),	and	was	frozen	at	-20	℃		for	later	use	as	the	non-induced	control	cells.	The	rest	of	the	culture	was	induced	with	the	appropriate	plasmid	inducer	to	the	appropriate	final	 inducer	 concentration	 (0.02	%	w/v	 final	 concentration	of	L-Arabinose	was	used	 to	 induce	 the	 overexpression	 of	 Int	 from	 pΦ24B-int,	 while	 the	 final	concentration	 of	 IPTG	 for	 overexpression	 of	 IHF	was	 5	mM	 (Table	 2.2.1)).	 The	induced	culture	was	incubated	at	37	℃	with	shaking	at	300	r.p.m.	for	a	further	3-4	hrs.	The	culture	was	then	placed	on	ice	and	a	sample	(1ml)	was	taken,	the	cells	in	that	1	mL	harvested	by	centrifugation	for	20-30	min,	at	10,000	g	at	4	℃,	and	then	resuspended	in	100	μl	of	Tricine	Sample	Buffer	(Table	2.3),	and	finally	frozen	at	-20	℃	until	 needed	 (induced	 control).	 The	 rest	 of	 cells	 in	 this	 culture	were	 then	harvested	by	centrifugation	for	20-30	min	at	10,000	g	at	4	℃.	The	resultant	pellet	was	 resuspended	 carefully	 in	5	ml	of	 ice-cold	 lysis	buffer	 for	purification	of	 the	His-tagged	 protein	 under	 native	 conditions.	 Using	 a	 sonicator	 with	 a	 microtip	probe,	 the	 sample	was	 sonicated	 6-8	 times	with	 10	 seconds	 pauses	 at	 200-300	Watt.	 The	 lysate	 was	 kept	 on	 ice	 at	 all	 times,	 until	 it	 was	 subjected	 to	centrifugation	 for	 20-30	min	 at	 10,000g	 at	 4oC.	 The	 supernatant	was	 harvested	(crude	cell	extract	A,	soluble	proteins)	and	stored	on	ice.	The	resultant	pellet	was	resuspended	in	5	ml	lysis	buffer	(crude	extract	B,	insoluble	proteins).		
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Crude	extracts	A	and	B	(5	μl,	each),	were	mixed	with	5	μl	of	Tricine	Sample	Buffer	(Table	 2.3).	 These	 samples,	 along	 with	 the	 noninduced	 and	 induced	 control	samples,	were	heated	at	95	℃	for	5	min.	The	samples	were	 then	centrifugaed	at	15,000g	for	1min,	before	being	loaded	(20	μl	from	each)	on	a	12%	SDS-PAGE	gel.	The	gel	was	run	at	150	V	min-1	for	30	min.		
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3.2.3.	SDS	PAGE	
Sodium	dodecyl	sulfate	polyacrylamide	gel	electrophoresis	(SDS-PAGE)(Laemmli,	1970),	was	 used	 to	 examine	 the	 protein	 preparations,	 using	 the	Mini-Protean	3	Unit	(Bio	Rad,	Serial	NO	67S).	The	size	of	the	vertical	running	gel	was	75	mm	and	composed	of	a	bottom	Separating	gel	(1	ml	water,	1.25	ml	3M	Tris-HCl/SDS	pH8.4,	1.12	ml	40%	acrylamide,	0.37	ml	glycerol,	5	$l	30%	APS,	and	5	$l	TEMED),	and	a	Stacking	 gel	 (2.03	 ml	 water,	 0.77	 ml	 3M	 Tris-HCl/SDS	 pH8.4,	 0.31	 ml	 40%	acrylamide,	 5	$l	 30%	 APS,	 and	 5	$l	 TEMED).	 The	 separating	 gel	 mixture	 was	poured	first	in	between	the	75	mm	glass	plates	(Bio-Rad,	#1653308),	and	covered	with	isopropanol	until	the	gel	polymerised	(20-30min).	Then,	the	isopropanol	was	washed	with	water,	 dried,	 and	 the	 stacking	 gel	mix	was	poured	over	 the	 top	of	Separating	gel	and	the	20	$l-size	comb	was	used	to	cover	the	top	of	the	stacking	gel	 until	 is	 polymerised.	 The	 fully	 polymerized	 gel	was	 placed	 into	 the	 running	unit,	and	the	middle	tank	was	filled	with	an	appropriate	volume	of	cathode	buffer	whilst	the	outside	area	of	the	unit	was	filled	with	anode	buffer	(Table	2.2.2).	The	comb	was	removed	and	20	$l	(15	ul	sample	and	5	ul	Tricine	sample	buffer)	of	the	bold	 samples	were	 loaded	 in	 the	gel	 in	 individual	wells	 along	with	a	prestained	molecular	weight	marker.	SDS-PAGE	was	performed	a	150	V	min-1	for	30	min.	
The	 unit	 was	 then	 dismantled	 and	 the	 gel	 was	 placed	 in	 Coomassi	 Blue	 Stain	solution	 (Table	 2.3)	with	 gental	 agitation	 for	 30	min.	 The	 gel	was	 destained	 by	replacing	the	stain	solution	with	Coomassi	Blue	Destain	solution	(Table	2.3).	The	destain	 solution	 was	 changed	 several	 times	 until	 a	 clear	 gel	 background	 was	obtained.	
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3.2.4.	Semi-Dry	Western	blot	
All	western	blot	buffers	are	 listed	 in	Table	(3.2.1).	Whilst	 the	SDS-PAGE	gel	was	running	 a	 piece	 of	 nitrocellulose	 transfer	membrane	 (Thermo	 Fisher	 Scientific)	and	 extra	 thick	 blot	 paper	 (Bio-Rad,	 1703969)	 were	 cut	 to	 the	 size	 of	approximately	 6	 cm	×	8	 cm.	 The	 extra	 thick	 blot	 paper	 was	 pre	 wet	 for	 5-10	minute	in	blotting	buffer	(Table	3.2.1).	
When	 the	 unstained	 gel	 become	 ready	 after	 SDS	 gel	 running	 was	 done;	 the	blotting	sandwich	was	assembled	on	the	blotter	as	follow:		
• The	extra	thick	blot	paper	presoaked	in	blotting	buffer.	
• The	SDS-Page	gel.	
• The	nitrocellulose	transfer	membrane	
• Another	 piece	 of	 the	 extra	 thick	 blot	 paper	 presoaked	 in	 blotting	buffer.	
The	blot	was	run	using	the	Trans-Blot	SD	semidry	Transfer	cell	(Bio-Red),	for	1h	at	78	mA	and	130	V.	Afterwards,	 the	blot	was	blocked	 in	blocking	buffer	 (Table	3.2.1)	for	at	least	1	hour	at	25°	C,	or	overnight	at	4°	C,	as	apporpriate,	with	gentle	agitation.	The	blot	was	washed	twice	with	TBST	buffer	for	5	min	before	being		
incubated	in	primary	antibody	solution	containing	at	a	1:10,000	dilution.	The	blot	was	then	was	washed	in	TBST	three	times	for	10	min,	each,	to	remove	all	weakly	bound	 primary	 antibody.	 After	 that,	 the	 blot	 was	 incubated	 in	 the	 secondary	antibody	solution	at	a	dilution	of	1:20,000,	for	1	h	at	25	°C.	The	TBST	wash	steps	
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were	then	repeated.	The	blot	was	then	incubated	in	detection	buffer	(Table	3.2.1)	for	10	min,	and	 finally	 in	 the	developing	buffer	 (Table	3.2.1)	and	 incubated	 in	a	dark	place	without	shaking.	Bands	usually	started	to	appears	after	a	few	minutes.	The	blot	was	analysed	and	recorded	using	the	Imagequant	Las	4000	system	(GE	healthcare	life	sciences,	Chicago,	USA).	
		 	
Table	3.2.1	Western	Blot	Buffers	Buffers	 Composition	Blotting	buffer	 3.03	g	Tris-HCl,	14.4	g	Glycine,	200	ml	methanol	and	water	up	to	1	L.	TBS	buffer	 24	g	Tris-HCl,	5.6	g	Tris	base,	88	g	NaCl	water	up	to	1L	(pH	8.0).	TBST	buffer	 100	mL	TBS,	900	mL	dH2O,1	mL	Tween	20	.	
Blocking	buffer	and	antibody	solution	 5%	(w/v)	Bovine	Serum	Albumin,	in	TBST		Detection	buffer	 1	M	Tris-HCl,	0.1	M	(pH	9.0).		Developing	buffer	 0.1	 CSPD	 substrate	 (Invitrogen),	 99	 ml	 detection	buffer.	
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3.2.5.	Protein	purification		
His-tagged	 proteins	 were	 purified	 using	 the	 HisTrap	 protein	 purification	 1ml	column	(GE	healthcare	life	sciences	GE	healthcare	life	sciences,	Chicago,	USA,	17-5247-01)	depending	on	the	Ni-NTA	technology.		
	
The	column	was	first	washed	with	water	5	times	its	size,	before	equilibration	with	an	 equal	 volume	 of	 lysis	 buffer.	 Then,	 the	 column	 was	 loaded	 with	 the	 crude	extract	 soluble	 protein.	 The	 column	 was	 then	 washed	 with	 several	 washing	buffers	that	comprised	different	imidazole	concentrations	(20,	30,	40,	50	and	60	mM),	and	finally	with	elution	buffer	(250	mM	imidazole).	The	amount	of	washing	buffers	and	the	elusion	buffer	that	used	were	5	times	the	size	of	the	column	size.	We	had	to	be	so	careful	to	avoid	any	air	getting	inside	the	column	throughout	the	purification	process.		
	
The	 washing	 outcomes	 from	 each	 washing	 buffers	 and	 the	 elution	 buffer	 were	collected	 in	graded	 test	 tubes.	And	a	sample	of	15	µl	 from	each	 tube	was	mixed	with	5ul	of	Tricine	Sample	Buffer,	and	loaded	onto	SDS-PAGE	gel.	The	column	was	then	 washed	 with	 lysis	 buffer,	 water	 and	 finally	 filled	 with	 20%	 ethanol	 to	 be	stored	 at	 4	°C.	 Protein	 samples	 were	 dialyzed	 to	 remove	 all	 binding	 imidazole	using	the	12-14	kDa	dialysis	tube	(Medicell,	London,	UK),	and	concentrated	using	Vivaspin	20	tubes	(5	kDa)	(GE	Healthcare, Buckinghamshire,	UK).	 	
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3.2.6.	In	Vitro	Recombination	Assay	
Escherichia	coli	 Integration	host	 factor	(IHF)	 is	a	heterodimeric	protein	that	acts	important	 roles	 in	 a	 variety	 of	 cellular	 mechanisms	 not	 only	 site-specific	recombination,	 but	 also	 transcription,	 and	 DNA	 replication.	 In	 order	 to	 get	 a	better	 expression	 of	 IHF	 protein,	 pEE2003	 (derivative	 of	 pET16b,	 5711bp),	harboring	 IHF	 genes	 was	 isolated	 from	 our	 -80°C	 bacterial	 stock	 and	retransformed	into	BL21	E	coli.	The	transformation	was	tested	using	both	plasmid	backbone	 primers	 and	 IHF	 genes	 primers.	 IHF	 protein	 overexpression	 was	induced	 using	 different	 IPTG	 concentrations;	 purified	 using	 a	 nickel-sepharose	column	 and	 the	 overexpression	 was	 tested	 by	 both	 SDS-PAGE	 and	 semi	 dry	western	 blot	 analysis.	 On	 the	 other	 hand,	 the	 Φ24B	 integrase,	 cloned	 into	pBAD/Myc-His	C	plasmid	(~4.1	kb),	was	overexpressed	from	E.	coli	TOP	10.	The	overexpression	was	tested	by	both	SDS-page	gel	and	semi-dry	western	blot	assay.	
	
Additionally,	pCR2.1	plasmids	(~3.5	kb),	harboring	a	region	of	DNA	encompassing	either	 the	 attP	 or	 attB,	 were	 isolated	 from	 E.	 coli	 TOP	 10	 strain.	 In	 order	 to	remove	all	small	unwanted	compounds,	like	imidazole,	both	of	IHF	and	Integrase	proteins	were	purified	from	cell	extracts,	dialyzed	using	dialysis	membrane	tube	and	 concentrated	 (Rigaut	 et	 al.,	 1999).	 The	 protein	 solution	 was	 concentrated	using	 Vivaspin	 20	 column	 (GE	 Health	 Care).	 The	 concentration	 of	 each	 protein	was	measured	using	the	Pierce	BCA	Protein	Assay	Kit.	
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Several	 recombination	 tests,	 in	 two	 replicates	 for	 each,	 were	 run	 using	 either	supercoiled	pattP	with	supercoiled	pattB,	supercoiled	pattP	with	 linear	pattB	or	linear	 pattP	 with	 supercoiled	 pattB.	 Furthermore,	 we	 used	 E.	 coli	 cell	 crude	extracts	without	any	protein	overexpression.	Both	pattP	and	pattB	were	cut	using	the	BamH	I	restriction	enzyme	to	make	a	linear	DNA	product.		
	
Approximately	 500	 ng	 each	 of	 linear	 or	 supercoiled	 substrate	DNAs	was	mixed	with	 200	 ng	 of	 approximately	 90%	 pure	 integrase	with	 and	without	 100	 ng	 of	approximately	90%	pure	IHF,	in	addition	to	about	500	ng	of	cell	extract,	in	a	final	reaction	volume	of	50	$l	(Fig.	3.3).	
	
Figure	3.3.	In	vitro	recombination	assay	using	pattB	and	pattP	plasmids	and	required	proteins	in	a	final	volume	of	50	*l	of	suitable	buffer.	recombination	tests	were	run	using	either	supercoiled	pattP	with	supercoiled	pattB	(The	bottom	test),	supercoiled	pattP	with	linear	pattB	(The	top	test)	or	linear	pattP	with	supercoiled	pattB.	In	each	test	the	DNA	substrate	was	mixed	with	Int	with	or	without	IHF	in	addition	to	cell	extract.	
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Two	 types	 of	 buffer	were	 used	 to	 achieve	 the	 final	 reaction	 condition;	 the	 first	(Buffer1)	one	was	composed	of	20	mM	Tris,	pH	7.5,	100	mM	NaCl,	1%	glycerol,	0.1	mM	EDTA	(Thorpe	and	Smith,	1998),	while	 the	second	 final	 condition	 (Buffer2)	was	 50	 nM	 Tris-Cl,	 pH	 7.8,	 60	mM	KCl,	 250	mg	 of	 BSA	 for	 each	 15	 µl,	 0.5	mM	EDTA,	10%	glycerol	and	5	mM	spermidine	(Goodman	et	al.,	1999).	The	reactions	were	 incubated	 for	 6	 hours	 or	 24	 hour	 at	 37°C,	 and	 stopped	 by	 separating	 the	recombination	 solutions	 in	 the	 electrophoresis	 gel.	 Any	 expected	 recombinant	band	has	been	cut	from	the	gel,	extracted	using	gel	PCR	and	Gel	kit	from	Bioline,	and	used	as	PCR	template	using	attRL	F/R	primers.		
	
3.3.	Results	
The	minimal	components	needed	for	l	phage	in	vitro	recombination,	are	attP	and	
attB	 sequences,	purified	 integrase,	 and	 purified	E.	coli-encoded	 integration	 host	factor.	Due	to	the	fact	that	the	Φ24B	integrase	is	a	member	of	the	tyrosine	family	of	 recombinases,	 like	 the	 l	 phage	 integrase,	 and	 Φ24B	 is	 a	 member	 of	 the	lambdoid	family	of	phages	it	was	reasonable	to	assume	that	the	integrase	of	Φ24B	would	 work	 similarly	 to	 the	 integrase	 of	 l	 phage.	 To	 these	 ends	 the	 various	reagents	were	produced	including	IHF,	attP	Φ24B,		attB	Φ24B,	and	Int	Φ24B	and	IHF.			
3.3.1	IHF	production	
The	 plasmid	 pEE2003	 possessing	 the	 himA	 and	 himD	 genes	 encoding	 IHF	 was	kindly	donated	by	E.	Haggard-Ljungquist	 (Table	2.2.1.).	In	order	to	utilize	IHF	in	
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an	 in	 vitro	 integration	 assay,	 it	 was	 necessary	 to	 purify	 IHF.	 	 Using	 IHF	 from	plasmid	 pEE2003-IHF	 where	 the	∝	subunit	 is	 labelled	 with	 a	 molecular	 tag	consisting	 of	 6	 contiguous	 histidine	 residues,	 both	 subunits,	 forming	 a	heterodimer,	could	be	purified	by	Ni-affinity	chromatography.	
	
		
Conditions	for	induction	of	IHF	expression	were	tested	(Fig.	3.4A)	and	optimized	following	 the	 isolation	 and	 retransformation	 of	 pEE2003-IHF	 into	 freshly	prepared	 chemically	 competent	 cells	 (See	 2.12.	 Transformation	 of	 chemically	competent	cells)(Fig.	3.3B).		 	
A	 B	
A	 B	
IHF A ~11.3 kDa 
IHF B ~10.6 kDa 
MW				1							2						3					4								5							6			
Figure	3.4:	Production	of	IHF	from	a	His-tagged	cloned	(kindly	provided	by	E.	Haggard-Ljungquist).	The	low	expression	of	 IHF(A)	was	 improved	when	its	pEE2003-Ihf	plasmid	was	 isolated	and	retransformed	to	new	chemically	competent	cells	for	protein	overexpression	and	purification.	We	can	see	 in	picture	B,	SDS-page	 gel	 of	 His-tagged	 IHF	 purification	 steps.	 MW,	 prestained	 molecular	 weight	 markers	 (2-250	 kD)	(BioRad);	1,	whole	 cell	 lysate;	2,	Ni-column	 flow	 through;	3-5,column	washes;	6,	 IHF	 in	60	mM	 imidazole	washing	buffer.	
A	 B	
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3.3.2	Int	Φ24B	Production	
The	 plasmid	 pBAD/Myc-His	 C,	 possessing	 the	 int	 gene	 encoding	 Int	was	 kindly	donated	by	P.	Fogg	 (Table	2.2.1.).	In	order	to	utilize	Int	in	an	in	vitro	integration	assay,	 it	 was	 necessary	 to	 purify	 Int,	 the	 main	 protein	 that	 performs	 DNA	recombination.	 	 This	 was	 done	 using	 Int	 from	 plasmid	 pΦ24B-int	 where	 the	protein	 molecule	 is	 labelled	 with	 a	 molecular	 tag	 consisting	 of	 6	 contiguous	histidine	 residues,	 and	 could	 be	 purified	 by	 Ni-affinity.	 The	 conditions	 for	induction	of	Int	were	tested	(Fig	3.5).	
	
		 	
Figure	 3.5.	 Production	 of	 Integrase	 from	 a	 His-tagged	 cloned.	 SDS-page	 gel	 of	 His-
tagged	 Integrase	 purification	 steps.	 MW,	 prestained	 molecular	 weight	markers	 (10-250	kD)	 (BioRad);	 1,	 whole	 cell	 lysate;	 2,	 Ni-column	 flow	 through;	 3-5,	 column	 washes;	 6,	Integrase	in	60	mM	imidazole.		
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3.3.3	Production	of	attP	Φ24B,	attB	Φ24B	constructs	
In	order	to	establish	a	working	protocol	for	an	in	vitro	integration	assay,	we	need	to	insure	that	we	have	all	components	needed	for	this	in	vitro	recombination	to	be	performed	by	the	act	of	Int	Φ24B	and	IHF.	The	DNA	substances	for	these	proteins	are	 attP	 Φ24B,	 and	 attB	 Φ24B.	 Therefore,	 different	 sizes	 of	 both	 attP	 and	 attB	sequences	 were	 amplified	 (See	 2.5	 PCR,	 Chapter	 2)	 and	 cloned	 into	 their	appropriate	plasmids	(Table	2.2.1).		
		Plasmids	 harboring	 either	 the	 100	 bp,	 200	 bp,	 300	 bp,	 400	 bp	 or	 600	 bp	attB	sequences	 were	 confirmed	 using	 the	 attB	 50	 F/R	 attB100	 F/R,	 attB150	 F/R,	
attB200	F/R	and	attB300	F/R	primers,	respectively,	as	well	as	the	M13	F/R	and	primers	 (The	 plasmid	 backbone	 primers).	 Further	 more,	 the	 transformation	 of	100	 bp,	 200	 bp,	 300	 bp,	 400	 bp	 or	 600	 bp	 attP-cloned	 pCR2.1	 plasmids,	 were	confirmed	using	attP	50	F/R	attP100	F/R,	attP150	F/R,	attP200	F/R	and	attP300	F/R	primers,	respectively,	as	well	as	the	M13	F/R	and	primers	(Fig.	3.6	&	3.7).	
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	1													2														3											4													5												MW								6	
Figure	3.6.	Colony	PCR	of	the	E.	coli	Top	10	transformants	to	confirm	the	construction	of	
pPCR2.1-attB200	bp.	A.	schematic	diagram	showing	the	sites	of	 the	backbone	primers	(Red	color)	 that	 used	 in	 the	 PCR	 reaction,	 the	 PCR	 products	 were	 generated	 with	 the	 M13	 F/R	primers.	 B.	 The	 electrophoresis	 agarose	 gel	 picture	 1-5,	 Colony	 PCR	 ~400	 bp	 fragments	amplified	using	M13	F/R	primers.;	MW,	1kb	Hyperladder	I	(Bioline);	6,	positive	control	using	plasmid	with	attB	600	bp	insert	as	template.			
~400	 bp	PCR	fragment	
B	
A	
~600bpPCR	fragment	
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Positive	control	 PCR	fragment		
~600bp	PCR	fragment	
Figure	 3.7.	 Colony	PCR	 of	 the	E.	 coli	Top	 10	 transformants	 to	 confirm	 the	 construction	 of	
pPCR2.1-attP400	bp.	A.	schematic	diagram	showing	the	sites	of	the	backbone	primers	(Red	color)	that	used	in	the	PCR	reaction,	the	PCR	products	were	generated	with	the	M13	F/R	primers.	B.	The	electrophoresis	 agarose	 gel	 picture:	MW,	 1kb	 Hyperladder	 I	 (Bioline);	 1-5,	 Colony	 PCR	~600	 bp	fragments	amplified	using	M13	F/R	primers.;	6,	Negative	control;	7,	positive	control	using	plasmid	with	attB	400	bp	insert	as	template.			
				MW							1										2										3									4										5																							6									7		
A	
B	
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3.3.5	Integration	Assay	(in	vitro)	
Before	 the	 first	 attempt	 at	 the	 integration	 assay,	 the	 presence	 of	 unwanted	nucleases	 in	 the	 recombinant	 IntΦ24B	 and	 IHF	 preparations	 was	 examined	 (Fig.	3.8).		
To	analyze,	if	Φ24B	integrase	is	able	to	promote	recombination	between	attP	and	
attB,	 in	 vitro	 recombination	 assay	 was	 done	 with	 present	 of	 both	 IHF	 and	 Int	proteins.	This	assay	was	repeated	more	 than	one	 time	using	different	buffers	 in	addition	to	Top	10	cells	crude	extract	without	any	gene	overexpression.		
	
		
MW																	1																					2																				3	
Figure	 3.8.	 Quality	 control	 for	 purified	 IHF	 and	 Integrase.	 MW,	 1	 kb	 DNA	molecular	weight	marker;	Lane1,	plasmid	(100	ng)	carrying	attP	composed	of	a	600	bp	 DNA	 segment	 (300	 bp	 flanking	 either	 the	 overlap	 region)as	 control.	 Same	plasmid	was	incubated	with	1	µg	of	either	IHF	(lane	2)	or	Integrase	(lane3)	at	30	°C	for	1	hour.	No	co-purifying	nuclease	activity	was	detected.	
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On	0.7	%	of	agarose	gel	no	recombination	could	be	detected	in	any	in	vitro	assays	,	with	 exception	 of	 those	 run	 with	 crude	 cell	 extract	 with	 linear	 pattB	 and	supercoiled	pattP	(Fig.	3.9).	This	positive	result	was	confirmed	by	harvesting	the	expected	recombinant	band	from	the	gel,	extracted	using	gel	PCR	and	Gel	kit	from	Bioline,	 and	 using	 PCR	 and	 the	 primer	 pairs	 M13	 F/R	 or	 attRL	 F/R	(attP150F/attBR)	to	confirm	the	identity	of	the	integrand	(Fig.3.10).		
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Figure	3.9.	In	vitro	recombination	tests	using	cells	crude	extract.	A,	After	6hr.	at	37°C	 incubation.	B,	 after	 24hr.	 at	 37°C	 incubation;	 1,4,	 test	 tubes	with	 coiled	 pattP	only	 without	 cell	 extract	 (negative	 control);	 2,5,	 test	 tubes	 with	 linear	 pattB	 only	without	cell	extract	(negative	contral);	3,6,	recombination	test	with	Linear	pattB	and	supercoiled	 pattP	 in	 addition	 of	 cell	 extract;7,	 supercoiled	 pattP	 and	 Linear	 pattB	without	any	other	factor	as	negative	control	.	
MW							1																						2																								3						
					MW									4										5												6													7					
Recombination	band~9000bp	
Recombination	band~9000bp	
A	
B	
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3.4.	Discussion	
Previous	 studies	 have	 demonstrated	 that	 experimental	 parameters	 required	 for	various	 integrases	 in	 in	vitro	 recombination	 assays	 are	 not	 always	 the	 same.	 In	case	 of	 recombination	 catalyzed	 by	 the	 bacteriophage	 P2-encoded	 integrase,	 a	tyrosine	 recombinase,	 integration	 requires	 2	 att	 sequences,	 integrase	 and	 IHF	(Sylwan	et	al.,	2010),	a	phenomenon	not	uncommon	across	tyrosine	recombinases	(Groth	 and	 Calos,	 2004).	 However,	 there	 are	 tyrosine	 recombinases	 like	 Cre,	encoded	by	bacteriophage	P1	that	function	without	accessory	proteins	(Groth	and	Calos,	2004).	The	ΦC31	recombinase	is	of	the	resolvase/invertase	family	and	can	catalyze	 reactions	 in	 the	 absence	 of	 integration	 host	 factor.	 This	 reaction	 was	
~780	bp	frag.	~800	bp	frag.	
~300	bp	frag.	
			MM									1											2												3											4							MW	
Figure	3.10.	PCR	assay	of	the	recombination	products.	MW,	1kb	Hyperladder	I	(Bioline);	1,	 positive	 control	 using	 M13	 F/R	 primer	 with	 pCR2.1-attP600	 as	 template;	 2,	 attRL	 PCR	fragment	amplified	using	M13	F/R	primers;	3,attRL	 PCR	 fragment	amplified	using	attP150	F/attB	R	primers.				
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measured	 over	 a	 time	 period	 of	more	 than	 8	 hr	 in	 in	vitro	 assays	 (Thorpe	 and	Smith,	1998).		
	
As	Φ24B	 integrase	belongs	 to	 the	 tyrosine	 family	 recombinases	and	most	of	 the	members	of	this	family	need	the	accessory	protein	IHF	to	drive	recombination,	we	considered	 IHF	 would	 be	 an	 important	 factor	 for	 Φ24B	 integrase	 to	 promote	recombination.	However,	we	did	not	obtain	any	recombination	product	unless	we	added	crude	E.	coli	cell	extract	to	the	reaction.	For	this	we	have	to	mention	that,	Sylwan	et	al.,	 (2010)	reported	the	 in	vitro	recombination	between	bacteriophage	P2	 attachment	 site	 and	E.	coli	attchment	 site	 attB,	 can	be	 catalyzed	by	 adding	 a	mix	 of	 two	 crude	 extracts,	 one	 of	 them	 is	 overexpressing	 P2-encoded	 integrase	and	the	other	overexpressing	 IHF	protein.	However,	 in	our	case,	having	positive	results	after	adding	crude	E.	coli	cell	extract	means	one	of	two	things:	1)	the	IHF	purified	 from	 pEE2003-IHF	 was	 not	 biologically	 active,	 or	 2)	 there	 is	 another	bacterial	host	accessory	factor(s)	needed	for	the	Φ24B	integrase	to	function	as	a	site-specific	recombinase.		
	
Moreover,	recombination	was	only	detected	in	the	in	vitro	assay	when	pattB	was	linearized,	a	phenomenon	reported	by	Frumerie	et	al.,	(2008),	who	demonstrated	that	the	use	of	linear	attB	DNA	fragments	with	supercoiled	attP	plasmid	and	IHF	was	 necessary	 to	 facilitate	 recombination	 by	 the	 P2	 integrase	 enzyme	 in	 vitro.	This	assay	was	cumbersome	to	perform	and	resulted	in	only	a	limited	amount	of	success.		In	order	to	be	able	to	better	characterise	the	Φ24B	integrase	the	decision	
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was	made	to	move	on	to	an	 in	situ	assay	(Fogg	et	al.,	2011).	This	assay	does	not	allow	the	parameters	of	the	recombination	events	to	be	as	strictly	controlled,	but	has	been	shown	to	be	dependable/robust	in	the	detection	of	recombination.		 	
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CHAPTER	4. IN	SITU	RECOMBINATION	ASSAY	
4.1.	Background		
Since	the	first	identification	of	a	site-specific	recombination	in	the	integration	and	excision	of	bacteriophage	lambda	genome	from	a	specific	site	in	the	E.	coli	genome	(Landy,	2015),	many	site-specific	recombination	systems	have	been	identified	and	characterized	 (Groth	 and	 Calos,	 2004).	 Most	 of	 these	 recombinases	 have	 been	associated	with	bacteria,	but	some	have	also	been	characterised	from	archaea	and	eukaryotic	cells,	 like	yeasts	(Jayaram	et	al.,	2015;	Smith	and	Thorpe,	2002).	DNA	rearrangement	by	 site-specific	 recombinases	 can	be	performed	by	bringing	 two	DNA	strands	together.	These	DNA	sites	can	be	either	at	separate	locations	within	a	single	DNA	molecule	or	just	simply	located	in	two	different	molecules.	Both	IHF	and	 integrase	 proteins	 then	 work	 by	 protein-protein	 interaction	 and	 DNA	homology.	 At	 a	 specific	 point	within	 the	 sites,	 the	DNA	 strands	 are	 broken	 and	reorganized	in	strand	exchange	reaction,	which	gives	new	DNA	product	(Fig	1.10,	Chapter	1)	(Craig	and	Nash,	1984).	The	result	of	this	reaction	can	be	integration,	inversion	 or	 excision	 of	 the	DNA	 substrate.	 The	 reaction	 outcome	 and	 duration	are	 precisely	 controlled.	 In	 case	 of	 temperate	 phage,	 this	 strict	 control	 is	important	 to	 minimize	 the	 opportunity	 for	 DNA	 damage	 during	 the	rearrangement.	 It	 is	 essential	 for	 phage	 genome	 integration	 and	 later	 phage	excision	and	for	lytic	or	lysogenic	life	cycle	(Smith	and	Thorpe,	2002).		
	
In	+	phage,	 the	 archetypal	 phage	 for	 the	 lambda	 family,	 the	 phage	 genome,	 at	entry	into	the	lysogenic	replication	cycle,	integrates	inside	the	E.	coli	genome	after	
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the	 recognition	of	 the	 specific	 attachment	 site	 in	 the	bacterial	 chromosome,	 the	
attB	 site.	 This	 site	 recombines	 with	 the	 the	 phage	 attachment	 site	 attP.	 The	outcomes	 of	 this	 process	 are	 two	 hybrid	 sites,	 attR	 and	 attL,	 flanking	 an	integrated	prophage	genome	within	the	host	chromosome.	Each	new	hybrid	site	is	 comprised	 of	 about	 half	 of	the	attB	 site	 and	 half	 of	 the	attP	 site	 (Ross	 et	 al.,	1979).		
	
Driving	 the	 incorporation	 of	 the	+	prophage	 into	 the	 now	 lysogenic	 host	 is	 the	phage-encoded	integrase	(Int)	enzyme,	which	is	a	member	of	the	tyrosine	family	of	 recombinases	 (Enquist	 et	 al.,	 1979).	 The	 specificity	 of	 recombination	 sites	 is	determined	by	shared	sequence	within	the	attB	and	attP	sites,	and	the	set	up	for	recombination	is	driven	by	both	DNA-DNA	sequence	homology	and	DNA-protein	interactions	(Weisberg	et	al.,	1983).	As	such,	+	phage	integrase	interacts	with	the	specific	sites,	attP	and	attB,	producing	an	Int/DNA	intasome	complex,	bringing	the	sites	 together	 to	 catalyze	 a	 unidirectional	 reaction	 that	 produces	 and	 then	resolves	 a	 Holliday	 junction	 intermediate,	 which	 ultimately	 results	 in	 the	production	of	an	integrated	prophage	(Chen	et	al.,	2000;	Azaro	and	Landy,	1997)	
.	Homology	between	overlap	regions	is	very	necessary	to	promote	recombination	(Echols	and	Green,	1979)	(see	also	3.1.2	Lambda	phage	integrase,	Chapter	3).		
	
To	 mediate	 the	 DNA	 recombination, 	+ 	phage	 integrase	 needs	 an	 attB	 site	consisting	of	21	nucleotides	with	an	integration	overlap	region,	also	known	as	the	
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point	 of	 crossover	 (OB),	 whereas.	 The	 attP	site	 is	 250	 bp	 long	 and	 possesses	 a	crossover	region	(OP).	The	lambda	overlap	region	is	7	bp	(Fig.1.10.	Chapter	1).		
	A	 bacterially	 encoded	 protein,	 integration	 host	 factor	 (IHF),	 is	 also	 required	 to	facilitate	 the	 integration	process	 (Sylwan	et	al.,	 2010,	Groth	and	Calos,	2004).	 It	has	been	reported	that	IHF	is	essential	for	+	phage	site-specific	recombination.	To	facilitate	 integrase	 activity,	 IHF	 binds	 to	 regions	 in	 attP	 at	 specific	 arm	 binding	sites,	 enabling	 integrase	 to	 bind	 to	 the	 attP	 site-arms	 with	 high	 affinity	 while	maintaining	a	 lower	affinity	 to	 the	attP	 core-binding	region	(Richet	et	al.,	1988),	(see	also	3.1.2	Lambda	phage	 integrase,	Chapter	3).	The	recombination	(Fig.4.1)	requires	 each	 monomer	 to	 have	 an	 N-terminal	 domain	 that	 resides	 over	 each	adjacent	core-binding	region	(Biswas	et	al.,	2005).	The	C-terminal	domains	(core	binding	 and	 catalytic	 domains)	 recognize	 and	 bind	 to	 the	 identical	 crossover	sequences	in	the	attP/attB	regions	in	a	square	planar	formation,	promoting	DNA	recombination	(Fig.	4.1)	(Van	Duyne,	2005).	
.		 	
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Figure	4.1.	The	 Int/DNA	intasome	complex	based	on	the	models	proposed	by	(Biswas	et	
al.,	 2005).	 A	 cartoon	 depiction	 of	 the	 protein-DNA	 interaction	 during	 bacteriophage	+	integration.	The	integrase	protein	binds	with	high	affinity	to	the	attP	site-arm	regions	and	with	low	affinity	 to	 the	attP	 core-binding	 region.	 	 Integration	host	 factor	 is	necessary	 for	extensive	
attP	DNA	binding	that	required	for	intasome	formation.	Red	colour	lines	highlight	the	crossover	region.	
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4.1.1.	The	Stx	Phage	,24B	
Φ24B	 is	an	Stx	encoding	bacteriophage	 that	 is	a	member	of	 the	 lambdoid	 family	(Allison,	2003).	All	members	of	this	family	have	a	double	stranded	DNA	genome,	and	 have	 similar	 morphological	 characteristics	 (icosahedral	 head	 with	 tail).	Moreover,	they	are	genetically	very	similar.	Lambda	phage	+,	the	archetype	of	this	family,	possesses	a	genome	of	48.5	kb,	which	is	enough	to	govern	all	its	biological	aspects	(Biswas	et	al.,	2005).	Φ24B	has	a	larger	genome	(57.67	Kb)	than	lambda.	Little	 is	 known	 about	 the	 function	 of	 this	 extra	 DNA	 carried	 by	Φ24B	 (Allison,	2003).	
	
Bacterial	and	phage	integration	attachment	sites	were	identified	by	the	alignment	of	 the	Φ24B	genome	 sequence	 (attP),	 the	MC1061	 genome	 sequence	 (attB)	 and	the	integrated	prophage	(within	lysogen	genome)	sequence	(attL)	(Fig.4.2)	(Fogg	et	 al.,	 2007).	 The	 primary	 bacterial	 integration	 site	 is	 located	within	 the	E.	coli	genome,	just	upstream	to	the	integrase	gene	within	the	cryptic	prophage	CPS-53.	
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4.1.2.	In	situ	assay	
The	term	in	situ	is	a	Latin	phrase	that	means	“on	site”	or	“locally	“,	and	it	describes	the	scientific	measurement	event	 that	happens	at	 the	same	place	as	 the	original	phenomenon	 is	 naturally	 occurring	 without	 altering	 the	 original	 conditions	(Lewis	 et	 al.,	 1969).	 In	biology	and	biomedical	 engineering,	 in	 situ	means	 to	examine	 the	 phenomenon	 exactly	 in	 place	 where	 it	 occurs.
Figure	 4.2.	 The	 identification	 of	 bacterial	 and	 bacteriophage	 integration	
attachment	sites.	The	 following	 sequences	were	aligned:	Φ24B	genome	 sequence	(attP),	 the	MC1061	genome	sequence	 (attB)	 and	 the	 integrated	prophage	 (within	lysogen	genome)	sequence	(attL)	(Fogg	et	al.,	2007)	to	identify	the	core	cross	over	regions.		
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We	call	the	system	that	we	used	for	the	intracellular	plasmid	recombination	an	in	
situ	 recombination	 system,	 as	we	 run	 the	 assay	 at	 the	 same	 original	 conditions	that	Φ24BInt	 needs	 in	 order	 to	 facilitate	 DNA	 recombination	 between	 the	Φ24B	phage	genome	and	the	E.	coli	bacterial	genome.		
	
Previously,	 we	 were	 trying	 to	 develop	 a	 repeatable	 system	 in	 which	 we	 could	precisely	 control	 all	 of	 the	 components	 involved	 in	 the	 recombination	 reaction	(DNA	 substrates,	 enzymes	 and	 proteins),	 so	 we	 started	 with	 an	 in	 vitro	recombination	system.	where	we	could	control	the	quantities	and	ratios	of	DNA,	enzymes,	and	proteins	as	well	as	the	reaction	conditions.	However,	in	vitro	assays	require	that	all	of	the	required	factors	are	known,	and,	our	limited	 in	vitro	assay	results	 led	us	 to	wonder	 if	 there	was	either	an	unknown,	E	coli	encoded	protein	necessary	 for	Φ24BInt	 activity,	 or	 if	 the	 purified	 IHF	 used	 in	 the	 in	vitro	 assay	lacked	biological	activity.	Therefore,	we	moved	to	work	with	a	system	that	would	provide	the	same	set	of	conditions	that	occur	within	the	host	cell,	where	we	knew	we	could	detect	Int-mediated	recombination.	This	system	was	the	three	plasmids	
in	situ	recombination	assay.		
	
In	order	to	run	an	efficient	in	situ	plasmid	system,	we	have	to	avoid	any	plasmid	incompatibility	 events.	 Plasmid	 incompatibility	 can	 be	 defined	 as	 the	 failure	 of	two,	 or	 more,	 co-resident	 plasmids	 to	 persist	 in	 a	 cell.	 In	 other	 words,	 if	transformation	of	second	plasmid	negatively	affects	the	inheritance	of	the	already	
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existing	 first	 plasmid,	 the	 two	 plasmids	 are	 considered	 to	 be	 incompatible.	 The	reason	behind	that	is	the	plasmid’s	origin	of	replications	(ori).	It	 is	impossible	to	have	two	different	plasmids	that	use	same	mechanisms	of	replication	in	one	single	cell	 (Novick	 et	 al.,	 1976).	 Therefore,	 to	 maintain	 three	 plasmids	 in	 an	 in	 situ	system,	we	had	to	use	compatible	plasmids,	and	that	means	each	plasmid	has	its	own	replication	strategy	and	different	from	the	other	two.	
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4.1.3	Aims	
	
• Cloning	 of	 both	 attB	 and	 attP	 into	 separate	 compatible	 plasmids	 to	 run	recombination	between	them.	
• Transformation	of	both	att	site	plasmids	and	pΦ24B-into	E	coli	competent	cells	(one	cell	harbours	3	plasmids).	
• Run	 DNA	 recombination	 driven	 by	Φ24B-INT	 protein	 using	 in	 situ	recombination	assay.	
• Using	the	in	situ	recombination	assay,	determine	the	minimal	sizes	of	both	
attB	and	attP	sites	that	are	necessary	to	support	integration.	
• Identify	 the	 necessary	 size	 of	 each	 arm	 binding	 sites	 (B	 and	 B’)	 of	attB	recognised	by	the	 integrase	and	surrounding	the	24	bp	overlap	region	or	the	core-binding	site	(O).	
• Identify	 the	 importance	 of	 the	 bacterial-encoded,	 integration	 host	 factor	for	integrase	activity.	
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4.2.	Specific	Methods		
4.2.1.	Plasmids	cloning	of	attB	and	attP	sites	 
An	already	prepared	pCR-Φ24B-attP600	plasmid	(Table	2.2.1.),	harboring	the	attP	core	and	600	bp	of	 flanking	 sequence	 (see	3.2.1.	Cloning	of	bacterial	 and	phage	attachment	sites,	Chapter	3),	was	isolated	from	E.	coli	TOP	10	strain	(Invitrogen).	The	attP	 fragment	was	 cut	using	BamH	 I	 and	XhoI	 endonucleases	 enzymes.	The	same	 digestion	 enzymes	 were	 used	 to	 cut	 the	 high	 copy	 number	 compatible	plasmid,	pCDF-Duet.	After	the	endonucleases	were	deactivated,	each	of	the	above	was	purified	by	 the	 agarose	 gel	 and	 recovered	using	PCR	and	Gel	 extraction	kit	from	 (Bioline,	 London,	 U.K.).	 The	 attP	 sequence	 was	 ligated	 into	 pCDF-Duet	 to	form	 pΦ24B-attP600	 (Table	 2.2.1.),	 before	 it	 was	 transformed	 to	 new	 Top	 10	competent	 E.	 coli	 cells.	 At	 the	 same	 time,	 both	 of	 already	 prepared	 pCR-Φ24B-attB600	harboring	the	attB	core	and	600	bp	of	flanking	sequence,	and	the	medium	copy	number	pACYC-Duet	compatible	plasmid	were	cut	using	same	endonuclease	enzymes	(BamH	I	and	Xho	I).	After	the	restriction	enzymes	were	deactivated,	both	of	 these	 DNA	 sequences	 were	 agarose	 gel	 purified	 and	 recovered.	 The	 linear	pACYC-Duet	plasmid	was	 ligated	by	attB	 sequence	 to	 form	pΦ24B-attB600	(Table	2.2.1.),	 before	 it	was	 transformed	 into	new	Top	10	 competent	 cells	 (Invitrogen)	(Table	2.1.1.).	 	
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4.2.2.	Restriction	free	cloning	
This	method	has	been	described	by	Bryksin	and	Matsumura	(2010)	and	(Bryksin	and	Matsumura,	 2010,	 van	 den	 Ent	 and	 Löwe,	 2006).	 All	attB	 site	 inserts	were	amplified	from	genomic	DNA	of	the	E.	coli	K-12	strain,	MC1061	(See	2.1.	Bacterial	Strains,	 Chapter	 2),	 while,	 all	 attP	 inserts	 were	 amplified	 from	 the	 DNA	 of	 the	Φ24B	 phage	 genome.	 The	 PCR	 amplification	 of	 the	 insert	 DNA	 was	 performed	using	Q5	hot	start	High-Fidelity	DNA	polymerase	(New England Biolabs,	Ipswich,	USA)	(See	2.5	PCR,	Chapter	2).	Primers	that	were	used	in	these	PCR	amplifications	are	listed	in	Table	2.5.2. (Chapter 2). The forward primer had 20 bp of sequence at its 
5’end that was complementary to the cloning site in the plasmid vector, with the last 
15-20 bp of the primer being complementary to the insert of interest. The revers primer 
was also capable of annealing to the plasmid cloning vector with 20 bp of 
complementary sequence whilst the rest of the primer was complementary to the insert 
being amplified and cloned. The total volume of the amplification reaction was 50 µl. 
PCR products were run in an agarose gel to confirm the apparent molecular weight and 
in order to purify the correct sized products using the PCR and Gel extraction kit from 
(Bioline, London, U.K.).  
	
Each	amplified	insert	was	now	flanked	by	DNA	sequences	homologous	to	the	area	of	the	plasmid	vector	where	the	insert	was	to	be	cloned.	After	the	gel	extraction	of	the	PCR	product,	for	each	cloning,	200-300	ng	of	insert	PCR	product	was	used	in	the	 linear	 amplification	 reaction	with	 20-30	 ng	 of	 the	 desired	 plasmid,	 200	µM	dNTP’s	(Bioline,	London,	U.K.),	1×	of	Q5	reaction	buffer,	and	0.02	U/µl	of	Q5	hot	
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start	High-Fidelity	DNA	polymerase.	The	 total	 volume	of	 the	 reaction	was	50	µl.	By	 denaturing	 the	 insert	 and	 plasmid	 DNA	 the	 homologous	 sequences	 shared	between	insert	and	plasmid	vector	could	align	and	the	insert	DNA	was	now	free	to	prime	the	extension	of	 the	plasmid	vector	 in	a	 linear	amplification	reaction.	The	reaction	 was	 heated	 for	 30	 s	 at	 98	°C,	 followed	 25	 cycles	 composed	 of	denaturation	at	98	°C	for	10	s,	annealing	at	60	°C	for	30	s,	and	extension	at	72	°C	for	30	s/kb	and	final	extension	for	5	minutes	at	72	°C.	The	resulting	product	was	the	plasmid	vector	with	the	cloned	insert	sequence.	
	
After	 the	 PCR	 reaction	was	 completed,	 the	 PCR	 product	was	 purified	 using	 the	PCR	and	Gel	extraction	kit	from	(Bioline,	London,	U.K.).	The	DNA	was	eluted	with	10	µl	 of	 pre-heated	 water	 (50°C)	 before	 the	 spin	 column	 was	 centrifuged	 at	11,000	g	for	1	min,	as	the	finale	step	of	that	purification	(See	2.6.1	Recovery	of	the	DNA	from	the	agarose	gel,	Chapter	2).		
	
In	order	to	digest	the	methylated	parental	plasmids,	8.5	µl	of	the	restriction	free	cloning	reaction	were	treated	with	0.5	µl	of	Dpn	 I	(Bioline),	and	1	µl	of	CutSmart	Buffer	 (Bioline, # B7204S)	 for	 2	 h	 at	 37	°C.	 Then,	 5	µl	 from	 the	 reaction	 was	transformed	into	new	Top	10	Competence	cells	and	transformants	were	selected	for	on	LB	agar	with	the	plasmid	resistance	antibiotic	at	its	specific	concentration	(Invitrogen)(Table	2.1.1.).	 Positive	 cloning	 was	 confirmed	 by	 plasmid	 prep	 and	DNA	sequencing	(Fig.	4.3).	
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Figure	 4.3.	 Restriction	 free	 cloning	
(Adapted	From	Bryksin	and	Matsumura,	
2010).	 Using	 primers	 comprised	 of	 two	distinct	 sequence	 domains	 (insert	 and	plasmid	sequences)	 the	 insert	 to	be	cloned	was	 amplified.	 This	 amplification	 product	was	then	flanked	by	sequences	homologous	to	 the	 insertion	 site	 in	 the	plasmid	cloning	vector.	Using	methylated	plasmid	DNA	and	the	 amplified	 insert	 product	 a	 second	amplification	 reaction	 was	 run	 using	 the	insert	DNA	 to	 prime	 the	 production	 of	 the	desired	 DNA	 clone.	 Once	 these	 primers	anneale	 to	 their	 sites	 in	 the	 plasmids,	 the	Q5	 plymarase	 extends	 and	 incorprates	 the	insert	 into	a	nicked,	circular	DNA	molecule	using	 the	 plasmid	 as	 tamblate	 untile	 it	reaches	 5’	 end	 of	 the	 insert.	 The	 parental	vector	 was	 digested	 away	 using	 the	restriction	 endonuclease	 Dpn	 I	 which	cleaves	 only	 methylated	 DNA	 (this	destroying	 only	 plasmid	 DNA	 in	 which	 no	insert	has	been	added.	The	remaining	DNA		product	was	transformed	into	New	Top	10	Competent	cells.	
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	4.2.3.	In	situ	recombination	assay		
All	 in	situ	 recombination	(RL)	assays	were	performed	inside	One	Short	TOP10	E	
coli	cells	(Table	2.1.1.).	Each	required	plasmid	transformed	sequentially	into	these	cells	until	all	required,	compatible	plasmids	for	each	assay	were	in	one	E	coli	host	cell.	An	appropriate	amount	of	LB	broth,	with	all	plasmid’s	resistance	antibiotics	at	their	specific	concentrations,	was	inoculated	with	1	ml	of	an	overnight	culture	of	cells	harbouring	the	compatible	plasmids.	This	culture	was	incubated	at	37	°C	with	 shaking	 at	 200	 r.p.m	 til	 the	 OD600	 0.5-0.8	 was	 reached.	 Expression	 of	 the	integrase	 protein	 (Int)	 was	 induced	 by	 the	 addition	 of	 L-Arabinose	 to	 the	 final	concentration	of	0.02%	w/v.	The	cultures	were	incubated	for	an	additional	three	hours	 at	 same	 incubation	 temperature.	 Finally,	 from	 each	 assay	 flask,	 5	 ml	samples	were	taken	and	all	plasmid	DNA	present	was	extracted	from	the	cells	in	the	 samples.	 The	 assays	 results	 were	 determined	 following:	 1)	 a	 PCR	 reaction	using	attRL	F/R	primers,	2)	agarose	gel	electrophoresis	and	3)	Sanger	sequencing	of	 the	 PCR	 products	 (See	 2.15.	 The	 Sequencing	 analysis,	 Chapter	 2).	 All	 these	assays	where	performed	along	with	negative	control,	comprised	of	a	sample	that	simply	was	not	induced	with	arabinose	so	that	no	Int	was	produced	(Fig.4.4).	 	
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4.2.4.	The	importance	of	IHF	for	!24B	integration	
An	E.	coli	strain	 that	carries	a	knockout	mutation	of	 the	 ihfA	gene	was	used	as	a	reaction	vessel	cell	in	the	in	situ	recombination	assay.	Chemically	competent	cells	were	prepared	for	this	strain	(See	2.11.	Preparation	of	chemically	competent	cells,	Chapter	2).	After	the	transformation	of	required	each	plasmid,	successively,	all	of	the	 following	plasmids,	pΦ24B-attB,	pΦ24B-attP	and	pΦ24B-int,	were	 introduced	into	one	E.	coli	host	cell.	The	in	situ	assay	was	run	as	described	above.	
	 	
Figure	4.4.	In	situ	recombination	assay.	The	ToP	10	E	coli	cells	harboring	all	of	pΦ24B-attB,	pΦ24B-attP	and	pΦ24B-int,	were	incubated	until	the	right	O.D.	when	the	overexpression	of	Int	protein	was	induced.	Int	protein	in	turn	drives	 the	 recombination	 between	 pΦ24B-attB	 and	 pΦ24B-attP	 in	 hybrid	recombination	product.	
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4.3.	Results		
4.3.2.	The	minimal	necessary	attP	size		
In	 order	 to	 determine	 the	minimal	 size	 of	attP	 sequence	 capable	 of	 supporting	integration,	E.	coli	cells	harboring	pΦ24B-attB1-600	and	pΦ24B-int	were	used	as	the	host	to	test	different	attP	sequence	sizes	in	separate	in	situ	recombination	assays	(Fig.4.5).	For	these	assays,	restriction	free	cloning	was	used	to	clone	the	site	attP	of	either	of	140	bp,	230	bp,	350	bp,	427	bp	(all	possessing	the	24	bp	site	core	at	their	 centre),	 separately,	 into	 the	high	 copy	number	pCDF-Duet.	Meanwhile,	 the	600	 bp	 attP	 sequence	 was	 also	 cloned	 into	 the	 same	 plasmid	 using	 standard	restriction	enzymes	and	ligase-based	cloning.	
Figure	 4.5.	 Colony	 PCR	 of	 plasmids	 in	 the	 E.	 coli	 Top	 10	 transformants	 confirming	 the	
transformation	of	pattP	 (600	bp)	to	 cells	already	harbouring	p!24B-int	and	pattB.	A.	A	 schematic	diagram	 showing	 the	 sites	 of	 the	 backbone	 primers	 (Red	 color)	 that	 used	 in	 the	 PCR	 reaction,	 the	 PCR	products	 were	 generated	 with	 the	 Forward	 ACYCDuetUP1 and Reverse T7 Terminator;	 B.	 The	electrophoresis	agarose	gel	picture.	MW,	1kb	Hyperladder	I	(Bioline);	Lanes	1-4&7,	~850	bp	bands	from	5	individual	clones	amplified	by	PCR;	 lane	5,	Positive	control:	plasmid	with	200	bp	insert;	Lane	6,	primers	negative	control:	PCR	without	template.		
1													2											3												4													5											6														7							MW		B	
~850bp	
A	
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Following	 each	 in	 situ	 recombination	 assays,	 which	 were	 performed	 in	 two	replicates,	integration	events	were	identified	by	determining	the	existence	of	the	large	hybrid	pΦ24B-attRL	plasmid.	Plasmids	were	harvested	following	the	 in	situ	assay	 and	 PCR-based	 DNA	 amplifications	 were	 performed	 using	 attRL	 primers.	Resulting	 products	 were	 analysed	 on	 an	 agarose	 gel	 and	 the	 identities	 of	 the	products	confirmed	by	Sanger	sequencing.	The	minimal	attP	sequence	necessary	to	support	phage	genome	integration	inside	E.	coli	genome	was	determined	to	be	427	bp,	with	almost	equal	P	and	P’	sizes	(Fig	4.6).	
	
	
	 	
A	 B	
MW        1            2             3           4 
Figure	4.6.	PCR	detection	of	the	resultant	attRL	hybrid	site	formation	from	minimal	
attP	sequence	detection	assays.	A.	Schematic	diagram	showing	the	sites	of	the	backbone	
attB	 F/R	 primers	 (Red	 color)	 and	 attP	 F/R	 primers.	 The	 bottom	 line	 shows	 the	 attRL	recombination	sequence	and	 its	F/R	primers	that	used	 to	generate	this	PCR	 reaction.	B.	The	 electrophoresis	 agarose	 gel	 picture	 Lanes:	 MW,	 1	 kb	 Hyperladder	 I	 (Bioline);	 1,	recombination	 product	 of	 pattP	 600bp	with	 pattB	 600	 bp;	 2,	 recombination	 product	 of	pattP	400bp	with	pattB	600bp;	3,	recombination	product	of	pattP	250bp	with	pattB	600	bp;	4,	recombination	product	of	pattP	200bp	with	pattB	600bp.		
~600bp	
~450bp	
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4.3.2.	The	minimal	necessary	attB	size		
Top	 10	 competent	 cells	 harboring	 pΦ24B-attP1	 and	 pΦ24B-int	 were	 used	 to	determine	 the	 minimal	 necessary	 attB	 sequence	 for	 integrase	 to	 drive	recombination.	These	cells	were	transformed	with	plasmids	harbouring	attB	DNA	fragments,	each	for	separate	recombination	assay	(Figs.	4.7).		
	
	 	
~850	 bp	frag.	 Control	positive	 PCR	fragment	
Figure	4.7.	PCR	results	from	the	E.	coli	Top	10	transformants	to	confirm	the	presence	of	
pACYC-Duet-attB	600	bp.	Top10	cells	harboring	pΦ24B-int	were	transformed	with	pACYC-Duet-attP600.	A.	A	schematic	diagram	showing	the	sites	of	the	backbone	primers	(Red	color)	that	 used	 in	 the	 PCR	 reaction,	 the	 PCR	 products	 were	 generated	 with	 the	 Forward	
ACYCDuetUP1 and Reverse T7 Terminator;	B.	The	electrophoresis	agarose	gel	picture.	MW,	1kb	Hyperladder	 I	(Bioline);Lanes	1-2,	PCR	~850bp	 fragments	 from	transfromants;	Lane	3,	negative	 result	 colony	 PCR;	Lane	4,	 negative	 control;	 Lane	5,	 positive	 control:	 :PCR	 for	 the	plasmid	with	its	insert	before	transformation	.	
MW									1										2												3										4									MW								5	B	
A	
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For	these	assays,	the	restriction-free	cloning	method	was	used.	DNA	fragments	of	either	25	bp,	64	bp,	82bp,	93	bp,	110	bp,	125	bp,	200	bp	or	300	bp	(all	carrying	the	24	bp	core)		were	cloned,	separately,	inside	the medium copy number pACYC-
Duet (Table	2.2.1.). The	600	bp	attB	sequence	was	cloned	in	the	same	plasmid	using	standard	restriction	enzyme	digests	and	ligation.	
 
The	 in	 situ	 recombination	 assays	 were	 performed	 in	 two	 replicates.	 The	integrations	 were	 detected	 by	 identifying	 the	 presence	 of	 large	 integrated	plasmids	pΦ24B-attRL.	After	a	plasmids	prep	of	5	ml	assay	sample,	The	outcome	was	 determined	 by	 running	 a	 PCR	 reaction	 using	 attRL	 F/R	 primers,	 on	 an	agarose	gel	and	sending	the	samples	for	sequencing.	The	results	showed	that	the	minimal	attB	sequence	that	Int	required	to	perform	integration	was	93	bp	of	DNA	(Fig	4.8).	
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	In	 order	 to	 identify	 whether	 the	 sequences	 that	 flanking	 the	 attB	 site	 must	 be	present	 to	 support	 integrationand	whether	 those	 flanking	sequences	must	be	of	equal	 lengths,	 several	 pattB	 plasmid	 constructs	were	made	 and	 transformed	 to	new	 Top	 10	 competent	 cells	 already	 harboring	 pΦ24B-attP1	and	 pΦ24B-int	 for	testing	 in	 the	 in	situ	 integration	assay.	The	results	of	 these	assays	 indicated	 that	the	flanking	sequencing	comprising	the	arms	of	attB	did	not	to	be	of	equal	size.		In	fact	it	ws	found	that	the	Φ24B-Int	needs	49	bp	of	flanking	sequence	on	the	B	side	
~240	bp		frag.	
A	 B	
        MW            1                 2                  3 
Figure	4.8.	PCR	detection	of	the	resultant	attRL	sites	from	minimal	attB	sequence	 in	situ	
integration	assays.	A.	Schematic	diagram	showing	the	sites	of	the	backbone	attB	F/R	primers	(Red	 color)	 and	attP	 F/R	 primers.	The	 bottom	 line	 shows	 the	attRL	 recombination	 sequence	and	 its	 F/R	 primers	 that	 used	 to	 generate	 this	 PCR	 reaction.	 Primers	 that	 used	 to	 check	 the	recombination	results	are	attB40F/attp200R	B.	The	electrophoresis	agarose	gel	picture	Lanes:	MW,	1	kb	Hyperladder	 I	 (Bioline);	Lane	1,	 recombination	product	of	pattP	 400bp	with	pattB	100bp;	Lane	2,	recombination	product	of	pattP	400bp	with	pattB	93bp;	Lane	3,	recombination	product	of	pattP	400bp	with	pattB	60bp.	
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of	the	core	region	of	the	attB	site	and	21	bp	flanking	sequence	on	the	B’	 	side	of	the	core	site	in	order	to	drive	integration	(Fig	4.9).		
			
		 	
Figure	4.9.	Comparison	between	the	essential	sequences	of	the	λ	attB	site	
&	Φ24BattB	sites.	
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4.3.3	IHF	importance	determination		
To	demonstrate	the	importance	of	IHF	for	Int	to	promote	the	integration	of	Φ24B	bacteriophage’s	genome’s	into	E.	coli	genome,	the	E.	coli	strain	JW1702-1 was used 
as the host cell in the in situ recombination assay. This strain is a deletion mutation of 
the himA gene (one of two IHF genes). The assays results showed that a large hybrid 
integrated DNA product could be detected after arabinose induction of integrase 
expression, demonstrating that integration could occur in the absence of IHF (Fig 
4.10).		
	
	 	
Figure	 4.10.	 In	 situ	 recombination	 assay	 using	 the	 E	 coli	 strain	 JW1702-1.	 The	 cells	harbouring	 the	 plasmid	 mixture	 composed	 of	 pΦ24B-attB,	 pΦ24B-attP	 and	 pΦ24B-int,	 were	incubated	until	the	O.D.600	of	(0.5-0.6)	was	reached.	At	this	point	the	expression	of	Int	protein	was	induced	with	arabinose.	 Int	protein,	 in	turn,	drives	the	 recombination	between	pΦ24B-attB	and	
pΦ24B-attP	to	produce	the	hybrid	recombination	product.		
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4.4.	Discussion	
As	we	were	not	 successful	 in	 characterising	 the	Φ24B	integrase	using	an	 in	vitro	recombination	assay,	we	moved	on	 to	 try	 a	 three-plasmid	 in	situ	 recombination	assay,	which	relied	on	the	use	of	a	series	of	compatible	plasmids.	This	system	was	used	by	Fogg	(2011),	in	order	to	demonstrate	the	relationship	between	Φ24B-Int	and	Φ24B-Xis	 in	 several	 recombination	 and	 excision	 in	situ	 assays.	 In	situ	 (or	 in	
vivo)	 DNA	 recombination	 techniques	 were	 also	 used	 in	 many	 other	 studies	including	 determining	 different	 cellular	 enzymes	 that	 are	 involved	 in	 several	types	of	DNA	recombination	and	to	understand	many	phage	genome	integrations	inside	the	bacterial	genome	(Rajeev	et	al.,	2009;	McCulloch	et	al.,	1994;	Bliska	and	Cozzarelli,	1987).		
	
Altering	our	approach	to	characterise	the	Φ24B	integrase	to	incorporate	the	use	of	an	in	situ	assay	enabled	us	to	identify	the	minimal	sequence	that	must	be	present	in	attP	to	support	integration.	We	began	the	attP	size	determination	experiments	fragments	 of	 600	 bp,	 and	 constructed	 several	 separate	 plasmids,	 each	 plasmid	carrying	 a	 different	 sized	 variant	 of	 the	 attP	 site,	 but	 not	 shorter	 then	 140	 bp.	Originally,	 the	reason	 for	not	examining	attP	 sequence	 lengths	shorter	 than	140	bp	was	because	the	minimal	attP	site	needed	by	lambda	integrase	for	integration	is	250	bp	(Sylwan	et	al.,	2010;	Groth	and	Calos,	2004).	The	Φ24B	bacteriophage	belongs	to	the	same	family,	so	we	expected	that	the	Φ24B-Int	would	have	similar	needs	 to	 those	 of	 lambda.	Moreover,	 in	 order	 to	 examine	whether	 the	 P	 and	 P’	arms	flanking	the	central	recombination	core	need	to	be	equal	sizes	or	not,	two	in	
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situ	assays	were	 run.	 The	 first	 assay	was	 done	with	 a	 pCDFDuet-attP	construct	that	had	a	P	arm	of~140	bp	and	a	P’	arm	of	~200	bp	surrounding	the	crossover	region.	 The	 other	 experiment	 used	 a	 pCDFDuet-attP	construct	 with	 a	 P	 arm	 of	~200	 bp	 and	 a	 P’	 arm	 of	 ~140	 bp.	 Neither	 of	 these	 constructs	 supported	recombination.	The	P’	arm	in	the	lambda	attP	is	composed	of	~80	bp	while,	the	P	arm	 possesses	 the	 integrase	 binding	 site	 and	 is	 larger	 at	 ~140	 bp	 than	P’(Goodman	et	al.,	1999).	Further	work	is	need	to	identify	all	of	Φ24B-	P,	P’,	H,	H’,	Xis	and	Fis	sites	 (Fig	3.2),	as	 they	are	already	 identified	within	 lambda	attP	 site	(Numrych	et	al.,	1992).	
	
In	 addition	 to	 identification	 of	 the	 minimal	 necessary	 attP	 site	 for	 Φ24B	integration,	 the	 in	 situ	 recombination	 assay	 enabled	 the	 determination	 of	 the	minimal	attB	 sequence	 requirements.	 The	 strategy	 for	 determining	 the	minimal	
attB	 sequences	 were	 examined	 from	 fragments	 as	 small	 as	 25	 bp	 short	(essentially	limited	to	the	core	overall	region	between	attB	and	attP).	The	rational	behind	 using	 such	 a	 short	 fragment	 is	 that	 Φ24B	Int	 is	 a	 site-specific	 tyrosine	recombinase	 (James	 et	 al,	 2001).	 These	 integrases	 have	 complex	 binding	 sites,	however	the	attB	site	is	usually	less	complex	then	the	attP	site.	Lambda	attB	site,	for	 example,	 is	 only	 21	 bp	 with	 7	 bp	 serving	 as	 the	 central	 crossover	 core	sequence	 that	 interacts	with	 the	attP	 site	 (Mizuuchi	 et	 al.,	 1981).	 Nevertheless,	according	to	our	results,	Φ24B-attB	site	is	not	that	simple.	The	25,	64,	and	82	bp	
attB	 sequences	 failed	 to	 support	 integration.	 Recombination	 was	 however,	detected	 when	 the	 attB	 site	 was	 125	 bp	 and	 the	 24	 bp	 crossover	 region	 was	
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flanked	by	~50	bp	sequences	in	both	the	B	and	B’	arms.	This	sequence	size	is	very	large	compared	to	other	characterised	tyrosine	recombinase	attB	sites(Lorbach	et	al.,	2000,	Kolot	et	al.,	1999).	The	non-integrase	tyrosine	family	members,	such	as	FLP	 and	 Cre,	 need	 attB	 sequence	 ~50	 bp,	 which	 is	 still	 less	 then	 what	 we	determined	 	 for	 the	Φ24B-attB	 site	 (Abremski	 and	Hoess,	 1984,	 Andrews	 et	 al.,	1985).		
	
To	identify	whether	the	B	and	B’	arms	are	equal	in	their	importance	in	supporting	integration,	several	in	situ	assays	were	run	with	pACYCDuet-attB	carrying	~50	bp	on	 the	B	arm	side	and	 from	21-40	bp	on	 the	B’	arm.	The	 large	hybrid	plasmids,	indicated	 that	 recombination	 occurred,	 were	 identified	 in	 attB	 site	 contructs	totalling	93	bp	and	mixed	arm	sizes	with	the	B	arm	at	49	bp	and	the	B’	arm	at	21	bp.	 This	 is	 an	 unusual	 result,	 as	 most	 previous	 reports	 characterising	 the	requirements	 for	 activity	 of	 tyrosine-mediated	 site	 specific	 recombinases	 have	identified	attB	sites	possessing	B	and	B’	arms	of	equal	size	(Lorbach	et	al.,	2000,	Kolot	et	al.,	1999).		
	
Φ24B_Int	 is	a	site-specific	 tyrosine	 integrase.	All	members	of	 the	 tyrosine	 family	require	 host	 encoded	 DNA	 binding	 proteins	 to	 perform	 integration	 (Groth	 and	Calos,	 2004).	 Φ24B	 bacteriophage	 belongs	 to	 the	 same	 family	 as	 lambda	 phage	integrase	(Allison,	2007),	so	we	assumed	that	Φ24BInt	would	be	the	same	or	have	requirements	similar	to	lambda	Int.	According	to	all	that,	our	hypothesis	was	that	Φ24BInt	 cannot	 drive	 DNA	 recombination	 without	 the	 presence	 of	 the	 host	
136	
encoded,	Integration	Host	Factor	(IHF).	However,	the	in	situ	recombination	assay	performed	 in	 E	 coli	 cells	 that	 do not produce IHF proved that DNA recombination 
can still be driven by Φ24B_Int.	 This	 novel	 finding	 enables	 us	 to	 rejected	 the	hypothesis	of	the	need	for	IHF.	However,	this	result	does	not	mean	Φ24B_Int	can	drive	recombination	without	host	encoded	DNA	binding	proteins	(see.	Chapter	3:	
in	vitro	recombination	assay).	
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CHAPTER	5. IDENTIFICATION	 OF	 INTEGRATION	 SITE	
PREFERENCES	
5.1	Background:	
Most	temperate	E.	coli	phages	can	integrate	in	their	host’s	genome	via	site-specific	recombination	 (Groth	 and	 Calos,	 2004).	 They	 can	 integrate	 their	 genomes	 in	 a	range	 of	 sites	 within	 the	 host	 genome,	 however,	 each	 phage	 species	 has	 high	preference	 to	 one	 specific	 site	 (Rajeev	 et	 al.,	 2009).	 When	 Lambda	 phage,	 for	instance,	lysogen	cells	that	lack	the	most	preferred	attachment	site,	it	can	occupy	one	of	the	many	secondary	sites	(Rutkai	et	al.,	2003).	These	secondary	sites	have	a	degree	 of	 homology	with	 the	 primary	 site	 in	 their	 core	 overlap	 region,	 flanking	sequence	or	both	(Richet	et	al.,	1988).	However,	the	affinity	to	these	sites	is	not	as	strong	 as	 that	 for	 the	 primary	 attachment	 site,	 and	 therefore	 their	 utilization	frequency	is	less	than	that	for	the	primary	attachment	site.	Integration	specificity	depends	on	protein-DNA	interactions	between	the	integrase	molecule,	the	phage	DNA	attachment	site	(attP)	and	the	bacterial	DNA	attachment	site	(attB),	as	well	as	 the	DNA/DNA	 interaction	between	 the	corresponding	overlap	regions	of	attP	and	attB	(Weisberg	et	al.,	1983).		
	
When	Lambda	phage	directs	 its	 integration	 into	 the	host’s	 genome	 to	become	a	prophage	 it	 produces	 a	 repressor	 (CI),	 which	 is	 controlled	 by	 a	 self-regulated	promoter,	PRM.	CI’s	role	is	to	inhibit	the	expression	of	all	other	phage	genes	in	the	lysogen	and	provide	 immunity	 to	 superinfection	by	other	Lambda	phages	 (Lisio	and	Weissbach,	 1965).	 Therefore	 a	 double	 lysogen	 of	 Lambda	 phage	 have	 only	
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been	 found	 in	 E.	 coli	 host	 cells	 that	 carried	 a	 Lambda	 with	 immunity	 mutant	prophages	(Freifelder	and	Kirschner,	1971).	
	
The	bacteriophage,	Φ24B,	is	a	lambdoid	phage	that	gives	the	enterohaemorrhagic	
E	coil	 (EHEC)	 their	ability	 to	produce	Shiga	 toxin	(Stx)	 (Paton	and	Paton,	1998).	The	 lambdoid	 CI-controlled	 immunity	 to	 superinfection	 does	 not	 necessarily	function	 the	 same	 in	 these	 phages.	 Isogenic,	 selectable,	 non-toxigenic	Φ24B	mutants	were	used	to	produce	a	multiply	infected	host	cell	(Allison	et	al.,	2003).	Derivatives	of	Φ24B	were	found	to	be	able	to	be	able	to	sequentially	infect	a	host	cell,	each	integrating	at	a	distinct	site	(Fogg	et	al.,	2007).	The	rate	of	occurrence	of	this	 superinfection	 increased	 in	 frequency	 with	 each	 successive	 superinfection	event.	The	harboring	of	more	than	one	isogenic	prophage	simultaneously	within	a	single	bacterial	host	cell	has	implications	for	enhanced	pathogenicity	as	a	result	of	the	presence	of	multiple	copies	of	the	Stx	genes	in	a	single	bacterial	cell	(Fogg	et	al,	 2010;	 Fogg	 et	 al,	 2012;	 Botstein,	 1980)Furthermore,	 it	 makes	 the	 host	 cell	more	 sensitive	 to	 an	 induction	 stimulus	 than	 lysogens	 harboring	 a	 single	prophage,	suggesting	that	maintenance	of	a	stable	prophage	is	less	likely	when	a	superinfection	is	present	(Fogg	et	al.,	2012;	Botstein,	1980)	.		
	
At	least	four	isogenic	prophage	genomes	were	identified	following	an	experiment	involving	 the	 sequential	 infection	 of	 a	Φ24B	 lysogen,	 with	 each	 prophage	integrated	at	 a	unique	 site	 (Fogg	et	 al.,	 2007).	The	attB1	 is	 just	upstream	of	 the	integrase	gene	from	the	cryptic	prophage	intS,	so	it	can	be	called	attBintS	site.	The	
139	
site	 attB2	 lies	 between	 the	 genes	 yfaL	 and	 nrdA,	 encoding	 an	 adhesion	 and	ribonucleoside-diphosphate	 reductase,	 respectively,	 therefore,	 it	 can	 be	 named	
attByfnr	 site.	 The	 site	 attB3	 lies	 within	 the	 yfbO	 gene	 encoding	 a	 hypothetical	protein,	 so	 it	 can	 be	 named	 attByfbO	 site.	 The	 site	 attB4	 is	 within	 sgcA	 gene	encoding	 a	 putative	 phosphotransferase	 enzyme	 IIA	 component,	 so	 it	 can	 be	named	 attBsgcA	 site.	 With	 the	 exception	 of	 the	 in	 integration	 site,	 which	 is	favoured,	there	seems	to	be	no	preference	(Fogg	et	al.,	2007)	(fig.5.1).	
	
Since	 it	was	 determined	 that	Φ24B-phage	 can	 drive	multiple	 integration	 events	(Allison	et	el,	2003),	within	at	least	four	sites,	the	four	sites	were	sequenced	(Fogg	
et	 el,	 2007).	 The	 alignment	 of	 the	 Φ24B	genome	 sequence	 (attP),	 the	 MC1061	genome	 sequence	 (attB)	 and	 the	 integrated	 prophage	 (within	 lysogen	 genome)	sequence	 (attL)	 clearly	 showed	 that	 the	 primary	 bacterial	 attachment	 site	 has	100%	 homology	 to	 phage	 attachment	 sites.	 On	 the	 other	 hand,	 the	 alignment	among	the	remaining	bacterial	attachment	sites	showed	that	the	similarity	among	them	is	about	50%	(Fig.5.1).	This	is	definitely	likely	to	explain	the	answer	for	why	
in	attachment	site	always	gives	lysogen	first.		 	
140	
	
It	has	been	reported	 that	E.	coli	 cells	can	be	simultaneously	 the	host	of	multiple	compatible	 plasmids	 with	 a	 high	 DNA	 concentration	 (see	 4.3.	 In	 situ	 assay,	Chapter	 4).	 This	 co-transformation	 is	 found	 due	 to	 the	 description	 of	 high	efficiency	 E.	 coli	 electroporation.	 Multiple	 vector	 transformants	 have	 been	described	 in	 previous	 studies	 (Dower	 et	 al.,	 1988).	 The	 ability	 of	 simultaneous	transformation	 of	 compatible	 plasmids	 played	 an	 important	 role	 during	 the	bacterial	constructions.		
	
Cells	with	multiple	plasmids	have	been	used	 in	previous	studies	 for	a	variety	of	purposes,	for	example:	to	determine	differences	in	the	expression	of	mutant	genes	
Figure	5.1:	The	alignment	of	four	distinct	bacterial	integration	sites	in	same	genome.		Site	attBintS	is	the	primary	attachment	site,	which	has	100%	homology	with	phage	attachment	site.	Site	attByfbO	has	62.5%	to	the	primary	attachment	site	and	to	phage	attachment	site.	Site	II	 has	 62.5%	 to	 the	 primary	 attachment	 site	 and	 to	 phage	 attachment	 site.	 Site	attByfnr	 has	50%	to	the	primary	attachment	site	and	to	phage	attachment	site.	And	finally	Site	attBsgcA	has	54%	to	the	primary	attachment	site.	DNA	nucleotides	that	are	highlighted	with	red	colour	are	present	 in	 all	 of	 the	 four	 sequences.	 Yellow	 color	 for	 that	 present	 in	 three	 of	 them,	 while	sequences	that	exist	in	two	of	them	are	highlighted	with	green	color.					
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compared	to	wild	type	genes	(Peixoto	et	al.,	2004).	The	outcome	of	such	studies	can	 be	 determined	 by	 using	 fluorescence-based	 quantitative	 Real-Time	 PCR	(qPCR)	 to	measure	 the	number	of	 copies	of	RNA	 transcripts	of	both	 the	mutant	and	 the	 wild	 type	 genes	 (Bustin,	 2000).	 Other	 studies	 have	 used	 this	 qPCR	 to	address	 the presence of some genes even without expression, utilizing the high 
specificity of this quantification technique, using primers that targeting their DNA 
sequences directly. qPCR is particularly suitable here, as even very small DNA copy 
number can be amplified and identified (Jonker et al., 2008; Rooks et al., 2010). Real-
Time PCR is a molecular technique based on the polymerase chain reaction (PCR), 
however it determines the targeted DNA amplification during the PCR, and not at its 
end as in conventional PCR. To obtain this feature, syber green, which interacts with 
dsDNA and marked with a fluorophore (a fluorescent chemical compound), is added to 
the reaction mixture in a thermal cycler contains sensors for measuring the 
fluorescence of the fluorophore after it has been created at required wavelength. This 
allows the generation rate of PCR amplification to be measured for one or more 
specific products at each PCR cycle. The generated data can be analysed by computer 
software (Excel Microsoft program) to calculate the mRNA or the DNA copy number 
in several samples (Bustin, 2000). 
	
qPCR	 is	 a	 powerful	 tool,	with	 its	 high	 capacity	 of	 determine	 and	measure	 small	amounts	 of	 the	 nucleic	 acid	 in	 different	 samples	 from	 variety	 resources.	 Its	specificity	along	with	its	speed	combination	have	made	it	criterion	for	nucleic	acid	quantification.	 In	 addition	 to	 the	 use	 of	 qPCR	 as	 a	 research	 instrument,	 several	medical	 diagnostic	 applications	 have	 been	 performed	 depending	 on	 the	
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quantification	 of	 DNA,	 for	 example:	 risk	 estimation	 of	 cancer	 recurrence,	 the	identification	of	gene	dosage,	and	forensic	applications	(Huggett	et	al.,	2013). 
	
In	 this	 study	 we	 have	 used	 qPCR	 to	 determine	 the	 outcome	 of	 the	 	 in	 situ	recombination	assay,	which	is	performed	inside	E.	coli	cells	that	are	transformed	with	 more	 then	 four	 compatible	 plasmids.	 qPCR	 requires	 a	 reference	 gene	 to	make	comparisons	with,	and	as	the	phage	attachment	site	was	going	to	be	present	in	 all	 of	 recombination	 products,	 the	marker	 gene	 of	 the	 plasmid	 CDFDuet	 that	harboring	attP	site	in	all	experiments	was	used	as	a	reference	gene	for	our	qPCR	assay.		
	
5.1.1	The	Aim		
	
• To	identify	the	recombination	events	within	each	bacterial	attachment	site	compared	to	the	primary	bacterial	attachment	site.		
• To	 identify	 the	 frequency	 and	 the	 order	 of	 preference	 for	 each	 attB	 site	over	time.	
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5.2.	Specific	Methods	
5.2.1.	Bacterial	strains,	plasmids	and	media	
The	 bacterial	 strains	 and	 plasmids	 used	 in	 this	 study	 are	 listed	 in	 Table	 2.2.1	(Chapter	 2).	 One	 Short	 TOP10	 E	 coli	 cells	 were	 used,	 as	 a	 host,	 for	 all	 in	 situ	recombination	assays.	The	genome	of	E.	coli	K-12	strain,	MC1061,	was	used	as	a	template	for	the	amplification	of	all	four	bacterial	attachments	sites	(attBs).	Each	
attB	 site	 was	 cloned	 into	 a	 plasmid	 with	 a	 unique	 replicon	 (Table	 2.1.1).	 The	phage	 attachment	 site	 (attP)	 was	 amplified	 from	 the	 genome	 of	 the	MC1060/Φ24B	 lysogen	 and	 cloned	 in	 its	 appropriate	 plasmid	 (Table	 2.1.1).	MC1060Φ24B	refers	 to	MC1061	when	 it	 carries	 the	Φ24B	 prophage,	while	 naïve	MC1061	refers	to	the	strain	when	it	has	not	been	infected	by	Φ24B.	The	routinely	used	culture	media	were	Luria-Bertain	broth,	Luria-bertani	agar	and	SOC	Growth	Media.	The	 following	antibiotics	were	used	where	appropriate:	chloramphenicol	(50	µg	ml-1),	 tetracycline	 (10	µg	ml-1),	 spectinomycin	 (100	µg	ml-1),	 ampicillin	(100	µg	ml-1),	kanamycin	(50	µg	ml-1),	and	gentamicin	(10	µg	ml-1).	
	
5.2.2.	PCR	cloning		
The	overlap	extension	PCR	cloning	was	performed	as	mentioned	previously	(See	4.2.1.2	 Restriction-free	 cloning	 method,	 Chapter	 4)(Bryksin	 and	 Matsumura,	2010)	.	Specific	primers	that	have	insert	sequence	at	the	3’	and	plasmid	sequence	at	the	5’	end	were	used	to	amplify	the	insert	sequence	first	(Table 2.5.2. Chapter 2).	The	second	step	of	this	process	is	to	use	these	inserts	as	mega-primers	to	amplify	
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the	plasmid	backbone	 in	 a	 secondary	PCR	 reaction.	The	Highly	Fidelity	Q5	high	fidelity	 polymerase	 was	 used	 in	 both	 first	 and	 second	 PCR	 reactions.	 PCR	conditions	 for	both	of	 the	reactions	 initial	denaturation	step	at	98	°C	for	30	sec.,	fallowed	by	30	cycles	of	denaturation	at	the	same	temperature	for	10	sec.,	primer	annealing	 time	 was	 15	 sec	 at	 the	 specific	 primer’s	 temperatures.	 The	 PCR	extension	 took	place	at	72	°C.	 It’s	 time	was	30	 sec.	per	kb	product.	The	original	plasmid	 templates	 in	 the	 PCR	 products,	 were	 digested	 using	 DpnI	 digestion	enzyme	(Biolabs).	The	final	products	were	transformed	to	new	One	Short	TOP10	
E.	coli	competent	cells.		
	
5.2.3.	In	situ	recombination	assay.		
All	 in	situ	 recombination	assays	were	performed	 inside	One	Short	TOP10	E.	coli	cells.	After	the	transformation	of	each	plasmid,	new	competent	cells	were	created	to	be	 ready	 for	 receiving	 the	next	plasmid	until	 all	 of	 compatible	plasmids	with	different	markers	were	all	 in	one	E.	coli	host	cell.	The	plasmids	are	five	different	compatible	 plasmid	 harboring	 four	 different	attB	 sites	 and	attP	 site	 along	with	plasmid	harboring	int	gene	(Fig.5.2.).	
	
An	100	ml	amount	of	LB	broth	was	inoculated	with	1	ml	of	an	overnight	culture	of	cells	harboring	the	compatible	plasmids.	This	was	incubated	at	37	°C	with	shaking	at	 200	 r.p.m	 to	 the	 OD600	 0.5-0.8.	 Integrase	 protein	 Int	 was	 overexpressed	 by	adding	L-arabinose	to	a	final	concentration	of	0.02%.	The	cultures	were	incubated	over	various	times,	as	indicated.	From	each	assay	flask,	5	ml	samples	were	taken	
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for	plasmid	extraction.	All	assays	where	performed	along	with	a	negative	control	where	 the	 plasmid	 bearing	 cells	 were	 not	 exposed	 to	 arabinose	 to	 repress	 the	expression	of	the	integrase	protein.	
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Figure	 5.2.	 The	 substrates	 and	 the	 final	 recombination	 products	 of	 in	 situ	 recombination	 assay.	 After	 inducing	 of	 Int	 protein	overexpression	from	 its	pBAd	plasmid	(Orange	color),	 	DNA	recombination	takes	place	between	attP	 	site	(yellow	color)	 in	 its	plasmid	(Blue	color)	and	each	of	attB	sites	 in	there	plasmids	(Black	color).	 	Each	recombination	event	takes	place	between	each	attB	site	and	attP	site	gives	specific	 product	 differs	 from	 other	 attB	 site	 recombination	 products.	 Depending	 on	 that	 we	 could	 have	 specific	 primers	 for	 each	 hybrid	recombination	product	to	be	used	for	finding	out	the	difference	between	the	recombinations	events	in	qPCR	technique.	The	reference	gene	that	used	 in	 the	 qPCR	 assays	 was	 the	 spectinomycin	 resistant	 gene	 (aadA2)	 (Light	 blue	 color),	 as	 it	 is	 present	 within	 all	 of	 the	 recombination	products.	
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5.2.4.	Comparative	qPCR	assay.		
	In	 situ	 recombination	 assays	 cultures	 were	 harvested	 for	 plasmid	 mini	 preps	(Bioline),	according	to	the	manufacturer’s	specifications.	The	reference	gene	that	was	used	in	the	qPCR	assays	was	the	spectinomycin	resistant	gene	(aadA2),	as	it	is	present	within	all	of	the	recombination	products	(Fig.5.2.).	Specific	primers	were	used	for	all	of	the	recombination’s	products	for	each	qPCR	reaction	in	SensiFAST	SYBR	qPCR	reaction	mixture	(Bioline).	All	experiments	were	performed	to	comply	with	 the	 standard	 cycling	 conditions.	 The	 experiments’	 annealing	 temperature	was	53	℃	and	the	amplicon	size	was	~200	bp	for	all	of	recombination	products.	The	qPCR	assays	were	performed	using	the	Step	One	Plus	Real-Time	PCR	Cycler	(Applied	Biosystems,	Waltham,	USA)(Fig.5.2).	The	efficiency	of	the	qPCR	primers	was	confirmed	by	standard	curve	analysis	for	each	pair	of	primers	(Copy	number	range	=3×104	-	3×108).	The	qPCR	outcomes	were	confirmed	by	running	them	on	a	agarose	gel.	The	DNA	band	of	 interest	was	cut,	purified	and	sent	for	sequencing.	The	typical	thermo	cycling	qPCR	program	started	with	20	sec.	initial	denaturation	step	at	95	℃.	The	cycling	stage	was	composed	of	second	denaturation	step	at	95	℃	for	2	sec.	followed	by	10	sec.	annealing	step,	and	extension	step	at	72	℃	for	20	sec.	A	melting	curve	analysis	was	performed	for	each	amplification	reaction,	with	a	 temperature	 gradient	 of	 1	℃	from	 53	℃	to	 95	℃.	 All	 qPCR	 assays	 were	performed	with	a	negative	control	which	has	exactly	same	conditions	but	without	template.	The	qPCR	resulted	data	were	analyzed	using	Delta	Delta	CT	method	to	calculate	the	quantitative	results	of	each	recombination	event	and	compare	it	with	
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In	 site	 recombination	 results.	 The	mathematical	 equation	 that	was	 used	 to	 find	out	the	Delta	Delta	CT	for	each	recombination	event	was:		
	
	
CT			is	the	PCR	cycle	at	which	the	fluorescent	signal	of	the	reporter	dye	crosses	an	arbitrarily	 placed	 threshold.	 The	 t-test	 analysis	 was	 used	 to	 find	 out	 the	significance	of	the	qPCR	results		 	
2										=(CT	of	reference	Gene	–	CT	of	In	site	recombination	product)	−	(CT	of	reference	Gene−	CT	of	tested	site	recombination	product)	∆∆CT	
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5.3.	Results		
In	order	to	have	all	&24B	bacterial	attachment	sites	cloned	in	separate	compatible	plasmids,	 all	 of	 the	 attB	 sites	 attBintS,	 attByfnr,	 attByfbO	 and	 attBsgcA	were	 cloned	inside	 pCYCDuet,	 pRSFDuet,	 pETDuet	 and	 pCOLADuet	 plasmids,	 respectively,	 to	create	 pΦ24B-attB1	 (pattBintS),	 pΦ24B-attB2	 (pattByfbO),	 pΦ24B-attB3	 (pattByfnr),	pΦ24B-attB4	(pattBsgcA)	and	pΦ24B-attP	(pattP)	(Table	2.2.1)(Fig.5.2.)		.			
Unfortunately,	 both	 pattByfnr	 plasmid	 and	 pattBsgcA	 plasmids	 possessed	 the	kanamycin	resistant	gene	(kanR2)	as	a	selectable	marker.	To	enable	selection	for	both	 plasmids	 simultaneously,	 the	 marker	 in	 pattBsgcA	 was	 replaced	 by	 the	tetracycline	 resistant	 gene	 (tetR).	 The	 tetracycline	 resistance	 gene	 (tetR)	 was	amplified	from	the	plasmid	pBR322	and	cloned	into pCOLADuet-Sg.	Furthermore,	the	ampicillin	 resistant	gene	 (bla)	 in	pattByfbO	was	replaced	with	 the	gentamicin	resistant	gene	(aacC1)	as	plasmid	marker.	The	phage	attachment	site	(attP)	was	cloned	 into	 pCDFDuet	 that	 carries	 the	 spectinomycin	 resistant	 gene	 (aadA2)	which	 served	 as	 the	 indicator	 gene	 for	 the	 qPCR	 assays,	 being	 found	 in	 the	plasmids	 bearing	 attP	 and	 the	 recombined	 plasmids	 (Table	 2.2.1).	 All	 plasmids	were	transformed	into	one	bacterial	host.	
5.3.1.	Relative	quantitative	recombination	events	
To	 determine	 the	 quantitative	 recombination	 events	 of	 all	 secondary	Φ24B	bacterial	attachment	sites,	the	number	of	recombination	events	occurring	within	the	Top10	cells	was	compared	to	the	number	of	recombination	events	within	the	
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primary	attachment	site.	Two	variations	of	 in	situ	assays	were	performed	in	two	replicates	 	 for	 each:	 first;	 pattBintS,	 pattByfnr	 and	 pattByfbO	were	 transformed	 into	
OneShotTOP10 competent cells along with both	 pattP	 and	 pΦ24B-int	 (plasmid	 that	harboring	integrase	gene);	second;	cells	harboring	pattBintS,	pattByfnr,	pattByfbO	and	pattBsgcA	as	well	as	pattP	and	pΦ24B-int	were	used.	Cell	cultures	harboring	these	plasmid	mixtures	 took	 longer	 to	grow	(6-8	h)	before	 reaching	an	OD600=0.5-0.8.	After	reaching	this	optical	density	the	integrase	gene	was	induced	with	arabinose	to	 drive	 its	 expression,	 enabling	 recombination.	 After	 14	 hours,	 plasmids	 were	recovered	 from	 the	 cells	 and	 recombination	 events	 between	 attP	 and	 the	 attB	sites	were	detected	by	qPCR	(Fig.	5.3).	
	
The	qPCR	data	 showed	 there	were	a	 significant	quantitative	difference	between	the	recombination	events	in	the	primary	attachment	site	(attBintS)	(attRL1)	and	in	other	 attachment	 sites	 (P-value	 =	 0.00)	 (Fig.	 5.3).	 The	 formation	 of	attRL2	 and	
attRL3	were	 low	compared	 to	 the	 formation	of	 the	attRL1	 site,	 and	 there	was	no	significant	 difference	 between	 their	 relative	 quantities.	 The	 fourth-bacterial	attachment	site	recombination	attRL4,	in	the	experiment	that	has	all	of	attachment	sites	 plasmids	 in	 one	 bacterial	 host	 cell,	 showed	 the	 same	 relationship	 to	 the	primary	 attachment	 site,	 as	 there	 was	 a	 significant	 lower	 number	 of	 attRL4	compared	to	attRL1.	Furthermore,	it	showed	no	significant	formation	Differences	were	detected	across	attRL4	,	attRL2	and	attRL3.		
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Figure	 5.3.	 The	 relative	 quantitative	 recombination	 events	 in	 the	 secondary	 sites	
mediated	by	Φ24B	Int	measured	by	qPCR	as	compared	to	the	use	of	attBintS.	Expression	of	integrase	was	driven	by	an	arabinose	inducible	promoter	at	37	°C	after	the	culture	reached	mid-exponential	 growth,	 14	 hours	 later,	 plasmids	 were	 harvested	 from	 the	 cells	 and	recombination	was	determined	by	qPCR.		A.	The	qPCRresults	of	the	recombination	assay	of	cells	harboring	pattBintS	(labeled	by	number	1),	pattByfnr	(yellow	color)	and	pattByfbO	(blue	color).	B.	The	qPCRresults	of	 the	recombination	assay	of	cells	harboring	pattBintS,	pattByfnr,	pattByfbO	and	pattBsgcA	(red	color).	The	in	situ	recombination	events	of	attP	with	attByfnr,	attByfbO	or	attBsgcA	were	significantly	less	frequent	 than	 the	 recombination	 with	 attBintS	 (p-value=	 0.00).	 The	 frequency	 of	 attP	recombination	 with	 in	 the	 secondary	 sites	 was	 similar,	 with	 no	 significant	 differences	detected.		
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5.3.2.	Recombination	site	preference	of	attP	site	
The	presence	of	Φ24B	bacterial	attachment	sites	in	different	compatible	plasmids,	having	different	plasmid	markers,	 in	one	E.	coli	 bacterial	host	 cell	 enabled	us	 to	find	the	difference	among	these	recombination	sites	not	only	in	their	integration	frequency	 but	 also	 in	 their	 recombination	 preferences.	 The	 preference	 of	 each	bacterial	attachment	site’s	integration	could	be	determined	by	performing	a	time	course	experiment.	Time	course	 could	be	demonstrated	by	 taking	5	ml	 samples	from	the	in	situ	recombination	bacterial	culture	after	5	m,	30	m,	60	m,	120	m,	180	m,	and	240	m,	after	integrase	protein	was	induced.	The	culture	was	then	left	for	a	further	10	h	before	it	was	harvested	for	final	sample.	These	samples	were	taken	for	plasmid	mini	prep	and	qPCR	experiments.	The	time	course	qPCR	of	the	in	situ	recombination	 assay	 that	 has	 pattBintS,	 pattByfnr	 and	 pattByfbO	 ,	 showed	 that	 the	first	 recombination	 events	 took	 place	 with	 attBintS	 and	 attByfnr	 after	 5	 m	 only.	While,	for	integrase	to	drive	the	attRL3	recombination,	120	m	was	needed.	Similar	results	were	seen	in	the	time	course	qPCR	of	the	in	situ	recombination	assay,	that	has	pattBintS,	pattByfnr,	pattByfbO	and	pattBsgcA,	for	all	attRL1,	attRL2	and	attRL3.	The	experiment	 results	 showed	 that	 attRL4	 took	 place	 within	 60	 m,	 before	 attRL3	(Fig.5.4).	
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Figure	5.4.	The	attB	secondary	sites	recombination	preference,	measured	by	qPCR	time	
course.		Samples	were	taken	for	plasmid	prep	and	qPCR	after	(0m,	5m,	30m,	60,	120m,	180m,	and14	h)	incubation	at	37	°C.		A.	The	qPCR	results	of	the	recombination	assay	of	cells	having	pattBintS	(labeled	by	number	1),	pattByfnr	(yellow	color)	and	pattByfbO	(Red	color).	B.	The	qPCR	results	of	 the	recombination	assay	of	 cells	having	pattBintS,	pattByfnr,	pattByfbO	and	pattBsgcA	(Blue	color).	The	 in	 situ	 recombination	 with	 pattByfnr	 was	 much	 preferred	 over	 pattByfbO	 and	 pattBsgcA.	Recombination	with	pattBsgcA	was	much	preferred	over	pattByfbO,	which	had	been	detected	after	120	min	incubation	time	of	the	experiment.				The	Frequency	with	attByfnr	was	increased	from	its	starting	point	(~10_5)	to	be	ended	with	less	then	 10-3,	 with	 significant	 difference	 the	 attBintS	 recombination	 (p-value=	 0.00).	 (NR	 means	undetected	recombination).		
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5.4.	Discussion 
Temperate	 phages	 that	 enhance	 the	 pathogenicity	 of	 their	 hosts	 are	 known	 as	converting	phages	(Saunders	et	al.,	2001).	These	phages	play	an	important	role	in	the	dissemination	of	virulence	and	other	genetic	determinants	 that	 increase	 the	genetic	diversity	across	members	of	bacterial	populations.	These	phages	can	even	transform	 nonpathogenic	 bacteria	 into	 causative	 agents	 of	 several	 diseases	 for	plant,	animal	or	human	hosts	(Allison,	2007).	
	
Stx-phages	enhance	the	evolution	and	virulence	of	its	E.	coli	pathogens	(Brüssow	et	 al.,	 2004;	 O'Brien	 et	 al.,	 1984).	 The	 pathogenicity	 enhancement	 is	 massively	increased	by	multiple	Stx	prophages	in	a	single	bacterial	host.	Moreover,	multiple	lysogens	are	playing	important	role	in	the	dissemination	of	phage-encoded	genes	among	 the	 bacterial	 populations	 (Allison	 et	el,	 2003)(see	 	 1.3	 Temperate	 Phage	and	HGT,	chapter	1).	The	temperate	phage,	Φ24B,	confers	upon	its	host	the	ability	to	produce	Shiga	toxin.	It	has	been	suggested	that	the	presence	of	more	than	one	copy	of	Shiga	toxin	encoding	genes	(stxAB),	due	to	the	multiple	lysogens,	might	be	the	key	virulence	factor	behind	the	capability	of	Shiga-toxigenic	E.	coli	of	causing	a	variety	of	clinical	symptoms	and	sequelae	ranging	from	mild	diarrhea	through	to	life	 threatening	 conditions	 such	 as	 hemolytic	 uremic	 syndrome	 and	 thrombotic	thrombocytopenic	purpura	(Fogg	et	el,	2007).		
It	 has	 been	 reported	 that	 integrase	 cannot	 drive	 integration	 in	 the	 secondary	attachment	site	without	the	absence	of	the	primary	site	or	the	primary	site	being	occupied	by	a	resident	prophage	(Rutkai	et	al.,	2003).	In	order	to	confirm	or	reject	
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this	 hypothesis,	 we	 cloned	 all	 the	 different	 bacterial	 attachment	 sites,	 each	 in	separate	 compatible	plasmids,	 and	put	 them	all	 into	 in	 one	host	 cell	 along	with	two	 other	 plasmids	 carrying	 attP	 and	 the	 integrase	 gene,	 respectively.	 After	running	 the	 in	situ	 recombination	 assay	 for	 these	 host	 cells,	 total	 plasmid	 DNA	was	 harvested	 and	 qPCR	 was	 used	 to	 confirm	 the	 ability	 of	 the	 integrase	 to	catalyze	 recombination	 of	 attP	 with	 all	 of	 the	 bacterial	 attachment	 sites,	concurrently.		
	
Φ24B	 integrase	 expression	 is	 not	 controlled	 by	 the	 phage	 repressor,	 which	 is	different	 from	 Lambda	 repressor	 that	 is	 capable	 of	 completely	 shutting	 down	lambda	 integrase	 expression	 by	 turning	 off	 PL.	 The	 integrase	 from	 Φ24B	 is	expressed	continuously	as	the	integrase	genes	and	its	promoter	lie	in	the	opposite	direction	 to	 PL.	 Therefore	 each	 successive	 prophage	 integration	 results	 in	increased	 expression	 levels	 of	 the	 Φ24B	 integrase	 enzyme.	 This	 continuous	production	 of	 integrase	 protein	 leads	 to	 its	 intracellular	 accumulation	 in	 the	cytoplasm.	 Even	 though	 endogenous	 repressor	 is	 being	made	 from	 the	 resident	prophage,	 which	 may	 block	 the	 expression	 of	 genes	 associated	 with	 newly	infecting	 phages,	 the	 transacting	 nature	 of	 the	 integrase	 enzyme	will	 direct	 the	integration	of	the	infecting	phage	into	an	available	attB	site.	The	increasing	levels	of	trans	acting	integrase	in	multiple	lysogens	also	explains	the	increase	in	lysogen	forming	 frequency	 of	 superinfected	 lysogens	 compared	 to	 naïve	 host	 infection	(Fogg	et	al.,	2011).	Induction	can	still	occur	for	Φ24B	because	the	Xis	is	controlled	
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by	 PL,	 and	 will	 be	 expressed	 upon	 the	 RecA	 mediated	 autocatalysis	 of	 Φ24B	repressor	(Fogg	et	al.,	2011).		
We	determined	the	quantitative	recombination	events	of	each	bacterial	secondary	integration	 sites	 attByfnr, attByfbO and attBsgcA	 and	 compare	 it	 to	 the	 primary	attachment	site’s	recombination	formation	attBintS,	the	first	site	that	is	recognized	by	 the	 phage	 integrase	 protein.	 It	 is	 clear	 from	 our	 data	 that	 the	 quantitative	formation	 of	 double	 and	multiple	 plasmids	 recombination	 are	 significantly	 less	then	that	with	the	attachment	site	attBintS.	Nevertheless,	the	integration	formation	at	 supplementary	 attB	sites	were	 comparable	 to	 each	 other	 after	 14h,	 as	 there	was	no	significant	difference	among	them.		
	
The	presence	of	four	Φ24B bacterial	sites	in	plasmids	can	utilize	recombination	with	other	plasmids	having	phage	attachment	site	in	one	bacterial	cells	can	help	as	to	found	out	the	preference	of	each	supplementary	recombination.	It	has	been	reported	 that	 the	 primary	 attachment	 site	 attBintS	 has	 24	 bp	 sequence	 of	 100%	identity	with	Φ24B	attP,	so	without	any	doubt,	this	site	is	the	most	preferred	as	it	is	 recognized	 very	 fast	 by	 the	 integrase	 protein.	 The	 alignment	 supplementary	sites	 sequences	 to	 the	 primary	 attachment	 site,	 showed	 that	 the	 similarity	percentage	to	 the	attByfnr	 site	 is	62.4%,	while	site	attBsgcA	was	54%	similar	 to	site	
attBintS,	and	50%	similarity	for	site	attByfbO (Fogg	et	al.,	2011).	These	data	can	be	the	reason	behind	the	existence	of	attRL1	and	attRL2	within	just	5m.	And	this	is	giving	an	explanation	why	attRL4	always	coming	before	attRL3,	as	the	similarity	of	attBsgcA	
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site	 is	 slightly	 higher	 then	 that	 of	 attByfbO	 so	 it	 can	 be	 faster	 recognized	 by	 the	integrase.	It	is	also	clear	from	our	data	that	the	frequency	of	attRL2	recombination	was	clearly	 increased	from	its	starting	point	at	5	minutes	to	the	 final	 time	point	(14h)	 of	 the	 experiment.	 This	 confirms	what	 has	 been	mentioned	 before	 about	frequency	 increasing	 of	 lysogen	 formation	 during	 superinfection	 compared	 to	infection	of	naïve	cells	(Fogg	et	al.,	2011).	
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CHAPTER	6. GENERAL	DISCUSSION	AND	FUTURE	WORK		
6.1.	General	Discussion	
Temperate	phages	are	bacteriophages	that	have	the	ability	to	infect	bacterial	cells	and	replicate	in	one	of	two	pathways:	the	lytic	replication	cycle,	where	the	phage	uses	 the	 bacterial	 host’s	 machinery	 to	 produce	 new	 phage	 particles	 and	 that	finally	 leads	 to	 the	demise	of	 the	bacterial	host	 cell;	or	 the	 lysogenic	 replication	cycle,	where	 the	 phage	 can	 directs	 its	 integration	 into	 its	 host	 cell’s	 genome	 to	become	a	prophage.	In	the	lysogenic	pathway,	the	prophage	can	be	passed	along	to	 the	 next	 generation	 of	 cells	 like	 any	 other	 genetic	 loci.	 Prophages	 can,	 upon	some	 inducing	 signal,	 also	 be	 reactivated	 into	 the	 lytic	 cycle.	 It	 has	 been	 stated	that	temperate	phages	have	the	ability	to	introduce	additional	genetic	material	to	their	bacterial	host	(Saunders	et	al.,	2001).	These	genetic	materials,	according	to	several	genome	sequencing	studies,	have	the	potential	to	encode	virulence	factors	or	virulence-associated	traits	that	can	alter	and	enhance	the	pathogenic	profile	of	the	bacterial	host	(Creuzburg	et	al.,	2005).	The	phage	Φ24B	is	a	temperate	phage	belonging	to	the	lambdoid	family.	This	phage	is	a	converting	phage	contributing	to	the	 pathogenic	 profile	 of	 its	 E.	coli	bacterial	 lysogen,	 by	 enabling	 the	 lysogenic	host	to	produce	Shiga	toxin	(Allison,	2007).	
	
For	 the	 incoming	 phage	 to	 become	 a	 prophage,	 the	 phage	 encoded	 integrase	enzyme	 must	 be	 produced	 to	 direct	 prophage	 integration	 into	 the	 bacterial	chromosome	and	repressor	protein	must	be	produced	to	prevent	the	expression	of	the	lytic	cycle-associated	genes	(Serra-Moreno	et	al.,	2008).		
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Lambda	 Int	 requires	host	encoded	 IHF	 to	promote	DNA	recombination	between	attB	 and	 attP	 sites	 (Craig	 and	 Nash,	 1984).	 We	 started	 our	 experiments	 with	minimal	 lambda	 Int	 requirements	 for	 use	 in	 our	 in	 vitro	 recombination	 assay	development,	 as	Φ24B	 phage	 belongs	 to	 the	 lambdoid	 family	 of	 phages.	 We	considered	that	the	Φ24BInt	would	need	similar	requirements	and	factors	to	drive	integration.	 Before	 we	 performed	 the	 in	 vitro	 recombination	 assay,	 we	 had	 to	produce	all	 the	needed	components.	These	components	were	 the	Φ24B	attP	and	Φ24B	 attB	 sequences,	 purified	Φ24B	 integrase,	 and	 purified	 E.	 coli-encoded	integration	host	factor.	We	focused	on	optimizing	the	IHF	purification,		as	we	were	aimed	 to	 have	 a	 highly-purified	 IHF	 protein	 at	 a	 high	 concentration	 before	intiating	 a	 number	 of	 in	vitro	 assays.	 IHF	 is	 a	 small	 heterodimeric	 protein	 that	assists	 in	 a	 variety	 of	 DNA	 transactions	 via	 site-specific	 binding.	 A	 common	mechanism	 underlying	 the	 diverse	 array	 of	 processes	 affected	 by	 IHF	 DNA	bending	(Nash,	1990).		
	
We	aimed	in	this	study	to	fully	understand	how	Φ24BInt	mediates	integration	and	to	 define	 the	 required	 factors	 needed	 for	 this	 enzyme	 to	 function,	 which	 could	make	 it	 applicable	 to	 several	 biotechnological	 applications	 and	 genetic	engineering.	
	
Previous	 studies	 have	 demonstrated	 that	 experimental	 parameters	 required	 for	various	 site	 specific	 recombinases	 for	 in	 vitro	 recombination	 assays	 are	 not	
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always	 the	 same.	 Most	 serine	 recombinases	 can	 drive	 in	 vitro	 recombination	events	without	any	host	encoded	accessory	proteins	(Fogg	et	al.,	2014).	Φ24BInt	is	a	site-specific	recombinase	belonging	to	the	tyrosine	family	of	integrases.	With	the	exception	 of	 Cre,	 encoded	 by	 bacteriophage	 P1,	 most	 members	 of	 the	 tyrosine	family	 of	 recombinases	 require	 host	 encoded	 accessory	proteins	 to	mediate	 the	integration	(Groth	and	Calos,	2004).	We	considered	that	IHF	would	be	a	necessary	factor	 for	 Φ24B	 integrase	 mediated	 integration.	 However,	 we	 never	 detected	recombination	events	 in	our	 in	vitro	assay	without	the	addition	of	a	crude	E.	coli	cell	 extract.	 It	 was	 difficult	 to	 address	 why	 this	 was	 the	 case	 because	 our	 cell	extract	 was	made	 from	 a	 culture	 that	 overexpressed	 IHF.	 This	 over	 expression	strain	was	actually	the	same	strain	that	produced	IHF	tagged	with	a	poly	histine	tag	 for	 affinity	 purification.	 Therefore,	 further	 work	 was	 required	 to	 find	 out	whether	our	purified	IHF	protein	was	biologically	active	or	not,	or	whether	some	other	 unknown	 accessory	 protein	 needed	 by	Φ24BInt	 to	 drive	 recombination.	Moreover,	recombination	was	only	detected	in	the	in	vitro	assay	when	pattB	was	linearized,	a	phenomenon	reported	by	Frumerie	et	al.,	(2008),	who	demonstrated	that	the	use	of	linear	attB	DNA	fragments	with	supercoiled	attP	plasmid	and	IHF	was	necessary	to	facilitate	recombination	by	the	P2	integrase	enzyme	 in	vitro.	 In	the	 end,	 this	 assay	was	 cumbersome	 to	 perform	 and	 resulted	 in	 only	 a	 limited	amount	of	interpretable	data.	
	
There	 are	 many	 advantages	 to	 the	 use	 of	 an	 in	vitro	 assay	 to	 characterise	 site	specific	DNA	recombination.	An	in	vitro	assay	enables	fine	control	of	the	amounts	
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of	 the	 DNA,	 protein	 and	 enzymes	 used	 in	 the	 assay,	 and	 subsequently	 their	required	 concentration	 and	 ratios	 to	 each	 other	 can	 be	 determined.	 The	constituents,	 cofactors	 and	 pH	 of	 the	 reaction	 buffer	 can	 be	 controlled	 and	optimized	 in	 order	 to	 provide	 the	 appropriate	 condition	 for	 the	 integrase	 to	function.	 These	 advantages	 would	 enable	 very	 precise	 characterisation	 of	 the	conditions	 under	 which	 the	 integrase	 functions.	 	 An	 in	 vitro	 assay	 would	 also	enable	 association	 constants	 and	 timing	 of	 the	 integration	 reaction	 to	 be	determined.	 However,	 because	 recombination	 between	attB	 and	 attP	 sites	 was	never	detected	without	adding	cell	lysate	to	the	recombination	conditions,	a	more	reliable	assay	was	needed.	This	is	the	reason	that	made	us	move	to	develop	an	in	
situ	recombination	assay	instead.	The	benefit	of	an	in	situ	assay	is	that	we	do	not	need	to	be	worry	about	the	identification	and	purification	of	host	encoded	factors	required	 for	 Int	 activity,	 as	 the	 conditions	present	 in	 the	 cell	 are	 the	 conditions	under	 which	 Int	 normally	 functions	 (bacterial	 cell	 cytoplasm).	 However,	 in	situ	assays	provide	us	with	less	control	over	the	amount	and	ratios	of	DNA	substrates,	proteins	 and	 enzymes	 that	 participate	 in	 the	 integration	 reaction.	 Furthermore,	we	 need	 to	 extract	 the	 recombined	 DNA	 products	 at	 the	 end	 of	 the	 assay	 to	analyse	them.		
	
The	three	compatible	plasmids,	 in	situ	recombination	assay	enabled	us	to	define,	under	 the	 conditions	 tested,	 the	 minimal	 sequence	 length	 required	 to	 support	integration	 events	 for	 both	 attP	 and	 attB.	We	 determined	 that	 427	 bp	 of	 attP	sequence	 was	 the	 smallest	 tested	 fragment	 that	 could	 support	 integration	 for	
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Φ24B.	Though	this	site	is	larger	than	attP	for	lambda	phage	(250	bp),	it	is	similar	to	the	minimal	attP	site	identified	for	ICEclc	phage	of	Pseudomonas	putida	which	is	450	bp	(Miyazaki	and	van	der	Meer,	2013)	or	attP	site	identified	for	HP1	phage	of	
Haemophilus	influenzae	which	is	420	bp	(Hauser	and	Scocca,	1992).		Both	of	these	
attP	sites,	are	also	recognised	by	tyrosine	recombinases		and	have		similar	size	to	the	Φ24B	attP	site	(427	bp).	However,	we	did	not	examine	attP	sequence	lengths	that	were	between	351-426	bp,	therefore,	further	work	is	needed	to	more	exactly	define	the	Φ24B	attP	site.			
We	found	out	that	93	bp	of	Φ24B	attB	sequence	was	the	smallest	tested	fragment	that	could	support	the	integration	of	phage	genome	inside	E.	coli.	So	far,	this	is	the	biggest	attB	site	for	tyrosine	integrase.	This	site	is	very	much	larger	than	attB	for	lambda	phage	(21	bp).	 (Lewis	and	Hatfull,	2003),	reported	that	attB	 site	needed	for	 the	 phage	 L5	 integrase	 activity	 is	 29	 bp	 inside	 Mycobacterium	 smegmatis	chromosome,	which	is,	also,	smaller	than	the	Φ24B	attB	sequence.	All	other	well-studied	tyrosine	integrases	need	an	attB	site	less	than	that	size	(Fogg	et	al.,	2014).	On	the	other	hand,	integrases	that	belong	to	the	serine	family	of	recombinases	use	large	attB	sites	to	drive	DNA	recombination.	For	example,	the	minimal	sequence	length	 of	 attB	 site	 that	 R4	 phage	 needs	 to	 introduce	 its	 genome	 inside	
Streptomyces	 parvulus,	is	 64	bp	 (Olivares	 et	 al.,	 2001).	Nevertheless,	we	did	not	examine	 attB	 sequence	 lengths	 that	 were	 between	 83-92	 bp	 sizes.	 Therefore,	further	 work	 is	 needed	 in	 future	 to	 find	 out	 the	 defined	 size	 of	Φ24B	 attB	 site	needed	for	Φ24B	Int	activity.		
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We	demonstrated	that	host	encoded	IHF	(integration	host	factor)	is	not	necessary	for	Φ24BInt	activity.	Most	tyrosine	integrases	can	not	mediate	DNA	recombination	without	 the	 help	 of	 the	 IHF	 protein	 (Fogg	 et	 al.,	 2014).	 However,	 efficient	integration	 derived	 by	 P22	 phage	 integrase,	 which	 infects	 Salmonella	
typhimurium,	can	be	detected	even	in	the	absence	of	IHF	protein	(Smith-Mungo	et	al.,	 1994).	 However,	 we	 also	 demonstrated	 that	Φ24B	 Int	 requires	 some	 host-encoded	 accessory	 factor	 to	 drive	DNA	 integration.	DNA	 recombination	 derived	by	Φ24B	Int	 in	 the	 in	 vitro	 recombination	 assay	 (chapter	 3)	 did	 not	 take	 place	without	 the	 addition	 of	 fresh,	 crude,	 cell	 extracts	 to	 the	 reaction	 test	 tube.	Therefore,	further	work	is	needed	here	to	find	out	what,	within	that	cells	lysate,	is	necessary	for	Φ24B	Int	activity.		
The	 use	 of	 restriction-free	 cloning	 for	 most	 DNA	 cloning	 assays	 in	 this	 study	provided	a	simple	method	to	precisely	insert	a	DNA	fragment	into	its	appropriate	plasmid.	 In	 contrast	 to	 other	 methods	 that	 depend	 on	 DNA	 amplification,	 this	method	 does	 not	 need	 the	 subsequent	 cloning	 of	 the	 amplified	 insert	 or	restriction	 and	 phosphatase	 treatment	 of	 the	 plasmid	 vector.	 Instead,	 DNA	amplification	was	used	 to	 fuse	both	 insert	and	plasmid	vector	DNA.	The	cloning	reaction	 is	 easily	 monitored	 and	 optimised	 (Shevchuk	 et	 al.,	 2004).	 In	 general,	PCR	outcomes	were	poor	when	the	reaction	primers	fail	to	anneal	or	if	they	drove	non-specific	 priming.	 These	 poor	 outcomes	 were	 identified	 when	 empty	 lanes	were	viewed	in	the	analytical	agarose	gel.	Sanger	sequencing	was	done	to	confirm	the	 identity	of	all	products.	The	efficiency	of	 the	PCR	reaction	was	optimized	by	
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altering	amplification	parameters	(annealing	temperature,	extension	timings,	the	number	 of	 the	 PCR	 amplification	 cycles)	 and	 reagent	 concentrations	 (primers,	templates,	buffer	ingredients).	
		
The	 use	 of	 five	 or	 six	 compatible	 plasmids	 in	 the	 in	 situ	 recombination	 assay	systems	enabled	us	to	characterise	the	preference	and	timing	of	integration	in	the	secondary	 attB	 sites.	 We	 already	 knew	 that	 the	 lambdoid	 phage	Φ24B	 had	 the	ability	to	form	multiple	lysogens	(able	to	integrate	in	several	places	within	the	E.	
coli	genome).	We	also	knew	that	more	that	one	prophage	could	integrate	into	the	
E.	 coli	 chromosome	 and	 that	 these	 sequential	 integration	 events	 could	 actively	promote	 the	 integration	 of	 another	 prophage	 (Fogg	 et	 al.,	 2007).	 There	 is	 an	apparently	 intact	 lambda-like	 immunity	 region	encoded	within	 the	 	Φ24B	phage	genome	 (Koudelka	 et	 al.,	 2004,	 Fattah	 et	 al.,	 2000),	 with	 equivalent	 repressor	binding	affinities,	however,	this	region	does	not	provide	the	host	cell	immunity	to	integration	of	a	newly	 infecting	phage	 in	 the	manner	 in	which	 lambda	prophage	provides	 immunity	 to	 superinfection.	 The	Φ24B	 immunity	 region	 differs	 in	organization	 from	 bacteriophage	 lambda.	 The	Φ24B	 repressor	 CI	 binds	 to	 two	operators	only	in	pL	rather	than	three,	as	in	lambda.	However,	this	does	not	affect	the	lysogen	stability	or	repression	of	pL	promoter	transcription	in	the	phage	Φ24B	and	related	Shiga	toxin	bacteriophages	(Koudelka	et	al.,	2004).	Furthermore,	the	Φ24B	Int	 is	 located	 the	 same	 genomic	 region	 as	 in	 the	 lambda	 genome,	 but	 the	transcription	of	Φ24B	Int	lies	in	an	inverted	orientation,	and	that	makes	integrase	expression	outside	the	control	of	the	global	repressor	protein	CI.	Instead	Φ	24B	Int	
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expression	 is	 constituous	 during	 stable	 lysogens,	 leading	 to	 accumulation	 of	integrase	within	the	host	cytoplasm.	The	build	up	of	active	Int	in	the	cytoplasm	is	the	 reason	 behind	 the	 raised	 frequency	 of	 prophage	 integration	 with	superinfection	while	the	orientation	of	Xis	under	the	control	of	PL	enables	excision	of	the	prophage(s)	still	linked	with	induction	(Fogg	et	al.,	2011).		
	
The	 integration	 assay	 run	over	 various	 time	points	with	 cells	 harbouring	 either	five	 or	 six	 compatible	 plasmids,	 showed	 in	 situ	 recombination	 frequencies	 five	minutes	 after	 the	 induction	 of	 integrase	 expression	 into	 the	 most	 preferred	secondary	 bacterial	 site	 attByfnr	 utilised	 ~104	 fold	 fewer	 times	 than	 attB1.	 The	difference	in	utilisation	differed	only	by	a	factor	of	the	order	of	103	fold	less	than	
attBintS	14	hrs	post	expression	of	Int.	The	reason	behind	increased	recombination	frequency	is	likely	because	the	increase	of	Int	production	from	its	gene	during	the	time	course	experiment	from	its	starting	point	(Fogg	et	al.,	2011).	Usage	of	attByfnr	for	recombination	occurs	at	a	much	lower	frequency	that	it	does	for	attBintS.	This	appears	 to	 be	 due	 to	 the	 fact	 that	 attByfnr	 shares	 only	 62.5%	 identity	 to	 attP	sequence.	 This	 idea	 is	 supported	with	 the	 relationship	 between	attB	 identity	 to	
attP	and	the	usage	of	the	attB	site	for	recombination.	The	order	of	usage	is	attBintS,	
attByfnr,	attBsgcA,	and	attByfbO	at	100,	62.5,	52	and	50%	identity	to	attP,	respectively.		
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6.2	Future	Work		
6.2.1	Synthetic	Recombination	Vectors	
Synthetic	 biology	 takes	 a	 ground-up	 approach	 in	 the	 genetic	 engineering	 of	cellular	 systems	 capable	 of	 build	 novel	 biomolecule	 components,	 network	 and	pathways,	and	to	used	these	constructs	rewire	and	reprogram	biological	systems	(Khalil	 and	 Collins,	 2010).	 The	main	 goal	 of	 synthetic	 biology	 is	 to	 use	 tools	 to	make	 it	 easier	 to	engineer	and	preform	 increasingly	 complex	biological	 systems	when	 needed.	 The	 aim	 of	 this	 future	 work	 section	 is	 to	 describe	 the	 use	 of	synthetic	biology	to	exhaustively	determine	the	required	DNA	nucleotides	for	the	by	Φ24B	Int	activity.		
6.2.1.1	Integration	and	DNA	homology	
The	 importance	 of	 homology	 in	 DNA	 recombination	 driven	 by	 site-specific	recombinases	 has	 been	 discussed	 in	 several	 previous	 studies.	 Some	 studies	suggested	that	the	homology	of	the	DNA	strands	in	recombination	plays	a	role	in	the	 formation	 of	 the	 synapsis	 between	 to	 the	 strands	 to	 be	 recombined	 and	HJ	formation	 but	 not	 in	 the	 DNA	 strand	 migration	 or	 resolution	 of	 the	 HJ.	 They	proposed	 that	 the	 requirement	 of	 DNA	 homology	 affects	 the	 DNA	 interaction	during	synapsis	that	preformed	the	creation	of	a	four-strands	helix	(Kikuchi	and	Nash,	 1979,	 Nash	 and	 Pollock,	 1983).	 Nevertheless,	 in	 reactions	 promoted	 by	lambda	 integrase,	 attB	 and	 attP	 sites	 that	 shared	 an	 overlap	 region	 with	mismatches	 (3-4	 bp)	 on	 the	 right	 side	 of	 its	 sequence	 were	 able	 to	 produce	
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uncompleted	HJ	 intermediates	 as	 only	 one	 pair	 of	 DNA	 strand	 exchanges	 could	generate	 a	 joint	 molecule	 of	 Holiday	 structure	 type	 (Fig.6.1)	 (Kitts	 and	 Nash,	1987).	Experiments	carried	out	with	DNA	substrates	composed	of	half-attP	sites	comprised	of	either	P	or	P’	arm	sequences	and	the	heterologous	crossover	region,	demonstrates	 that	 sequence	mismatch	did	not	 affect	 the	production	of	 the	DNA	synapsis	production	or	even	the	initial	strand	exchange	event	(Nunes-Düby	et	al.,	1989).		
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Figure	6.1.	The	effect	of	DNA	sequence	homology	in	 the	lambda	attB	and	 attP	site	recombination	outcome	mediated	by	lambda	 Int.	A.	when	both	att	sites	share	an	overlap	region	with	complete	matching	sequence.	The	outcome	in	this	case	is	the	hybrid	attL	and	attR	sites.	B.	attB	and	 attP	 sites	 that	 shared	 an	 overlap	 region	with	 mismatches	 (Black	 DNA	 sequence)	 on	 the	 right	 side	 of	 attB	 sequence	 are	 able	 to	 produce	uncompleted	HJ	intermediates	as	only	one	pair	of	DNA	strand	exchanges	could	generate	a	joint	molecule	of	holiday	structure	type. The direction of 
resolution of the lambda Int-mediated HJs that has mismatches on the right side of the crossover region is backward to the parental products.	
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The	outcome	of	each	recombination	event	mediated	by	site-specific	recombinases	appears	 to	 be	 determined	 by	 the	 location	 of	 the	 sequence	 mismatch.	 In	recombination	mediated	 by	 lambda	 Int,	 HJ	 were	 observed	 to	 accumulate	 when	mismatches	were	 located	 in	 the	 right	 side	 of	 the	 core	 crossover	 region	 in	 attB	(Fig.6.1),	 however	 the	 results	were	 different	when	 the	mismatches	 occurred	 on	the	 left	 hand	 side	 of	 the	 core	 crossover	 region	where	 the	 first	 strand	 exchange	creates	HJ	(Kitts	and	Nash,	1987).	The direction of resolution of the lambda Int-
mediated HJs that has mismatches on the right side of the crossover region is backward 
to the parental products (de Massy et al., 1989).  
 
The role of sequence mismatch in the order of strand exchange governs the choice of 
secondary recombination sites into which phage lambda integrates. The first three 
nucleotides on the left side of the overlap region in all of the secondary attB sites are 
conserved. The remaining bases to the right are not conserved, probably because 
during phage integration into a secondary site, the HJ intermediates that are produced 
by first strand exchange are resolved by chromosome replication or by RuvC instead of 
Int (Rutkai et al., 2003). 
 
 If we examine the alignment of the	Φ24B primary and secondary bacterial attachment 
sites (Fig 5.1 Chapter 5), we can clearly recognized that the bases on the right side of 
crossover core in the secondary attB sites contain more sequence mismatches than are 
found to the left of the cross over core. If we flip the crossover region orientation of 
attP to the attB sites and/or do some modification in the sequence bases, we might see 
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similar recombination outcomes to those described for lambda phage, above. These 
sequence manipulations would define our understanding of the impact of sequence 
mismatches between attP and attB sites in the recognition and integration of Φ24B	phage	 genome	 in	 more	 than	 five	 different	 attB	 sites,	 as	 well	 as	 defining	 the	nucleotides	that	are	essential	for	Φ24B	Int	to	mediate integration. 
	
6.2.1.2	Gibson	Assembly	
Scientists	have	become	able	to	join	DNA	sequences,	for	nearly	four	decades.	This	allows	them	to	produce	DNA	segments	that	are	not	present	in	nature.	The	process	of	 cutting	 and	 rejoining	 DNA	 sequences	 is	 called	 recombinant	 DNA	 technology.	Recombinant	 technologies	 were	 initiated	 after	 the	 discovery	 of	 restriction	enzymes	and	DNA	ligase	(Gellert,	1967,	Smith	and	Wilcox,	1970).	In	2009,	Daniel	Gibson	 and	 his	 group	 developed	 an	 in	vitro	 recombination	 system	 that	 differed	from	 the	 older	 DNA	 cutting	 and	 ligation	 methods	 and	 involved	 ligating	 DNA	sequences	 a	 single	 isothermal	 reaction	 (Gibson	 et	 al.,	 2009)	 (Figure	 6.2).	 The	Gibson	system	requires	a	few	enzymes	to	mediate	the	DNA	combination	reaction	with	 minor	 manipulation.	 Three	 enzymes	 activities	 are	 required	 in	 Gibson	reaction:	an	exonuclease	(like	5’	T5	exonuclease),	a	DNA	polymerase	(like	Phusion	DNA	 polymerase,	 Biolabs)	 and	 a	 DNA	 ligase	 (like	Taq	 ligase,	 Biolabs).	 Up	 to	 15	DNA	 fragments	can	be	simultaneously	combined.	The	combination	between	 two	DNA	fragments	require	 them	to	have	~20-40	bp	overlap	at	 there	adjacent	ends.	These	 activities	 are	 sufficient	 to	 join	 DNA	 fragments	 as	 large	 as	 500	 kb.	 All	required	enzymes	and	reagents	are	commercially	available.				
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Figure	 6.2.	 Gibson	 assembly	
overview.	 A	 short	 region	 of	homology	 is	 created	on	 both	of	the	 DNA	 fragments	 (Black	region)	so	that	there	is	a	region	of	 complementarity	 shared	 by	both	 DNA	 fragments.	 The	 T5	exonuclease	 chews	 back	 the	 5’	ends	 in	 both	 fragments,	 which	allows	 the	 two	 different	fragments	 to	 anneal	 to	 each	other.	 After	 that	 the	 Phusion	DNA	 polymerase	 closes	 all	 the	gaps,	 and	 Taq	 DNA	 ligase	finishes	 the	 process	 by	 healing	the	 remaining	 nicks	 in	 the	sequences	(Gibson	et	al.,	2009).				
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An	 enzymatic	 master	 mix	 is	 produced	 from	 ('Isothermal	 Reaction	 (Gibson	Assembly)	 Master	 Mix,'	 2017).	 The	 cloning	 reaction	 is	 performed	 by	 the	incubation	 of	 the	 master	 mix	 with	 DNA	 fragments	 sharing	 regions	 of	complementarity	at	their	ends	at	50	°C	for	a	 few	short	minutes	(time	depend	on	the	 desire	 outcome	 and	 the	 enzymes	 and	 reagents	 requirements),	 which	simplifies	the	creation	of	biological	systems	using	small	constituent	parts.		
	
Exonucleases,	like	the	5′	T5,	are	enzymes	that	cleave	DNA	fragments	one	at	time	from	 the	 5’	 ends	 of	 a	 polynucleotides	 chain.	 The	 exonuclease	 activity	 (5’	 T5	exonuclease,	Epicentre)	results	in	the	production	of	single	stranded	regions	at	the	end	of	 the	desired	DNA	 fragments	 (Fig.	6.2),	which	can	anneal	 to	each	other	 for	the	 next	 step	 in	 the	 cloning	 reaction.	 The	 activity	 of	 DNA	 polymerase	 (Phusion	DNA	 polymerase,	 Biolabs)	 then	 adds	 nucleotides	 to	 fill	 in	 the	 gaps.	 Finally	 the	action	 of	 DNA	 ligase	 (Taq	 DNA	 ligase,	 Biolabs)	 joins	 the	 DNA	 sequences	 and	resolves	any	nicks	in	the	DNA	products	(Fig.	6.2)(Gibson	et	al.,	2009)	.	
	
There	 are	 two	kinds	of	Gibson	 assembly	 approaches:	 a	 one	 step	 assay	or	 a	 two	step	assay.	The	one	step	assembly,	is	used	for	assembly	of	up	to	5	different	DNA	fragments	using	a	single-step,	isothermal	process.	The	DNA	fragments	are	mixed	with	 the	enzyme	master	mix	before	 the	entire	mixture	 is	 incubated	at	50	°C	 for	one	hour.	For	the	construction	of	more	complicated	DNA	products,	composed	of	up	 to	 15	 DNA	 fragments,	 a	 two	 step	 Gibson	 approach	 is	 used.	 This	 process	
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requires	separate	additions	of	 the	relevant	enzymes	rather	 than	use	of	a	master	mix;	 the	 first	 enzyme	 addition	 is	 for	 exonuclease	 during	 which	 the	 5’	 end	 and	removed	and	the	annealing	step	occurs.	Then	the	DNA	polymerase	and	DNa	ligase	are	 added.	 Each	 step	 has	 different	 optimal	 incubation	 temperatures	 to	 perform	the	DNA	assembly	(Gibson,	2011).  
	
6.2.1.3	BioBricks		
BioBricks	 are	 DNA	 sequences	 that	 work	 a	 bit	 like	 wooden	 or	 plastic	 building	blocks.	BioBricks	are	used	to	assemble	larger,	synthetic,	biological	circuits.	These	building	parts	 have	 a	 defined	 structure	 and	 functions,	which	 enable	 them	 to	 be	incorporated	 into	 living	 cells	 to	 artificially	 construct	 new	 biological	 systems.	There	 many	 examples	 of	 these	 parts:	 ribosomal	 binding	 sites,	 promoters,	terminators	 and	 coding	 sequences.	 These	 functional	 parts	 can	 be	 combined	 in	novel	combinations	to	build	a	Device,	comprised	of	complementary	BioBrick	parts.	A	 collection	of	 devices	 can	 linked	 to	perform	as	 a	 higher	biological	 system.	The	reliability	of	synthetic	higher	biological	system	is	improved	because	of	the	ability	to	 test	 each	 individual	 biological	 part	 and	 each	 device	 (Shetty et al., 2008).	Every 
BioBrick part is currently a physical DNA sequence on a circular plasmid that is stored 
and distributed by the Registry of Biological Parts (http://www.partsregistry.org) 
(Sleight et al., 2010).   
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In	 order	 to	 perform	 these	 biological	 systems,	 several	 BioBricks	 assembly	standards	 can	 be	 used.	 The	 first	 BioBricks	 assembly	 standard	 was	 reported	 in	2003	 by	 Tom	 Knight	 (Shetty	 et	 al.,	 2008);	 it	 was	 called	 “standard	 sequence	assembly	of	BioBricks“.	However,	since	2003,	this	very	first	assembly	method	has	gone	 out	 of	 favour	 and	 many	 other	 assembly	 techniques	 have	 been	 reported	(Røkke	et	al.,	2014).		
	
The	 ability	 of	 the	 standard	 assembly	method	 to	 join	 two	 BioBricks	 depends	 on	their	sequences	via	 the	action	of	restriction	endonuclease	enzyme	digestion	and	ligation	 (Canton	 et	 al.,	 2008).	 The	 key	 innovation	 of	 the	 BioBrick	 assembly	standard	is	that	two	BioBrick	parts	can	be	assembled	together,	and	the	resulting	product	itself	can	still	be	considered	to	be	a	BioBrick	part	ready	to	be	joined	with	any	other	BioBrick	part.	The	BioBrick	assembly	standard	enables	a	collection	of	compatible	biological	parts	from	different	biological	sources.		
	
In	 contrast	 to	 the	 traditional	 ad	 hoc	 molecular	 approaches,	 this	 assembly	 is	amenable	to	optimization	and	most	importantly,	automation	(Shetty	et	al.,	2008).	All	 BioBricks	 components	 are	 flanked	 by	 short	 functional	 sequences	 known	 as	prefixes	 and	 suffixes.	 The	 prefix	 and	 suffix	 sequences	 are	 useful	 for	 joining	together	 two	 different	 BioBrick	 parts,	 as	 they	 contain	 restriction	 endonuclease	digestion	sites.	Different	assembly	standards	have	been	developed.	Each	proposed	assembly	has	 its	 specific	prefix	 and	 suffix	 (with	a	unique	digestion	 site)flanking	the	 BioBricks.	 The	 main	 goal	 of	 most	 assembly	 standards	 is	 to	 make	 BioBrick	
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fusions	of	protein	coding	domains	possible.	Stability	and	degradation	rates	of	the	fusion	 proteins	 are	 issues	 that	 have	 led	 to	 more	 recently	 proposed	 assembly	standards	(Røkke	et	al.,	2014).		
	
6.2.1.4	BioBrick	Standard	Assembly	
BioBrick	 Standard	 Assembly	 or	 Assembly	 standard	 10,	 was	 proposed	 by	 Tom	Knight	 in	 2007	 (Røkke	 et	 al.,	 2014).	 It	 is	 the	 most	 commonly	 used	 assembly	standard.	 Each	 BioBrick	 part	 is	 actually	 a	 DNA	 sequence	 carried	 by	 a	 circular	plasmid.	 The	 first	 step	 toward	 the	 BioBrick	 standard	 is	 the	 introduction	 of	 the	prefix	 and	 suffix	 sequences	 with	 their	 specific	 restriction	 enzymes	 sites	 (Voigt,	2011).	 In	 this	 assembly	 standard,	 BioBricks	 have	 one	 standardized	 suffix	while	one	of	two	types	of	prefix	can	be	used.	Which	type	of	prefix	depends	on	whether	or	not	the	BioBrick	is	a	protein-coding	sequence	or	not.	Both	prefixes	have	sites	that	can	be	recognized	and	cleaved	by	restriction	endonucleases	EcoR	I	and	Not	I.	The	non-protein	coding	prefix	has,	in	addition	to	these	two	sites,	a	site	utilizable	by	Xba	I.	The	Xba	I	site	present	in	the	protein-coding	prefix	is	fused	with	a	protein	coding	sequence	starting	with	ATG	(Røkke	et	al.,	2014).	Restriction	endonuclease	sites	that	are	present	in	the	suffix	sequence	are	recognized	by	Spe	I,	Not	I	and	Pst	I	enzymes	 (Radeck	 et	 al.,	 2013).	 The	 common	 method	 to	 combine	 two	 BioBrick	parts	 following	 the	 BioBrick	 Standard	 Assembly,	 is	 to	 digest	 the	 first	 BioBrick	using	 the	 restriction	enzymes	EcoR	 I	 and	Spe	 I.	The	 second	BioBrick	 is	digested	with	EcoR	I	and	Xba	I	(Fig.6.3)(Sleight	et	al.,	2010).		
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The	 two	digested	BioBricks	 then	both	possess	 sticky	 ends	 that	were	 created	by	
EcoR	I	and	can	be	easily	joined	together	to	restore	a	recognisable	EcoR	I	site.	On	the	 other	 hand,	 the	 sticky	 ends	 that	 were	 created	 by	 Xba	 I	 and	 Spe	 I	 are	compatible	 and	 can	be	 ligated	 together	 to	 produce	 a	 ligated	DNA	molecule	 that	will	 be	 a	 fusion	of	 the	 two	 restriction	 sites	 (Fig.6.3)	 (Liu	 et	 al.,	 2014).	This	new	DNA	sequence	 cannot	be	 recognized	by	Spe	 I	 or	Xba	 I.	 This	new	sequence,	now	called	 a	 scar,	 will	 be	 composed	 of	 the	 bases	 TACTAGAG	 in	 the	 cases	 when	 the	second	BioBrick	is	not	a	protein	coding	part	or	it	will	be	TACTAG	if	that	BioBrick	is	a	protein-coding	region	(Røkke	et	al.,	2014).		
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Figure	 6.3.	 A	 schematic	 diagram	 depicting	 the	 assembling	 of	 two	 BioBricks	 using	 BioBrick	 Standard	 Assembly.	 The	restriction	 enzyme	 that	 used	 to	 digest	 the	 first	 part	 (1)	 are EcoR I and Spe I, and that used for the second part (2) are EcoR I 
and Xba I. The digested DNA molecules are then ligated, producing a new BioBrick made up of the two initial ones. Here E, 
X, S and P denotes EcoR I, Xba I, Spe I, and Pst I, respectively. 	
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This	 commonly	 used	 assembly	was	 an	 example	 of	 BioBricks	 assembly	 standard	approaches;	other	approaches	are	BglBricks	assembly	standard	(Lee	et	al.,	2011),	Silver	 (Biofusion)	 standard	 and	 Freiburg	 standard	 (Røkke et al., 2014).	The	difference	among	them	is	in	the	the	prefix	and	suffix	sequences	and	the	restriction	sites	within	these	sequences.	
		
6.2.2.	Proof	of	concept:	synthetic	recombination	vector	assay	
In	 order	 to	 create	 a	 synthetic	 recombination	 assay	 and	 identify	 the	 essential	nucleotides	in	the	attB	sites	required	by	Φ24B	Int	to	promote	the	recombination,	we	 have	 design	 a	 vector	 that	 harbors	 both	 the	 attBintS	and	 attP	 sites	 facing	 in	opposite	 directions.	 These	 sites	 lie	within	 a	 synthetically	 produced	 fragment	 of	DNA	that	is	5271	bp	long.	The	full	description	of	this	synthetically	derived	DNA	is	
attP	(427	bp)	derived	from	Φ24B,	GFP	promoter	sequence,	the	full	gene	encoding	the	b-galactosidase	enzyme	(lacZ),	T7	terminator	sequence,		attBintS	(124	bp)	from	
E.	coli	strain	MC1061	and	a	promoterless	green	 fluorescent	 reporter	gene	 (GFP)	(Fig.	 6.4).	 The	 GFP	 reporter	 is	 placed	 within	 the	 vector	 so	 that	 it	 is	 expressed	following	a	recombination	event.	The	plasmid	backbone	for	this	synthetic	vector	is	the	high	copy	number	plasmid,	pCDFDuet,	which	has	a	spectinomycin	resistant	gene	as	a	 selectable	marker.	This	work	was	done	 in	 cooperation	with	Gene	Mill	within	the	Centre	for	Genomic	Research	at	the	University	of	Liverpool.	
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Figure	 6.4.	 The	 synthesized	 integration	
vector.	 The	 size	 of	 the	 entire	 vector	 is	 8593	bp.	 attBintS	 in	 this	 version	 is	 in	 forward	direction	 and	 its	 size	 is	 124	 bp	 (highlighted	with	gray	color	(attB1)).	attP	shown	here	is	in	the	 reverse	 direction	 and	 is	 427	 bp	(highlighted	 with	 gary	 color).	 GFP	 promoter	sequence	 presented	 with	 dark	 green	 color,	the	 lacZ	 gene	 with	 its	 own	 promoter	highlighted	 with	 pink	 color,	 T7	 terminator	sequence	 presented	with	 red	 color,	 and	 GFP	gene	 highlighted	 with	 yellow	 color.	 The	ligation	sites	are	labeled	with	light	green.	The	lacZ	gene	and	the	pCDFDuet	plasmid	provide	ample	 flexibility	 for	 recombination	 to	 occur	intramolecularly.	
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There	are	two	reasons	behind	the	use	of	the	lacZ	gene	in	the	synthetic	construct:	One,	 to	 provide	 enough	 flexibility	 in	 the	 DNA	 plasmid	 to	 enable	 intramolecular	recombination	 events;	 and	 two,	 to	 be	 able	 to	 screen	 for	 blue	 colonies	 after	 the	transformation	of	the	vector	into	cells	when	they	grow	on	a	media	containing	X-gal	(Fig.	6.2).		
	Since	the	start	point	of	this	work,	seven	vectors,	including	a	positive	control,	were	created	 in	 order	 to	 measure	 recombination	 events	 through	 the	 production	 of	green	fluorescence	cells	(Table	6.1).	After	the	production	of	each	plasmid,	it	was	transformed	 into	 Top10	 E.	 coli	 competent	 cells	 that	 already	 harbored	 the	 Pint	plasmid.	Cells	were	grown	overnight	for	in	situ	recombination	assays	(see	4.2.2.	In	
situ	 recombination	assay,	Chapter	4).	After	each	completed	assay,	 samples	were	taken	for	examination	by	fluorescence	microscopy.		
Figure	 6.5.	 Bacterial	 growth	 of	 Top10	 E	coli	 cells	 following	 transformation	 of	 the	
integration	vector.						
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Table	6.1.		The	recombination	vectors	that	we	created	for	synthetic	recombination	derived	by	Φ24B	Int.	
Vector	Version	 Vector	details	 The	recombination	assay	result			V1	 Int	test	V1,	attP-Rev.,	attB	–Fwd,	Wk	GFP	RPS	 Recombination	resulted	in	the	production	of	two	DNA	molecules	and	no	fluorescence.	V2	 Int	test	V2,	attP-Fwd.,	attB-Fwd,	Wk	GFP	RPS	 Recombination	resulted	in	the	production	of	two	DNA	molecules	and	no	fluorescence.	V3	 Int	test	V3,	attP-Fwd.,	attB-Fwd,	Str	GFP	RPS	 Recombination	resulted	in	the	production	of	two	DNA	molecules	and	no	fluorescence.	V4	 Int	test	V4,	attP-Fwd.,	attB-Fwd,	Str	GFP	RPS	 Recombination	resulted	in	the	production	of	two	DNA	molecules	and	no	fluorescence.	V5	 Int	test	V5,	attP-Rev.,	attB-Fwd,	Med	GFP	RPS	 Recombination	resulted	in	the	production	of	two	DNA	molecules	and	no	fluorescence.	V6	 Int	test	V6,	attP-Rev.,	attB-Fwd,	Str	GFP	RPS	 Recombination	resulted	in	the	production	of	two	DNA	molecules	and	no	fluorescence.	Positive		control	 Int	positive	control	V.,	attR.,	attL,	Str	GFP	RPS	 This	gave	very	nice	fluorescent	cells.	
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cell	 after	 recombination.	DNA	Recombination	was	 confirmed	 following	 recovery	of	 the	 plasmid	DNA	 from	 the	 cells	 and	 a	 PCR	 reaction	 using	attRL	primers.	 The	identity	 of	 the	 amplified	 bands	 was	 confirmed	 by	 Sanger	 sequencing.	Furthermore,	the	recovered	plasmid	DNA	was	transformed	into	new	Top10	cells,	grown	 on	 agar	 media	 containing	 spectinomycin	 (give	 final	 concentration)	 and	subjected	to	restriction	digest	with	Apa	I	to	confirm	if	it	was	a	single	molecule	of	the	right	size	(state	correct	size	here) (Fig. 6.3).  
	
		
Figure	 6.6.	 Recombination	 product	 following	 plasmid	 harvest,	 restriction	 enzyme	
digestion	and	electrophoresis	gel	 run.	Lane	1)	Result	of	 the	vector	 recombination	 that	resulted	 in	 two	 separate,	 DNA	 molecules,	 each	 molecule’s	 size	 ~	 4300	 bp	 during	recombination.	 Lane	 2)	 MW,	 Hyperladder	 1	 kb	 (Bioline)	 .	 Lane	 3)	 Result	 of	 the	 vector	recombination	 that	 resulted	 in	 one	 DNA	 molecule	 of	 the	 same	 of	 as	 the	 original	 vector	(8593	bp).	
											1																								2																								3	
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All	of	our	synthetic	vectors	were	capable	of	 supporting	recombination,	however	we	 were	 unable	 to	 detect	 fluorescence	 from	 the	 recombination	 product.	 The	result	 was	 either	 a	 recombination	 producing	 a	 single	 recombined	 plasmid	 that	should	 enable	 GFP	 expression,	 or	 recombination	 producing	 two	 circular	 DNA	molecules	(Fig.	6.8)	that	produce	white	and	blue	colonies	when	the	recombination	products	 were	 extracted	 from	 the	 cells	 in	 the	 in	 situ	 recombination	 assay	 and	transformed	into	new	competent	cells	(Fig.	6.7	A&B).		
	
	
	
Figure	6.7.	Bacterial	colonies	that	resulted	after	the	transformation	of	the	purified	
recombined	 vector	 to	 New	 Top10	 competent	 cells.	 A:	 Result	 of	 the	 vector	recombination	 that	 gave	 two	 separate	 DNA	molecules.	 One	 of	 these	molecules	 has	 the	antibiotic	marker	gene	and	the	other	has	the	LacZ	reported	gene,	the	white	colonies	are	for	cells	harboring	the	marker	gene	DNA	molecules	only	while	the	blue	cells	have	both	of	them	as	the	vector	backbone	is	the	high	copy	number	pCDFDuet	plasmid.	B:	These	unique	blue	colonies	are	performed	after	the	transformation	of	 the	positive	recombined	vector	that	gave	one	DNA	molecule.							
A	 B	A	 B	
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Figure	 6.8.	 A	 schematic	 diagram	explains	 the	recombination	events	 between	 attP	 (blue	 arrows)	 and	 attB	 (Red	 arrows)	 sites	within	 the	 synthesized	integration	vector.	The	results	that	we	got	was	either:	A	,	Recombination	gave	two	separate	circular	DNA	molecules,	B,	or	Recombination	resulted	to	a	one	molecule	recombined	vector,	and	this	is	the	right	way	of	recombination	that	should	allow	the	GFP	transcription.											
	
	
	
	
	
	 	
	
attB	
attP	
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B	
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Nevertheless,	we	were	so	closed	to	have	fluorescent	cells	from	the	recombination	as	the	positive	version	of	the	synthetic	vector	gave	so	nice	fluorescent	cells	(Pic,	6.4).	 Farther	work	 is	 needed	 to	 find	 out	why	 the	 GFP	 gene	 does	 not	 transcript	properly	 even	 with	 positive	 recombination.	 Using	 this	 assay	 for	 determine	 the	required	enucleated	for	the	by	Φ24B	Int	is	so	less	time	consuming	and	so	less	cost.		
		
Figure	 6.9.	 Positive	 control	 vector	 demonstrating	 the	 ability	 to	 capture	 integration	
events.	 The	 successful	 production	 of	 this	 vector	 will	 can	 be	 followed	 by	 the	 synthesis	 of	directed	mutations	in	all	4	attB	sites	to	identify	the	nucleotide	sequences	that	are	essential	for	recombination.			
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6.2.3	Necessary	Integration	Host	Factors		
Φ24B	Int	 is	 tyrosine	 recombinase,	most	 of	 tyrosine	 integrases	 can	 not	 drive	 the	phage	genome	 recombination	 in	 side	 the	host	 chromosome	without	 assistant	of	the	host	encoded	accessory	proteins.		
The	aim	of	this	future	work	is	to	identify	the	necessary	host	factor	or	factors	for	Φ24B	Int	directed	integration.	
	
6.2.3.1	Protein	fractionation	
Protein	 fractionation	 is	 a	 process	 or	 series	 of	 processes	 intended	 to	 isolate	 a	single	or	multiple	types	of	proteins	from	a	complex	mixture	of	proteins.	The	most	common	 approach	 used	 for	 protein	 fractionation	 is	 column	 chromatography	fractionation.	 In	which	 the	 solution	of	 the	proteins	mixture	 is	 passed	 through	 a	column	 containing	 a	 porous	 solid	matrix.	 This	 system	 uses	 Different	 extents	 to	retard	 different	 proteins	 by	 their	 interaction	 with	 the	 matrix,	 and they can be 
collected separately as they flow out of the bottom of the column.	 Proteins	 can	 be	separated	 depends	 on	 their	 size	(gel-filtration	 chromatography),	charge	 (ion-exchange	 chromatography),	hydrophobicity	 (hydrophobic	 chromatography),	or	their	 ability	 to	 bind	 to	 particular	 small	 molecules	 or	 to	 other	macromolecules	(affinity	chromatography)	(Wilson	and	Hunt,	2002)	
The	 size	 and	 subunit	 composition	 of	 a	protein	can	 be	 determined	 by	 SDS	polyacrylamide-gel	electrophoresis	(Zhang	et	al.,	2008a).		
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Other	 techniques	 can	 be	 used	 in	 protein	 fractionation	 are	 homogenization	(Schmidt	 et	 al.,	 2012),	 centrifugation(Siegel	 and	Monty,	 1966),	 fractionation	 by	precipitation	 using	 ammonium	 sulfate	 (Wingfield,	 2001)	 and	 ultra	 filtration	(Bonnaillie	et	al.,	2014).		
	
6.2.3.2	Proof	of	concepts	
Lambda	integrase	is	responsible	for	the	direction	of	lambda	phage	genome	inside	a	unique	site	in	the	bacterial	chromosome.	However,	this	protein	cannot	promote	its	function	without	presence	of	the	bacterial	encoded	DNA	binding	protein	IHF	or	Integration	 Host	 Factor(Craig	 and	 Nash,	 1984).	 As	 Φ24B	 Bacteriophage	 is	lambdoid	family	member,	we	considered	IHF	would	be	so	important	for	Φ24B	Int	for	 directed	 integration,	 as	 most	 of	 other	 family	 members.	 Therefore,	 we	performed	an	in	vitro	recombination	assay	with	purified	IHF	protein	and	Int	only	(see	 chapter	 3).	 This	 assay	 had	 not	 given	 any	 positive	 recombination	 until	 we	added	 a	 cells	 crude	 extract	 to	 the	 reaction	 tube.	 Furthermore,	 to	 confirm	 the	importance	 of	 IHF	 for	 Φ24B	 Int	 function	 in	 situ	 recombination	 assay	 was	performed	 in	 the	 	 	 JW1702-1 E	 coli	 cells	 that have a deletion mutation of the himA 
gene inside its genome (one of two IHF genes) (see chapter 4). The results showed that 
recombination was actually performed. The results of all these assays suggested there	is	 another	 bacterial	 host	 accessory	 factor(s)	 needed	 for	 the	 Φ24B	 integrase	 to	function	 as	 a	 site-specific	 recombinase.	 Therefore,	 further	 work	 is	 needs	 to	 be	performed	 to	 find	 out	 what	 is	 the	 necessary	 host	 encoded	 protein	 needed	 for	Φ24B	Int	to	promote	the	DNA	recombination.		
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